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The mitochondrial oxidative phosphorylation machinery is comprised by five individual 
complexes and arranged in supramolecular structures, so-called supercomplexes, as it is shown 
for complex I, III, IV and V. In yeast S. cerevisiae complex I is substituted by three singular 
NADH dehydrogenases and therefore lacks multimeric complex I. Thus, it displays a suitable 
model for investigating the dynamics within supercomplex formation of complex III and IV. 
Although some players could be identified so far, it is mostly unknown which factors contribute 
to forming these complexes (III2IV(1-2)). Besides, the mechanism behind re-/arrangement of the 
supercomplexes to adapt to different conditions such as changing oxygen levels remains 
obscure. 
 
The yeast Rcf-proteins (respiratory supercomplex factors) Rcf1, Rcf2 and Rcf3 were identified 
as proteins with partly corresponding homologous domains and can interact independently with 
complex III and complex IV. This is a unique feature promoting an important role of the 
protein family for recruiting and/or association of the two complexes. Furthermore, they could 
serve as regulator of complex IV and prevent from undesired ROS production but the exact 
localization and functional domains remained unknown. 
 
A crosslinking approach on isolated yeast mitochondria could identify the interacting site of 
Rcf2 and Rcf3 at the periphery of complex IV contrary to first suggestions for the association 
at the interface of complex III and IV. During this investigation we discovered a putative novel 
subunit of complex IV – Min8 – and proved it as being involved in complex IV biogenesis. For 
determining the functionality of the different domains of Rcf-proteins, artificial fusion proteins 
out of Rcf1, Rcf2 and Rcf3 were constructed and expressed in various mutational strains. The 
effects of those proteins were assessed by various experiments addressing the respiration, 
complex biogenesis and ROS production. While Rcf1 operates on both, complex IV and 
supercomplex assembly suggesting an even higher dynamic than originally anticipated, Rcf2 and 
Rcf3 are acting predominantly at the site of supercomplexes. At the same time, we discovered 
that the functionality of transmembrane regions of Rcf2 depend on the overall topology of the 
protein. By further studying the involvement of the respective protein domains in supercomplex 
assembly, we found an interesting interaction of Rcf2 and its processed versions at the site of 
complex III2 under alleged hypoxic conditions in a COX5A mutant. This suggests a specific 





1.1 The eukaryotic cell 
There are three main domains which comprise all living organisms: Bacteria and archaea, as 
single-cell micro-organisms also named as prokaryotes, and eukaryotes. The unique feature of 
eukaryotes and in parallel the main difference to prokaryotes, is that they harbor a nucleus and 
a variety of other membrane coated organelles, compartmentalizing the particular enzymatic 
functions within the cell (Nelson and Cox, 2009; Gabaldón and Pittis, 2015). This leads to the 
evolutionary advantage that cellular, maybe conflicting, processes are separated and protected 
by lipid bilayers. Specializing the respective organellar functions allows highly efficient processes 
which can be differentiated by investigating the organelles themselves (Nelson and Cox, 2009). 
This in turn, can give valuable information about molecular and biochemical mechanisms in 
order to gain insight into processes in different tissues which are connected e.g. to diseases, 
their treatment or response to xenobiotics. Consequently, it was a revolutionary development 
when subcellular fractionation was accomplished by differential centrifugation steps – first, to 
isolate mitochondria enriched fractions and later refined for further discrimination (Claude, 
1946; de Duve et al., 1955). 
1.2 Mitochondria – structure and function 
Mitochondria represent already an exceptional organelle by its unusual structure. They possess 
a double membrane which allows developing a proton gradient across the separate 
compartments, in the end essential for ATP synthesis. Studying isolated mitochondria became 
especially relevant since several conditions and diseases such as ageing, diabetes, 
neurodegenerative and cardiovascular diseases were associated with dysfunctional mitochondria 
(Schapira, 2006; Falabella et al., 2021). An important process also in this regard is the dynamic 
network of mitochondria, undergoing constant fission and fusion (Suárez-Rivero et al., 2016).  
The double-membrane of mitochondria and harboring an additional mitochondrial genome, led 
to the hypothesis that mitochondria originated from endosymbiosis of a-proteobacteria. 
Furthermore, it was postulated that the presence of mitochondria and by this increased 
availability of energy, enabled the development of large cells and higher complexity (Gabaldón 





Figure 1-1: Overview mitochondrial compartments.  
Mitochondria comprise four compartments: the outer membrane, the intermembrane space, the inner membrane and the 
matrix. The inner membrane possesses a large surface pronounced by invaginations called cristae, stabilized by cristae junctions, 
while the inner boundary membrane runs parallel to the outer membrane. The matrix houses the mitochondrial genome with 
the associated translation machinery. 
Four main compartments can be identified within mitochondria: the outer mitochondrial 
membrane (OMM), the intermembrane space (IMS), the inner mitochondrial membrane (IMM) 
and the mitochondrial matrix (Figure 1-1). While the OMM is permeable for small molecules 
and ions through porin channels, the IMM is impermeable for most small molecules, including 
protons (Benz, 1994). Consequently, specific transporters and mechanisms are required for 
translocating molecules into the matrix but also inversely – from the matrix into the IMS and 
cytosol. The IMS as hydrophilic interspace between OMM and IMM harbors soluble proteins 
including chaperones involved in protein import (Wiedemann and Pfanner, 2017). 
Embedded into the IMM lies the oxidative phosphorylation machinery (OXPHOS), comprising 
the respiratory chain complexes in addition to the ATP Synthase (ATPase). Characteristic for 
the protein-rich IMM is the large surface, accomplished by invaginations, subclassifying the 
membrane into the inner boundary membrane, cristae and cristae junctions which connect these 
domains. Responsible for stabilizing cristae junctions is the so-called MICOS (mitochondrial 
contact site and cristae organizing system) complex (Colina-Tenorio et al., 2020). It was also 
shown that this compartmentalization coexists with a distinct arrangement of the OXPHOS 
machinery in cristae while the translocase complexes reside at the inner boundary membrane 
aligned in parallel to the OMM (Vogel et al., 2006). 
The mitochondrial matrix harbors the mitochondrial genome and the intrinsic expression 
machinery. Additionally, all fueling metabolism pathways of the eukaryotic cell except for 
glycolysis take place within the matrix – citrate cycle, fatty acid b-oxidation, amino acid 





ATP synthesis is the most prominent function of mitochondria; it is the major source of energy 
for the cell. Nevertheless, the organelles are also involved in Fe-S protein maturation (Benz, 
1994), steroid synthesis (Miller, 2013), Ca2+ homeostasis (Romero-Garcia and Prado-Garcia, 
2019) and apoptosis induction (Wang and Youle, 2009) of the cell. Although we focus on the 
feature of the respiratory chain in this study, mitochondrial functions are quite divers and 
contribute to cellular maintenance by various essential mechanisms. 
1.3 Mitochondrial proteins – dual genetic origin 
Emerging from an endosymbiotic event, mitochondria transferred a large proportion of their 
genome into the nucleus. In parallel, an import system had to be established, ensuring the 
required supply of the mitochondrial proteins, now translated in the cytosol. However, 
mitochondria partly kept their own genome still encoding for 37 proteins in human and 
35 proteins in yeast Saccharomyces cerevisiae (S. cerevisiae) (Malina, Larsson and Nielsen, 2018). 
1.3.1 Mitochondrial encoded proteins 
From S. cerevisiae to human, the mitochondrial genome is conserved with only few exceptions 
and encodes for proteins of the electron transport chain and oxidative phosphorylation, 
22 tRNAs and 2 rRNAs, required for mitochondrial translation. S. cerevisiae lack multimeric 
NADH-Dehydrogenase (complex I), thus, genes encoding for subunits of complex I (in human 
ND1-6; 4L) are not present (Malina, Larsson and Nielsen, 2018). Expressed within yeast 
mitochondria is the ribosomal protein of the small subunit Var1 and ATPase subunit Atp9 
additionally to the conserved cytochrome c oxidase (complex IV) subunits Cox1, Cox2, Cox3; 
cytochrome bc1 complex (complex III) subunit Cob and ATPase subunits Atp6, Atp8 (Malina, 
Larsson and Nielsen, 2018). It is assumed that these core proteins remained under 
mitochondrial regulatory control in order to respond quickly to environmental changes (Allen, 
2015). 
1.3.2 Yeast mitochondrial import machinery 
The vast majority of mitochondrial proteins are translated on cytosolic ribosomes and need to 
be translocated through mitochondrial membranes. For this, specific import routes were 
developed which fulfill the responsibility transporting the diverse spectrum of mitochondrial 
proteins to their destination. These contain targeting signals stimulating the appropriate pathway 





Figure 1-2: Main import pathways for nuclear encoded mitochondrial proteins - overview.  
Precursor proteins carrying a presequence are translocated via TOM and TIM23 complexes, the presequence is cleaved by the 
peptidase MPP. Matrix protein import is driven by the Import motor PAM. Cysteine rich proteins are imported into the IMS 
via TOM and MIA. Carrier proteins are transported through the IMS by chaperones upon passing through TOM and handed 
to TIM22 complex for membrane insertion. Outer membrane proteins are inserted via MIM or TOM and SAM depending on 
their structure. 
Translocase of outer mitochondrial membrane – TOM. The translocase of outer 
membrane (TOM) represents the predominant entry gate for the precursor proteins (Figure 
1-2). Tom40 forms a channel through the OMM whereas Tom20, Tom22 and Tom70 represent 
specific receptors for presequence and non-cleavable precursors, respectively (Abe et al., 2000; 
Yamano et al., 2008; Wiedemann and Pfanner, 2017). The TOM complex forms certainly not a 
passive channel which allows passage through the OMM. In fact, it transports the proteins 
actively by hydrophobic and hydrophilic interplay (Hill et al., 1998; Shiota et al., 2015). According 
to the targeting signal the precursors are guided to the different compartments.  
 
Translocase of inner mitochondrial membrane – TIM23. Most mitochondrial proteins 
have a cleavable N-terminal presequence of various lengths, addressing the classical import 
pathway: the presequence pathway (Figure 1-2). Presequences contain an amphipathic a-helix, 
recognized by TOM receptors (Abe et al., 2000; Yamano et al., 2008). After passing TOM, the 
protein is handed over to the presequence translocase of the inner mitochondrial membrane 
(TIM23). Two subsequent pathways are covered by TIM23 which are membrane potential 
dependent: protein transport into the matrix or embedding into the IMM from the IMS side. 
Main constituents are the pore building protein Tim23, together with the close interactor Tim17 
INTRODUCTION 
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and the regulators Tim50 and Tim21, which is only involved in sorting TIM23 (Lytovchenko et 
al., 2013; Wiedemann and Pfanner, 2017). The proton motive force acts here by electrostatic 
effects on the positively charged presequence and by directly activating TIM23 via voltage 
dependent change of conformation (Martin, Mahlke and Pfanner, 1991; Malhotra et al., 2013). 
Subsequently, the presequence is removed by the mitochondrial processing peptidase (MPP) 
(Hawlitschek et al., 1988). Matrix proteins are translocated completely through the IMM with 
the help of the presequence translocase associated motor (PAM) in an ATP dependent manner. 
In contrast, IMM proteins using TIM23 are laterally released (sorted) with the help of a 
stop-transfer sequence and the membrane potential (van der Laan et al., 2007; Schulz, 
Schendzielorz and Rehling, 2015; Wiedemann and Pfanner, 2017). The hydrophobic sorting 
signal, in turn, can be cleaved by the inner membrane peptidase IMP and the protein is either 
released into the IMS or remains integrated within the IMM via additional transmembrane spans 
(Gakh, Cavadini and Isaya, 2002; Wiedemann and Pfanner, 2017). Interestingly, it was seen that 
sorting TIM23 interacts via Tim21 with complexes of electron transport chain, apparently 
promoted by the increased proton motive force in vicinity to the respiratory chain (reviewed in 
Schulz, Schendzielorz and Rehling, 2015). 
 
Oxidase assembly translocase – OXA. IMM proteins which need to be inserted from the 
matrix side make use of the oxidase assembly (OXA) translocase. This is the case for 
mitochondrial encoded proteins but also the combined interplay together with the TIM23 
presequence pathway was observed. The main component Oxa1 acts together with Mba1 on 
mitochondrial ribosomes facilitating co-translational protein insertion into the IMM (Ott and 
Herrmann, 2010). A cooperative import route with TIM23 is called the conservative sorting 
pathway. Here, IMM proteins are partly imported into the mitochondrial matrix by passing 
TIM23 with the help of PAM and subsequently exported by Oxa1 (Bohnert et al., 2010; 
Wiedemann and Pfanner, 2017). 
 
Carrier translocase of the inner mitochondrial membrane – TIM22. Mitochondrial 
metabolite carriers are highly hydrophobic IMM proteins. They do not contain a cleavable 
presequence and are directed via several internal targeting signals (Brix et al., 1999; Endres, 
Neupert and Brunner, 1999; Wiedemann and Pfanner, 2017). Chaperones increase the solubility 
and the carriers can be transported through the cytosol and IMS (Figure 1-2). Initially, it was 
proposed that all carrier have six transmembrane spans but the spectrum was recently extended 
to carriers with less transmembrane spans (Gomkale et al., 2020). After entry through TOM, the 
INTRODUCTION 
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protein is translocated through the IMS with the help of small TIM chaperones. Upon binding 
to the carrier translocase of the inner mitochondrial membrane (TIM22), the chaperones 
dissociate and the carrier is inserted into the IMM in a membrane potential dependent manner 
(Rehling, Brandner and Pfanner, 2004; Horten, Colina-Tenorio and Rampelt, 2020).  
 
Intermembrane space import and assembly machinery – MIA. Various IMS proteins form 
a disulfide bond via characteristic cysteine motifs (CX3C, CX9C) and are translocated along the 
mitochondrial intermembrane space import and assembly (MIA) pathway (Figure 1-2) 
(Chacinska et al., 2004). The precursors enter the TOM complex from the cytosol in a reduced 
state and Mia40 acts as a receptor from the IMS side. By utilizing its own redox-active cysteine 
pair, Mia40 establishes a mixed disulfide bond with the precursor which is transferred to the 
protein for correct folding. The factors Erv1 and Hot13 re-oxidize Mia40 for new substrate 
recognition (Mesecke et al., 2005; Fischer and Riemer, 2013). This pathway does not depend on 
the proton motive force of the inner membrane but solely on Mia40 and its the redox activity 
(Wiedemann and Pfanner, 2017).  
 
Import of outer mitochondrial membrane proteins. Most outer mitochondrial membrane 
proteins are b-barrel proteins. Upon entry through TOM and transport through the IMS with 
small TIM chaperones, they are folded and inserted into the membrane via the sorting and 
assembly machinery SAM (Figure 1-2). a-helical OMM protein import is accomplished via the 
mitochondrial import complex MIM, partly in cooperation with TOM. However, some 
tail-anchored OMM proteins seem to be embedded exclusively due to their hydrophobic feature 
(reviewed in Walther and Rapaport, 2009; Wiedemann and Pfanner, 2017). 
 
1.4 Oxidative Phosphorylation System 
The proton motive force of the inner mitochondrial membrane, as mentioned above, is the 
driving force of most protein import routes into mitochondria. It is built by a series of electron 
transferring redox reactions through the electron transport chain or respiratory chain, 
embedded in the IMM. However, key motivation is to drive the phosphorylating activity of 
ATP synthase to generate ATP – the universal energy resource of the cell (Rich and Maréchal, 
2010; Neupane et al., 2019). 
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1.4.1 Structure and function of the respiratory chain 
Catabolic pathways such as glycolysis, citrate cycle and fatty acid b-oxidation deliver electrons 
by channeling them to the universal electron carrier NAD+. In principle, electron transport 
through the respiratory chain is achieved by various redox reactions via enzymes containing 
flavin nucleotides, Fe-S centers, hemes and copper centers (Rich and Maréchal, 2010).  
The mammalian respiratory chain comprises four complexes: NADH dehydrogenase 
(complex I), succinate dehydrogenase (complex II), cytochrome bc1 complex or 
ubiquinol- cytochrome c oxidoreductase (complex III) and cytochrome c oxidase (complex IV) 
(Figure 1-3A). The complexes were found to associate with each other in so-called 
supercomplexes. Various formations in mammalian and yeast mitochondria involving the 
complexes I-III2-IV(1-4) and III2-IV(1-2), respectively, were obtained using mild detergents and 
native separation methods (see also section 1.5) (Schägger and Pfeiffer, 2000).  
 
 
Figure 1-3: Schematic overview of oxidative phosphorylation machinery in mammals and yeast.  
The mammalian oxidative phosphorylation system comprises the respiratory chain with complexes I-IV and complex V. 
Electrons enter via complex I and complex II, transferring them by a series of redox reactions. Co-enzyme Q and cytochrome c 
act as electron shuttles transporting the electrons from complex I and II to complex III and from complex III to complex IV, 
respectively. The terminal reaction is the reduction of oxygen to water, accomplished by complex IV. During electron 
translocation, protons are pumped across the IM, generating a proton gradient. The energy from the gradient and back-flow of 
protons through complex V drives ATP production. B) The yeast oxidative phosphorylation system functions similarly, except 
for the single NADH dehydrogenases (Nde1, Nde2, Ndi1) that substitute multimeric complex I. 
Yeast S. cerevisiae lack multimeric complex I. Instead, NADH is oxidized by single NADH 
dehydrogenases Nde1, Nde2 and Ndi1 without proton translocation through the IMM (Figure 
1-3B) (Grandier-Vazeille et al., 2001). Complex II represents the other direct electron entry of 
the respiratory chain. Coenzyme Q and cytochrome c serve as free electron shuttles, transferring 
the electrons to complex III and from complex III to complex IV, respectively. While 
coenzyme Q as a hydrophobic co-factor diffuses through the membrane, cytochrome c is 
soluble and binds to complex III and complex IV via IMS facing proteins. The cytochrome c 
oxidase is the terminal enzyme using the transported electrons for reduction of molecular 




complex I (in the mammalian system), complex III and complex IV. In the end, ATP 
production is driven by the back-flow of protons into the matrix through the F0F1-ATP synthase 
(complex V) (Figure 1-3) (reviewed in Rich and Maréchal, 2010; Nolfi-Donegan, Braganza and 
Shiva, 2020). 
1.4.2 Cytochrome bc1 complex 
The mitochondrially encoded cytochrome b (Cob) represents the conserved core of complex III 
and forms together with the nuclear encoded Rieske iron-sulfur protein Rip1 and cytochrome c1 
(Cyt1) the catalytic redox center of the cytochrome bc1 complex (Ndi et al., 2018). These core 
subunits are surrounded by the additional nuclear encoded proteins Cor1, Cor2, Qcr6, Qcr7, 
Qcr9 and Qcr10 in yeast (Mileykovskaya et al., 2012; Hartley et al., 2019). Complex III assembly 
is suggested to start with insertion of cytochrome b into the IMM and the other nuclear subunits 
are incorporated with the help of numerous assembly factors (Ndi et al., 2018). The complex 
exists only as a homodimer under in vivo conditions. The dimerization is reported to occur during 
early assembly independent from late-stage assembly proteins like Rip1 and Qcr10, whereas 
integration of the core subunits Cor1 and Cor2 appear to be crucial (Conte et al., 2015; Stephan 
and Ott, 2020). Mature complex III2 contributes to the proton gradient via the two-step Q-cycle 
(Mitchell, 1976). To this end, electrons derived from ubiquinol (reduced state of coenzyme Q) 
oxidation travel through complex III by reducing the active centers of cytochrome b and 
c1 (heme) and Rip1 (Fe-S cluster) while releasing protons to the IMS side. Terminally, 
cytochrome c1 (Cyt1) reduces cytochrome c (Cyc1) in order to transfer the electrons to 
complex IV (reviewed in Ndi et al., 2018; Zhao et al., 2019). Co-enzyme Q represents a 
two-electron donor, whereas the heme-groups of cytochrome b, c1 and c are single-electron 
acceptors. Although this two-step oxidation of ubiquinol increases the efficiency of proton 
transfer, it involves the possible danger of reactive oxygen species (ROS) production. It appears 
that the Q-cycle intermediate ubisemiquinone is a potential source of superoxide anions by 
reaction with molecular oxygen (reviewed in Turrens, 2003; Brand, 2010).  
 
1.4.3 Cytochrome c Oxidase – function and biogenesis 
Cytochrome c oxidase consists of three mitochondrially encoded core subunits (Cox1, Cox2, 
Cox3) plus 9 and 11 additional nuclear encoded structural subunits in yeast and human, 
respectively (Zong et al., 2018; Hartley et al., 2019). While Cox3 does not contain a catalytic 
center, Cox1 and Cox2 contain various active sites with two heme groups (a and a3) and two 
copper centers (CuA and CuB). Cytochrome c binds to Cox2 for electron transmission to Cox1 
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where oxygen is reduced in the final step by overall four electrons. The oxygen molecule and 
required protons for the reduction likely enter the complex through Cox3 while the released 
energy is employed for additional proton pumping into the intermembrane space (reviewed in 
Fontanesi et al., 2006). All intermediate products remain tightly bound to the complex in order 
to prevent insufficient electron transfer and undesired ROS production (Blomberg, 2016).  
 
In contrast to complex III as described above, complex IV harbors several mitochondrial 
encoded subunits. This results in a more complex assembly that has to be achieved by arranging 
both mitochondrial encoded and nuclear encoded subunits. It is envisioned that this occurs in 
a modular way, where first the co-factors are integrated into the active centers and some 
structural subunits are recruited specifically until the modules COX1, COX2, COX3 are 
assembled together into mature complex IV (Figure 1-4) (Herrmann and Funes, 2005; Mick, 
Fox and Rehling, 2011; Barros and McStay, 2020).  
 
 
Figure 1-4: Model – overview of yeast cytochrome c oxidase modular assembly.  
Transcription of mitochondrial encoded proteins Cox1, Cox2, Cox3 are initiated by various factors depicted in dark blue. 
Proteins essential for assembly or stabilization of the single lines are depicted in light blue. Structural subunits entering the 
assembly line are depicted as white boxes. The model represents the modules as they were shown to interact and found in 
intermediate complexes. ? indicate unsolved but probable assembly lines. The sequence of interactions is not completely 
resolved and the model does not claim completeness (modified after Mick, Fox and Rehling, 2011; Barros and McStay, 2020).  
Mitochondrial translation of yeast Cox1, Cox2 and Cox3 can be regulated by different mRNA 
activators that bind to the respective transcript. Pet309 interacts with Cox1 mRNA, Pet111 with 
Cox2 mRNA and Cox3 has three mRNA activators: Pet54, Pet122 and Pet494 (Herrmann and 




COX1 module. The information we have about the COX1 module is more profound 
compared to the other two, which can be reasoned by the number of involved factors and 
intermediate assembly states. This allows a better understanding of the different steps and the 
sequence of events. Besides Pet309, Mss51 is known to bind with COX1 transcript to control 
the translation (Decoster et al., 1990; Manthey and McEwen, 1995). Newly synthesized Cox1 is 
inserted into the IMM by Oxa1 and other insertases where it directly binds to the assembly 
factors Coa1, Coa3 and Cox14 (Mick et al., 2007; Pierrel et al., 2007; Mick et al., 2010). This 
complex recruits again Mss51 which remains bound upon further assembly. By this, Mss51 is 
withdrawn from activating Cox1 translation and is believed to ensure that hemylation and 
copper insertion only take place when other subunits are present (Barrientos, Zambrano and 
Tzagoloff, 2004). The intricate procedure of integration of the prosthetic groups is not 
completely resolved. Several accessory factors were shown to be involved in Cox1 heme 
maturation and copper insertion (reviewed in Barros and McStay, 2020). Mss51 dissociates from 
the maturating module to initiate a new cycle of Cox1 translation, whereas Cox14 and Shy1 
seem to remain associated (Mick et al., 2007). The first structural subunit to be associated with 
Cox1 is Cox5a/b. The protein is the only complex IV subunit present in two isoforms and 
expression depends on the oxygen status of the cell (see also 1.4.4). Cox6 and Cox8 are other 
structural subunits which are shown to interact within the COX1 module, while Shy1 acts as an 
assembly factor (Figure 1-4) (Mick et al., 2007; McStay et al., 2013).  
 
COX2 module. Maturation of Cox2 requires proteolytic processing. Upon insertion into the 
IMM, Cox2 is processed by the inner membrane protease Imp1, while Cox20 and Cox18 act as 
assisting factors (Tzagoloff et al., 2000; Elliott, Saracco and Fox, 2012). The integration of the 
binuclear CuA center is achieved by copper chaperones involving Sco1 and Coa6 (Lode et al., 
2000; Ghosh et al., 2016). No other structural subunit was found to interact with Cox2 prior 
interaction with Cox1 and Cox3 which could also be due to detergent lability reasons. However, 
Cox12, Cox26 and Cox9 could be possible candidates judged by their association in mature 
complex IV (Figure 1-4) (Franco et al., 2018; Hartley et al., 2019). 
 
COX3 module. Cox3 does not require co-factor insertion since it does not harbor prosthetic 
groups. The role of Cox3 for complex IV function is not completely resolved since it is not 
directly involved in electron transport. However, it was reported that it influences the proton 
uptake, stabilizes complex IV and protects the active sites during oxygen reduction (Tiranti et 
al., 2000; Gilderson et al., 2003; Varanasi et al., 2006). Several phospholipids are integrated into 
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the structure of Cox3, suggested to promote the influence on Cox1 (Tsukihara et al., 1996; 
Shinzawa-Itoh et al., 2007; Hartley et al., 2019). 
Furthermore, Cox3 was shown to interact with the structural subunits Cox4, Cox7 and Cox13 
prior to complex IV assembly (Su, McStay and Tzagoloff, 2014). Rcf1, first connected with 
supercomplex assembly (see also section 1.5) seem to play a role in Cox3 module maturation 
since it interacts with newly synthesized Cox3 (Figure 1-4)  (Chen et al., 2012; Strogolova et al., 
2012). Although not essential for complex IV biogenesis, it seem to facilitate the modular 
assembly and acts as a lipid chaperone for Cox3 (Chen et al., 2012; Vukotic et al., 2012; 
Strogolova et al., 2019). However, the sequence of subunit associations as it could be shown for 
Cox1 module is still elusive.  
 
Overall, the final association and chronology of module association is not resolved completely. 
It was hypothesized that the single modules maturate in separate pathways until they merge to 
holo-complex IV. However, the structural subunit Cox4 was discovered to interact also with 
Cox1 in early stages of complex IV maturation (Mick et al., 2007; Su, McStay and Tzagoloff, 
2014). Other structural subunits like Cox9, Cox12 and Cox26 (Hartley et al., 2019) in contrast, 
could not be proven to associate with a specific module prior to maturation. It was be 
envisioned that Cox1 is the first module to be assembled due to undergoing less frequent 
turnover than Cox2 or Cox3 (McStay, Su and Tzagoloff, 2013).  
 
1.4.4 Cytochrome c oxidase - oxygen sensitive subunits 
As mentioned before, the structural subunit Cox5 exists in two iso-forms. Expressed from two 
different genes, both proteins possess 66 % similarity (Cumsky et al., 1987). Their expression 
level depends on the oxygen status of the cell – while Cox5a is the predominant isoform under 
normoxia, Cox5b is expressed under hypoxia (Hodge et al., 1989; Zitomer, Carrico and Deckert, 
1997; Fontanesi et al., 2006). Similarly, the mammalian homologs Cox4i-1 and Cox4i-2 are 
regulated inversely by the availability of oxygen (Fukuda et al., 2007). Although both homologs 
share this characteristic expression control, the cellular mechanisms of sensing oxygen differ 
fundamentally (reviewed in Trendeleva, Aliverdieva and Zvyagilskaya, 2014).  
Mammalian cells process the information of low oxygen supply by the specific hypoxia inducible 
factor HIF. Adaptation to hypoxia is mediated post-translationally on the level of HIF protein 
stability (Semenza, 2007). The factor represents a heterodimer of oxygen sensitive HIF-a and 
constitutive HIF-b subunits. While HIF-a is degraded rapidly under normoxia, the responsible 
ubiquitin-proteasome is restrained under hypoxia. This leads to accumulation of HIF that 
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subsequently translocates into the nucleus and upregulates respective hypoxia specific genes. In 
parallel it is suggested that the protease LON helps with Cox4i-1 degradation to facilitate the 
subunit exchange (Fukuda et al., 2007). In contrast, yeast oxygen sensing utilizes the indirect and 
oxygen dependent pathway of heme biosynthesis. Under aerobic conditions, accumulated heme 
activates the transcription factors Hap1 and supposedly Hap2/3/4/5. The Hap2/3/4/5 
complex promotes COX5a transcription while Hap1 acts on ROX1 transcription. Rox1, in turn, 
is a transcriptional repressor of COX5b resulting in Cox5a being the prevalent isoform. In case 
of dropping oxygen levels, the Hap proteins are not active due to restricted heme synthesis. 
Consequently, COX5b transcription is de-repressed and its protein isoform dominates 
(Zitomer, Carrico and Deckert, 1997; Kwast, Burke and Poyton, 1998; Trendeleva, Aliverdieva 
and Zvyagilskaya, 2014). Other proteins connected with the respiratory chain that have a 
hypoxic counterpart and are controlled similarly, are the electron carrier cytochrome c 
Cyc1/Cyc7 and the ADP/ATP carrier AAC2/AAC1/AAC3 (Zitomer, Carrico and Deckert, 
1997). 
 
Interestingly, Cox5a/b (and Cox4i-1/Cox4i-2) were suggested to be the first structural subunit 
interacting with Cox1 (Fontanesi et al., 2006; Mick et al., 2007; McStay et al., 2013; Richter-
Dennerlein et al., 2016). Thus, subunit exchange could occur at a very early stage of complex IV 
maturation. At the same time, recent studies showed, that Cox5a/b provide an essential physical 
link of complex IV to complex III2 in the supercomplex (see also section 1.5.1) (Hartley et al., 
2019, 2020; Rathore et al., 2019). 
 
1.5 Respiratory supercomplexes 
In today’s studies the association of the respiratory chain as supercomplexes is a well-accepted 
and thoroughly proven model. However, two opposing theories were first proposed for the 
state of respiratory complexes: the “solid state” and “fluid state” model (Lenaz and Genova, 
2007). According to the “solid state” model, the respiratory complexes associate into single 
supramolecular units. In parallel, co-enzyme Q and cytochrome c act as electron shuttles within 
one unit and do not exchange with other complex units (Chance and Williams, 1955; reviewed 
in Lenaz and Genova, 2007). In contrast to this stands the “fluid state” model where the single 
complexes are diffusing free and independent from each other. Thus, electron transfer would 
be coupled to diffusion kinetics while the redox reactions occur upon random collision. This 
was based on the finding that mammalian co-enzyme Q and cytochrome c show pool behavior 
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and the kinetics are saturated at certain concentrations of the electron shuttles (reviewed in 
Hackenbrock, Chazotte and Gupte, 1986; Milenkovic et al., 2017).  
 
Schägger and Pfeiffer (2000) then revealed biochemically that the respiratory chain of yeast and 
bovine mitochondria are arranged in supercomplexes. They established a protocol for resolving 
the association of respiratory supercomplexes by blue-native polyacrylamide electrophoresis 
(BN-PAGE). In this way, interactions between the complexes remain preserved which 
represented a fundamental leap in investigating the membrane embedded respiratory 
complexes. In particular, they showed that yeast complex IV was interacting almost entirely with 
complex III2 building a complex with one or two complex IV copies: III2IV and III2IV2 
(Schägger and Pfeiffer, 2000; Stuart et al., 2000). Analyzing bovine mitochondria, they could 
show that complex I was predominantly present in a supercomplexed state with complex III2 
(I-III2) and most complex IV was associated within I-III2-IVn complexes (Schägger and Pfeiffer, 
2000). Plenty of studies followed, showing similar results in different organisms (Schägger and 
Pfeiffer, 2001; Eubel, Jänsch and Braun, 2003; Stroh et al., 2004). These findings pointed 
towards the “solid” model to be true, although it was under debate if the isolation of 
supercomplexes is an artefact of using detergents and results in aggregation of the complexes. 
Consequently, it was a final evidence for in vivo existing supercomplexes, when cryo-tomography 
of both bovine and fungi mitochondria showed respiratory complexes being associated to 
supramolecular structures in a detergent free environment (Davies et al., 2018).  
Along this line, earlier published in-gel activity assays could prove that the supercomplexes 
represent active entities but also the free and non-assembled complexes were active as shown 
for complex IV in yeast (Acín-Pérez et al., 2008a). They also provided evidence for genuine 
supercomplex assembly by radioactive pulse labeling of mitochondrial encoded subunits 
followed by different chase timepoints. In the end, this data led to the suggestion of the 
“plasticity” model that imagines the respiratory chain complexes being present as both, single 
complexes but also supercomplexes – in a highly dynamic manner (Acín-Pérez and Enriquez, 
2014). By this, the two initially contradictory models were unified into one model while still 
appreciating the biochemical proof for the one and the other. In fact, it was experienced that 
the respiratory chain complexes respond to a higher demand of energy. Greggio et al. (2017) 
and Huertas et al., (2017) could show that the amounts of supercomplexes are increased in 
human and rat after exercise, respectively. This provides strong evidence that the respiratory 




1.5.1 Structure of respiratory supercomplexes 
In the recent years of the 21st century, various studies were focusing on the structure of the 
respiratory supercomplexes. Remarkable 3D cryo-electron microscopy (EM) data, often 
combined with embedding X-ray structures, were published in steadily increasing resolution. 
Structures of yeast supercomplexes III2IV(1-2) and mammalian I-III2-IV revealed the 
arrangement of the single complexes within the supramolecular association (Althoff et al., 2011; 
Dudkina et al., 2011; Mileykovskaya et al., 2012; Letts, Fiedorczuk and Sazanov, 2016). Even 
higher molecular weight complexes, so-called megacomplexes, of human mitochondria have 
been obtained (Guo et al., 2017). While complex I appears to serve as a possible scaffold for 
association with complex III2 and complex IV, it is lacking in yeast respiratory chain. Still, the 
singular NADH-Dehydrogenase (Ndi1) was found to interact with complex III, proposing a 
close association with the yeast supercomplex (Matus-Ortega et al., 2015; Linden et al., 2020).  
 
It was puzzling when Mileykovskaya et al. (2012) resolved the first 3D cryo-EM structure (24 Å 
resolution) of yeast supercomplex III2IV2 which showed a substantially different interacting site 
of complex IV than previous studies of bovine respirasome (Althoff et al., 2011; Dudkina et al., 
2011) and 2D analysis of yeast supercomplexes (Heinemeyer et al., 2007). Bovine complex IV 
was demonstrated to interact via its convex shaped side via COX6A (yeast Cox13) with 
complex III (Figure 1-5A) (Althoff et al., 2011; Dudkina et al., 2011; Letts, Fiedorczuk and 
Sazanov, 2016; Guo et al., 2017), and yeast complex IV appeared to associate via the opposite 
side, pointing towards an interaction between Cox5a/b and complex III (Figure 1-5B) 
(Mileykovskaya et al., 2012). Cryo-EM structures with considerably improved resolution of yeast 
supercomplex III2IV(1-2) (3.3-3.5 Å) provided the evidence that Cox5a is in direct contact with 
complex III subunits Cor1, Qcr6 and Cyt1 within the mitochondrial matrix and IMS, 
respectively (Hartley et al., 2019; Rathore et al., 2019). Furthermore, the data showed that Cox5a 
forms a conjunction to Rip1 and Qcr8 via cardiolipin within the IMM (Hartley et al., 2019). 
Considering that complex IV subunit Cox5 can be present in two forms (see also 1.4.4), they 
eliminated the possibility of mixed supercomplex populations by investigating the cox5b∆ strain. 
The subsequent study of Cox5b-containing supercomplexes displayed once more that the 
interface between complex IV and III2 is conserved between the two subunits (Hartley et al., 
2020). It was suggested that the difference between mammalian and yeast complex IV 
orientation relative to complex III2 depends on the presence of complex I. In fact, the conserved 
interacting site of complex III is occupied by complex I in mammalian structures, absent in 
yeast S. cerevisiae (Rathore et al., 2019). This could be indicative for advantageous channeling of 
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coenzyme Q bringing the catalytic centers of complex I and III in closer proximity to each 
other. At the same time, yeast cytochrome c appears to have a reduced electron transport length 
from complex III binding site of Cyt1 to the designated complex IV binding site of Cox2. 
Consequently, it was argued that the respiratory chain functionally adapted to more favorable 
arrangements in terms of efficient substrate usage (Rathore et al., 2019). 
 
 
Figure 1-5: Model – structure of mammalian and yeast respiratory chain complexes.  
A) The mammalian respiratory chain complexes associate to supramolecular structures, the most abundant complexes are 
complex I-III2 and I-III2-IV, the so-called respirasome. Complex IV associates via its convex side with complex III (Althoff et 
al., 2011; Dudkina et al., 2011). B) Yeast respiratory chain complexes associate to the supercomplexes III2IV2 and III2IV with 
the convex site of complex IV opposing the interaction side with complex III (Mileykovskaya et al., 2012; Hartley et al., 2019; 
Rathore et al., 2019). 
 
1.5.2 Function and biogenesis of respiratory supercomplexes 
To date, a plethora of studies provided valuable information about the existence and 
arrangement of the respiratory supercomplexes in various organisms and tissues (Schägger and 
Pfeiffer, 2000; Eubel, Jänsch and Braun, 2003; Reifschneider et al., 2006). However, a functional 
relevance could only be speculated. It was postulated that they could serve the purpose of 
substrate channeling since cryo-structures resolved cytochrome c bound to complex IV (Althoff 
et al., 2011; Mileykovskaya et al., 2012). It was argued that the respective active sites of 
complex I, III and IV which bind the electron shuttles cytochrome c and coenzyme Q are still 
too distant and allow free diffusion of the carriers (Althoff et al., 2011; Dudkina et al., 2011; 
Rathore et al., 2019). Furthermore, studies demonstrated a certain interdependency of single 
complex stability as shown for patient mutations affecting complex III or complex IV (Acín-
Pérez et al., 2004; Li et al., 2007). This could indicate that supercomplex assembly sustains the 
single respiratory complexes and might even facilitate the particular assembly as Moreno-Lastres 
et al. (2012) proposed for complex I.  
Due to the spatial proximity of active sites, it was also suggested that supercomplexes decrease 
the undesired release of ROS. As supported by a study of Maranzana et al. (2013), the 
supercomplex I-III2 protects from ROS production originating from complex I. Since 




data from Berndtsson et al. (2020) addressed the same proposition by specific disruption of yeast 
respiratory supercomplexes III2IV(1-2) by mutating the interacting protein Cor1. They could 
show that ROS production was not significantly different when the complexes were not 
interconnected. Yet, they provided valid evidence that the arrangement of supercomplexes 
offers kinetic advantage for the electron transfer and respirational activity is significantly 
decreased upon supercomplex disruption (Berndtsson et al., 2020). The increased amounts of 
supercomplexes measured after exercise further support the suggestion that this association 
results in a more efficient respiration and hence energy production (Greggio et al., 2017; Huertas 
et al., 2017).  
Besides supercomplex function, the mechanism behind supercomplex biogenesis is still 
obscure. It is under debate if there are single assembly lines of the complexes, first associating 
to holo-complexes followed by the assembly into supercomplexes (Acín-Pérez et al., 2008b; 
Moreno-Lastres et al., 2012; Guerrero-Castillo et al., 2017; Protasoni et al., 2020). This was 
supported by the above mentioned labeling experiments of Acín-Pérez et al. (2008) where they 
determined a time lag between complex and subsequent supercomplex assembly. Similar results 
were conducted when following complex I assembly after reversed treatment of inhibiting 
mitochondrial translation by chloramphenicol (Guerrero-Castillo et al., 2017). Moreno-Lastres 
et al. (2012) however, could show that complex I maturation occurs after supercomplex 
formation. This is further supported by data implying a specific role for complex III2 as a starting 
point for supercomplex assembly while serving as a platform for complex I and complex IV 
maturation. And this in turn, would point to the supercomplexes as important for overall 
respiratory chain complex biogenesis (Protasoni et al., 2020). 
 
1.5.3 Respiratory supercomplexes – assembly and stabilizing 
factors 
Although the role and function of the respiratory supercomplexes remains ill-defined, all 
theories have in common that they indicate an essential role in proper mitochondrial function. 
Given the high consistency in particles obtained by cryo-EM in different laboratories (Althoff 
et al., 2011; Dudkina et al., 2011; Mileykovskaya et al., 2012; Hartley et al., 2019, 2020; Rathore et 
al., 2019) and therefore largely uniform population of supercomplexes, it seems obvious that 
the coordination underlies a specific mechanism. Yet, not completely resolved, several 
proteins/factors were found to be involved in supercomplex assembly additionally considering 




Cardiolipin. The inner mitochondrial membrane is mainly composed of the lipids 
phosphatidylcholine, phosphatidylethanolamine and cardiolipin. The latter is found exclusively 
in mitochondria and was proven to be a key player in supercomplex stabilization (Zinser et al., 
1991; Schenkel and Bakovic, 2014; Rappocciolo and Stiban, 2019). 
However, it is discussed if cardiolipin is only responsible for supercomplex stabilization or if it 
takes part in the formation itself (Pfeiffer et al., 2003; Bazán et al., 2013). Several cryo-EM 
structures demonstrated that cardiolipin is integrated into yeast supercomplex III2IV(1-2) and 
recently it was even resolved at the interaction site between complex IV subunit Cox5 and 
complex III subunits Rip1 and Qcr8 (Mileykovskaya et al., 2012; Hartley et al., 2019, 2020; 
Rathore et al., 2019). Furthermore, the right balance between cardiolipin and 
phosphatidylethanolamine with the inner mitochondrial membrane appears to be important 
since they showed opposing features. Absence of phosphatidylethanolamine leads to a more 
stable supercomplex in yeast but causes similar defects in respiration and membrane potential 
(Böttinger et al., 2012). Defects in human cardiolipin synthesis cause heavily compromised 
mitochondrial structures and manifests in a disease called Barth syndrome. Patients with Barth 
syndrome suffer from multi-system disorder, first characterized as cardiac disease, emphasizing 
once more the physiological importance of supercomplex stability (reviewed in Clarke et al., 
2013). 
 
SCAF1 (COX7A2L). SCAF1 is expressed in higher eukaryotes and has no yeast homolog. It 
was first identified due to its high sequence similarity to COX7 isoforms, therefore the name 
COX7A2L (Lapuente-Brun et al., 2013). Further investigations characterized it as a possible 
assembly factor of supercomplexes containing complex III and complex IV, since it was only 
present in those but not the single complexes (reviewed in Lobo-Jarne and Ugalde, 2018). 
Although initially reported as stabilizing complex IV at the site of complex I (Ikeda et al., 2013; 
Lapuente-Brun et al., 2013), other studies argued that it is not essential for respirasome 
(I-III2-IVn) assembly (Pérez-Pérez et al., 2016). Only the association of complex III and 
complex IV appears to be affected. Lobo-Jarne et al. (2018) suggested that SCAF1 is involved 
in a check-point step of complex III assembly and furthermore demonstrated that knock-out 
cells did not suffer from dysfunctional respirasomes but delayed assembly. This lines up with 
various observations with mouse models expressing the putative non-functional shorter isoform 
(Mourier et al., 2014; Davoudi et al., 2016). Although this questions the physiological relevance 
for complex III2IV(1-2), it indicates that complex I is able to serve as a scaffold in the respirasome 
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but that the association between complex III and complex IV is favorable in terms of efficient 
supercomplex assembly and metabolic fitness (García-Poyatos et al., 2020). 
 
Coi1. Coi1 is conserved among fungi and was identified by Singhal et al. (2017) as a transient 
interactor of complex IV. Mutant strains display defective supercomplex assembly while heme 
insertion into Cox1 appears to be affected in parallel. Coi1 does not directly bind to heme or 
Cox1, yet, it seems to facilitate heme incorporation into complex IV (Singhal et al., 2017). 
Consequently, it is elusive if supercomplex assembly is directly affected. However, several 
complex III and complex IV subunits and the Rcf-proteins (see below) were found in its 
interaction spectrum indicating an involvement in supercomplex assembly and/or stabilization 
(Singhal et al., 2017). 
 
Rcf-proteins. Rcf1, Rcf2 and Rcf3 share homologous sequences among each other and were 
characterized as possible assembly factors of respiratory supercomplexes. All three proteins are 
independently interacting with complex III and complex IV, while predominantly associating 
via the supercomplex III2IV(1-2) in a substoichiometric manner (Chen et al., 2012; Strogolova et 
al., 2012; Vukotic et al., 2012; Römpler et al., 2016). Rcf1 appears to be involved in Cox3 modular 
assembly, however, it remains associated at the supercomplex and facilitates Cox13 and Rcf2 
association (Strogolova et al., 2012; Vukotic et al., 2012; Garlich et al., 2017). While supercomplex 
formation is not completely abolished in rcf1∆ but strongly affected, the idea of a true assembly 
factor was questioned (Chen et al., 2012; Vukotic et al., 2012; Strogolova et al., 2019; Dawitz et 
al., 2020). Rcf2 and Rcf3 in turn, were demonstrated to have overlapping roles in respect of 
complex IV regulation (Römpler et al., 2016). It was intriguing when Rcf2 was resolved in a 
recent cryo-EM structure of allegedly fully assembled hypoxic supercomplex III2IV arguing for 
a stoichiometric interaction under these conditions (Hartley et al., 2020). 
Rcf2 and Rcf3 are conserved among fungi, whereas Rcf1 possesses two mammalian homologs 
the hypoxia inducible HIGD1A and the constitutively expressed HIGD2A (Timón-Gómez et 
al., 2020b). HIGD2A was first reported as the functional homolog of Rcf1 and appears to be 
involved in COX3 module maturation and its assembly into complex IV (Chen et al., 2012; 
Vukotic et al., 2012; Hock et al., 2020). Nevertheless, Timón-Gómez et al. (2020a) recently found 
HIGD2A to be involved in supercomplex assembly, while it displays overlapping functions with 
HIGD1A in complex IV biogenesis. HIGD1A in turn, was demonstrated to play an additional 




1.6 Aims of this study 
Efficient mitochondrial respiration is the basis for generating a membrane potential among the 
inner mitochondrial membrane and by this, for a vast amount of mitochondrial operations, vital 
for the cell. The discovery of the arrangement as higher molecular respiratory supercomplexes 
(Schägger and Pfeiffer, 2000) was revolutionary and resulted in various attempts to explain their 
function. It appears that already small imbalances can cause e.g. dysfunctional respiration, 
uncontrolled ROS production, underlining the importance for proper regulation. In light of the 
plasticity model, supercomplex formation is a highly dynamic process, adapting to cellular 
demands by continuous change between single complexes and supramolecular structures (Acín-
Pérez and Enriquez, 2014). For this, biogenesis and organization of these associations are crucial 
analyses that have to be accomplished. Since there is a sophisticated interplay and dependency 
between mammalian complex I and complexes III and IV (Moreno-Lastres et al., 2012; 
Milenkovic et al., 2017; Lobo-Jarne and Ugalde, 2018), the yeast model system, lacking 
multimeric complex I, represents a perfect starting point for insights into the association of 
complex III and IV.  
Proteins which were demonstrated to be involved in yeast supercomplex assembly are the 
Rcf-protein family. While Rcf1 facilitates supercomplex assembly, Rcf2 and Rcf3 were reported 
to rather play a regulatory role (Chen et al., 2012; Vukotic et al., 2012; Römpler et al., 2016). 
Besides the interaction of Rcf1 with newly synthesized Cox3 (Strogolova et al., 2012; Garlich et 
al., 2017), the interacting sites of the Rcf-proteins were unknown at the beginning of this study. 
One major aim of this work was to identify the localization of the proteins within the respiratory 
chain in order to conclude interactors and specify their function. During this localization 
analysis, a so far uncharacterized protein Min8 (YPR010C-A) emerged as associated and was 
investigated for a basic characterization and influence on the respiratory chain. A cryo-EM 
structure, published in parallel (Hartley et al., 2020), revealed Rcf2 as a peripheral interactor of 
hypoxic supercomplex III2IV and helped us to validate our established data. In context of an 
oxygen dependent subunit exchange within complex IV, a potential involvement of Rcf2 was 
studied more in-depth. Additionally, the feature of the Rcf-proteins sharing partly homologous 
sequences, let us observe the respective properties of their domains. By constructing several 
fusion proteins originated from the Rcf domains and thorough analysis in regard of modulation 
of the supercomplexes, we were aiming for an understanding of the distinct roles of the protein 
regions. 
Conclusively, the Rcf-protein family and their respective domains are evaluated with respect to 
their role in supercomplex assembly, stabilization and regulation.  
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2 Material and Methods 
2.1 Material 
All standard chemicals in analytical grade for e.g. buffer preparation were purchased from 
Merck KGaA (Darmstadt, Germany), Carl Roth (Karlsruhe, Germany), Serva (Heidelberg, 
Germany) or Sigma Aldrich (now also Merck KGaA; Taufkirchen, Germany). DNA primers 
were synthesized by and ordered from Microsynth SEQLAB (Göttingen, Germany). 
Commercial kit systems (Table 2-1) were used as described in the manufacturer’s protocol. 
Special enzymes and reagents used in this study are listed in Table 2-2. 
2.1.1 Kit systems, enzymes and reagents 
Table 2-1: Kit systems used in this study. 
Kit system Supplier 
Fast Digest restriction enzymes Thermo Fisher Scientific 
Gene ruler DNA ladder mix 1kb Thermo Fisher Scientific 
KOD Hot Start DNA Polymerase Merck Millipore 
mMESSAGE mMACHINEÒ SP6 DNA Transcription Kit Invitrogen 
Precision Plus ProteinÔ All Blue  
Prestained Protein Standards 10-250 kDa 
Bio-Rad 
Rapid Ligation Kit Thermo Fisher Scientific 
TNT Flexi Translation Promega 
TNT Quick Coupled Transcription/Translation SP6 Promega 
WizardÒ PLUS SV Minipreps DNA Purification System Promega 
WizardÒ SV Gel PCR Clean-Up System Promega 
 
Table 2-2: Special reagents and enzymes used in this study 
Reagent/enzyme Supplier 
b-Mercaptoethanol Roth 
[35S]-Methionine Hartmann Analytic 
Acrylamide 4x crystallized Roth 
ADP Roche 
Agarose NEEO ultra quality Roth 
Ampicillin Roth 
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AmplexTM UltraRed Invitrogen 
ANTI-FLAG M2 affinity gel Sigma Aldrich 




Bis(sulfosuccinimidyl)suberate (BS3) Thermo Fisher Scientific 
Bovine serum albumin (BSA), essentially fatty acid free Sigma Aldrich 
Bromphenol blue Merck Millipore 
CNBr activated sepharose 4B GE Healthcare 
Complete supplement mixture MP biomedicals 
cOmplete, EDTA free protease inhibitor Roche 
Coomassie Brilliant Blue G250 Roth 
Coomassie Brilliant Blue R250 Roth 
Creatine kinase Roche 
Creatine phosphate Roche 
Cycloheximide Sigma Aldrich 
Digitonin Merck Millipore 
Dimethyl pimelidate dihydrochloride (DMP) Sigma Aldrich 
DTT Roth 
FLAGÒ peptide Sigma Aldrich 
FlexiÒ Reticulocyte Lysate System Promega 
G418 sulphate GE Healthcare 
GTP Sigma Aldrich 
Herring Sperm DNA Promega 
Horse radish peroxidase Sigma Aldrich 
IgG from human serum Sigma Aldrich 
IgG protein standard BioRad 
ImmobilonÒ-P PVDF Merck Millipore 
LiOAc Applichem 
Malate Sigma Aldrich 
n-Dodecyl b-D-maltoside (DDM) Sigma Aldrich 
N,N‘-Methylene-bisacrylamide, 2x crystallized Serva 
NADH Roche 
Nourseothricin Roth 
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Oligomycin Sigma Aldrich 
PEG maleimide, average Mn 3350 Sigma Aldrich 
PierceÒ ECL Thermo Fisher Scientific 
PierceTM Anti-HA Agarose Thermo Fisher Scientific 
PMSF Roth 
Powdered milk (Frema Reform) Heirler Cenovis GmbH 
Protein-A sepharose GE Healthcare 
Proteinase K, recombinant Roche 
Pyruvate Sigma Aldrich 
Röntgenfilm Blau RX-N Fuji 
RotiÒ-Quant Roth 
RotiphreseÒ Gel 30 (37.5:1) Roth 
Sodium azide Merck KGaA 
Succinate Sigma 
TEMED Roth 
TMPD Sigma Aldrich 
Trichloroacetic acid Roth 
Valinomycin Merck Millipore 
Zymolyase-20T Nacalai Tesque Inc. (Kyoto, 
Japan) 
2.1.2 Antibodies 
Polyclonal antibodies were generated in rabbit against C-terminal peptides, recombinant protein 
domains or recombinant whole protein (Gramsch Laboratories, Schwabhausen, Germany). 
Commercially purchased monoclonal antibodies and secondary antibodies used in this study are 
listed below in Table 2-3. Primary antibodies were used in diluted solutions with TRIS buffered 
saline with 0.1 % Tween 20 (TBS-T) supplemented with 5 % powdered milk. Secondary 
antibodies were used in a dilution of 1:10 000 in TBS-T. 
Table 2-3: Commercially available antibodies used in this study. 
Antibody Supplier 
a FLAG Sigma Aldrich 
a MTCO3 (Cox3) Abcam 
a HA Roche 
Goat a Rabbit HRP Dianova 
Goat a Mouse HRP Dianova 
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2.1.3 Oligonucleotides and plasmids 
Oligonucleotides used for sequencing, generating gene cassettes for deletion or tagging of 
proteins, cloning and primers used for generating DNA templates for subsequent transcription 
and translation were synthesized by Microsynth SEQLAB (Göttingen, Germany) and listed in 
Table 2-4. 
Plasmids used and generated in this study for expression in yeast and as templates for PCR, are 
listed in Table 2-5. The plasmids carrying the genes for fusion protein expression were generated 
following the procedures in sections 2.2.2.5 and 2.2.2.6. The corresponding open reading frames 
were first fused via PCR with overlapping primers in three consecutive PCRs by homologous 
recombination and then subcloned into the plasmid pRS416. 
 
2.1.4 Yeast strains 
S. cerevisiae strains used in this study are based on the wild-type strains YPH499 and 777-A3. 
The genotypes of the wild-type strains and the derivatives used in this study are listed in Table 
2-6. Not listed are the respective strains serving as a URA+ control carrying the empty plasmid 
pRS416. This is the case for Wt, rcf1∆, rcf2∆rcf3∆, rcf1∆rcf2∆rcf3∆, cox5a∆, cox5a∆rcf2∆. 
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Table 2-4: Oligonucleotides used in this study. 
Oligonucleotide Sequence Target/Function 
pBH1 5’- tat atc tag aAA GAC AAT GTT ATC ATG CCT TTG AAG A 
-3’ 
Forward primer to amplify RCF3 (-500 bp upstream) 
pBH2 5’- act aga tgg cat gcg tga cat TGT AGT TGA CCG GGA AGA 
GTT CAA AC -3’ 
Reverse primer to amplify RCF3 (without Stop), 
overlapping sequence with RCF1; creating Rcf3-Rcf1 
pBH3 5’- gtt tga act ctt ccc ggt caa cta caA TGT CAC GCA TGC CAT 
CTA GT -3’ 
Forward primer to amplify RCF1, overlapping sequence 
with RCF3 (without Stop); creating Rcf3-Rcf1 
pBH4 5’- tat aga att cCT CGC TTG ACC ATA TAG TAA ATT TG -3’ Reverse primer to amplify RCF1 (+500 bp downstream) 
pBH8 5’- act aga tgg cat gcg tga cat GTA CAT TGT AGC GTC GAA 
ATT GTT CGA G -3’ 
Reverse primer to amplify RCF21-83, overlapping sequence 
with RCF1; creating Rcf2N-Rcf1 
pBH9 5’- CTC GAA CAA TTT CGA CGC TAC AAT GTA Cat gtc acg 
cat gcc atc tag t -3’ 
Forward primer to amplify RCF1, overlapping sequence 
with RCF21-83; creating Rcf2N-Rcf1 
pBH10 5’- gtt tga act ctt ccc ggt ca acta caG GAT CCG GTT CCT CCT 
CGG A -3’ 
Forward primer to amplify RCF284-224; creating Rcf3-Rcf2C 
pBH11 5’- tcc gag gag gaa cgg gat ccT GTA GTT GAC CGG GAA GAG 
TTC AAA C -3’ 
Reverse primer to amplify RCF3 without Stop, overlapping 
sequence with RCF284-224; creating Rcf3-Rcf2C 
pBH12 5’- tat ata gtc gac CAT GTA TGT GTA GAT ATG TA -3’ Forward primer for amplifying RCF2 (-500 bp upstream) 
pBH13 5’- tat ata gag ctC CCT CGT CGT CCA CTG TTA TA -3’ Reverse primer for amplifying RCF2 (+500 bp downstream) 
pBH15 5’-tcc gag gag gaa ccg gat ccC ATT GTG CGA TGT TGG TGA 
GT--3’ 
Reverse primer to amplify promotor region of RCF2 + 
ATG, overlapping sequence with RCF284-224; creating Rcf284-
225 expressed under endogenous promotor 
pBH16 5’-act cac caa cat cgc aca atg GGA TCC GGT TCC TCC TCG 
GA-3’ 
Forward primer to amplify RCF2C + ATG, overlapping 
sequence with promotor region of RCF2; creating Rcf284-225 
expressed under endogenous promotor 
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pBH17 5’- tat aga att ctt aGT ACA TTG TAG CGT CGA AAT TGT TCG 
AGG-3’ 
Reverse primer for amplifying Rcf21-83 + STOP 
 
pBH23 5’- TTG GAG ACA GCA AAG GCA CCC GAG CAG GCG 
TGG AAA CAC ACG ATG cgt acg ctg cag gtc gac -3’ 
Forward primer for deleting PET494 
pBH24 5'- GAT GAT GAG TGT GAT TTG GGA GGT ACA TAT TTA 
CAT GTT TTA TTA atc gat gaa ttc gag ctc g -3’ 
Reverse primer for deleting PET494 
oMD555 5’- TAG CAT TAA CTT GTC TAT TTT TCT TTA TAT CGG 
TCT TGC AGT ATG cgt acg ctg cag gtc gac -3’ 
Forward primer for deleting MIN8 (-250 bp upstream) 
oMD556 5‘- CCC TAC AGG GCT TTC TTT TTT ATT GCA TGG TCT 
ATC ATC AGG TTC atc gat gaa ttc gag ctc g -3’ 
Reverse primer for deleting MIN8 (+250 bp downstream) 
oMD557 5’- CCA GAA TTA TCT AGT TTA GAT GAA GTC CTT GCC 
AAA GAT AAG GAT cgt acg ctg cag gtc gac -3’ 
Forward primer for tagging MIN8 
MVP72 5’- gat cga ttt agg tga cac tat agA TGT TTA GAC AGT GTG CTA 
AGA GAT ATG CA -3’ 
Forward primer to amplify Cox13 (+SP6) 
MVP73 5’- TTA ATC GTC GTG CTC GAT GTG CCT G -3’ Reverse primer to amplify Cox13 
SP6-Cox12 5’- gat cga ttt agg tga cac tat agA TGG CTG ATC AAG AAA ACT 
CTC CAC TAC AT -3’ 
Forward primer to amplify Cox12 (+SP6) 
Rv-Cox12 5’- CAT TTT TCG ATC CAG TCT AGG GGA CAT AAG -3’ Reverse primer to amplify Cox12 
 
Table 2-5: Plasmids used in this study. 
Name Purpose Features Marker Reference 
pFA6aHIS3MX6  PCR template for gene deletion by HIS3  HIS3 Amp Longtine et al., 1998 
pFA6aKANMX4 PCR template for gene deletion by KAN  KAN Amp Longtine et al., 1998 
pFA6NATNT2 PCR template for gene deletion by NAT  NAT Amp Janke et al., 2004 
27 
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pRS416 Yeast plasmid CEN URA3 Amp Sikorski and Hieter, 1989 
pYM2 PCR template for C-terminal 3HA tagging 3HA HIS3 Amp Janke et al., 2004 
FLAGRcf2 Expression of N-terminally FLAG tagged 
Rcf2 
FLAGRcf2 in pRS416 URA3 Amp Römpler et al., 2016 
Rcf1 Expression of Rcf1 RCF1 orf + promotor in pRS416 URA3 Amp This study 
Rcf2 Expression of Rcf2 RCF2 orf + promotor in pRS416 URA3 Amp Römpler, 2016; 
dissertation 
Rcf3 Expression of Rcf3 RCF3 orf + promotor in pRS416 URA3 Amp This study 
Rcf3-Rcf1 Expression of Rcf3-Rcf1 RCF3 orf + promotor + RCF1 orf in 
pRS416 
URA3 Amp This study 
Rcf2N-Rcf1 Expression of Rcf21-83-Rcf1 RCF21-83 orf + promotor + RCF1 orf 
in pRS416 
URA3 Amp This study 
Rcf3-Rcf2C Expression of Rcf3-Rcf284-224 RCF3 orf + promotor + RCF284-224 orf 
in pRS416 
URA3 Amp This study 
Rcf2N Expression of Rcf21-83 RCF21-83 orf + promotor in pRS416 URA3 Amp This study 
Rcf2C Expression of Rcf284-224 RCF284-224 orf + promotor in pRS416 URA3 Amp This study 
 
Table 2-6: Yeast strains used in this study. 
Strain Genotype Reference 
777-3A MATα, ade1 op1 Netter et al., 1982 
pet494∆ MATα, ade1 op1, pet494::KANMX6 This study 
YPH499 MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801 Sikorski & Hieter, 1989 
rcf1∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, rcf1::loxP Vukotic et al., 2012 
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rcf2∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, rcf2::HISMX6 Römpler et al., 2016 
rcf3∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, rcf3::HISMX6 Römpler et al., 2016 
rcf2∆rcf3∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, rcf2::KANMX4, rcf3::HISMX6 Römpler et al., 2016 
rcf1∆rcf2∆rcf3∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, rcf2::KANMX4, rcf3::HISMX6, 
rcf1::NATNT2 
Römpler, 2016; dissertation 
cox5a∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, cox5a::HISMX6 Römpler et al., 2016 
cox5b∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, cox5b::HISMX6 Rehling group collection #580 
cox5a∆rcf2∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, cox5a::HISMX6, rcf2::NATNT2 This study 
min8∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, min8::HISMX6 Linden et al., 2020 
Min8-HA MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, min8::min8-3HA-HISMX6 Linden et al., 2020 
min8∆rcf2∆ MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, min8::HISMX6, rcf2::KANMX4 This study 

























MATα, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, lys2-801, rcf1::loxP + [pRS416-RCF3-
RCF2C-(URA3)] 
This study 
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2.1.5 Instruments and Software 
Instruments which were utilized for conducting the experiments are listed in Table 2-7. Software 
for processing the data and finalize this work is listed in Table 2-8. 
 
Table 2-7: Instruments used in this study. 
Instrument Manufacturer 
AmershamTM ImageQuantTM800 GE Healthcare 
AmershamTM TyphoonTM Scanner GE Healthcare 
Bio Photometer Eppendorf 
Centrifuge 5424 Eppendorf 
Centrifuge 5424R Eppendorf 
Centrifuge Avanti J-26 XP Beckmann Coulter 
Centrifuge Sorvall Bios16 Thermo Scientific 
Curix 60 (developing machine) AGFA 
JA-10 (rotor) Beckman Coulter 
JA-20 (rotor) Beckman Coulter 
Nanodrop ONEC Thermo Scientific 
Oroboros 2k Oxygraph Series G Oroboros (Innsbruck, Austria) 
Potter S (dounce homogenisator) Sartorius 
SAFAS Xenius XC spectrofluorometer SAFAS (Monaco) 
SE600 Ruby system  Hoefer, GE Healthcare 
Storage Phosphor Screens GE Healthcare 
Thermomixer comfort Eppendorf 
Vacuum Gel dryer 3545 LTF Labortechnik 
Varian Cary Bio UV-Visible Spectrophotometer Varian 
Vortex Genie 2 Scientific Industries 
 
Table 2-8: Software used in this study 
Software Producer 
DatLab Version 6.0 Oroboros Instruments  
(Innsbruck, Austria) 
Fiji (ImageJ) Open Source; fiji.sc  
(Schindelin et al., 2012) 
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Geneious  Biomatters  
(Auckland, New Zealand) 
Illustrator CS6 Adobe Systems  
(San Jose CA, USA) 
ImageQuant TL GE Healthcare BioSciences AB 
(Uppsala Sweden) 
Microsoft Office 2011 Microsoft Corporation  
(Redmond USA) 
Photoshop CS6 Adobe Systems  
(San Jose CA, USA) 
Snapgene Viewer Insightful Science 
(San Diego CA, USA) 
The PyMOL Molecular Graphics System,  
Version 2.4.2 
Schrödinger, LLC 
(New York NY, USA) 
Zotero Open Source; Corporation for 
Digitial Scholarship  
(Vienna VA, USA) 
 
2.1.6 Buffers, Solutions and Media 
Buffers, special solutions and media used for the methods described in section 2.2 are listed 
below in Table 2-9. 
 
Table 2-9: Buffer and solutions used in this study. 
Buffer/Medium Ingredients and concentrations 
Blue-Native anode buffer 50 mM BIS-TRIS pH 7.0 with HCl 
Blue-Native cathode buffer 50 mM Tricine, 15 mM BIS-TRIS pH 7.0 with HCl 
Blue-Native gel buffer (1x) 66.67 mM 6-aminocaproic acid, 50 mM BIS-TRIS, pH 7.0 
with HCl 
Blue-Native sample buffer 5 % Coomassie Brilliant Blue G250, 
500 mM 6-aminocaproic acid, 100 mM BIS-TRIS,  
pH 7.0 with HCl 
Blue-Native solubilization 
buffer 
20 mM TRIS pH 7.4 with HCl, 1 mM EDTA, 100 mM 
NaCl, 5 % glycerol and 1 mM PMSF 
BN-PAGE resolving gel mix 4-16 % acrylamide/bisacrylamide (49.5 %/3 %), 1x BN gel 
buffer (see above), 0-20 % Glycerol 
BN-PAGE stacking gel mix 2 % acrylamide/bisacrylamide (49.5 %/3 %), 1x BN gel 
buffer (see above)  
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Coomassie Brilliant Blue 
destaining solution 
10 % HAc, 40 % ethanol 
Coomassie Brilliant Blue 
staining solution 
Coomassie Brilliant Blue R250, 10 % HAc, 40 % ethanol 
Crosslinking buffer 20 mM HEPES pH 7.5 with KOH, 100 mM NaCl 
DTT buffer 100 mM TRIS pH 9.4 using H2SO4, 10 mM DTT 
EM buffer 10 mM MOPS, 1 mM EDTA, pH 7.2 with KOH 
Homogenization buffer 600 mM sorbitol, 10 mM TRIS pH 7.4 using HCl, 
1 mM EDTA, 2 g/l BSA, 1 mM PMSF 
Import buffer 250 mM sucrose, 10 mM MOPS pH 7.2 with KOH, 80 mM 
KCl, 2 mM KH2PO4, 5 mM MgCl2, 5 mM methionine, 3 % 
fatty-acid free BSA 
IP solubilization buffer 20 mM TRIS (pH 7.4 with HCl), 80 mM NaCl, 0.5 mM 
EDTA (pH 8.0 with NaOH), 10 % glycerol, 1x cOmpleteTM 
protease inhibitor cocktail (Roche/Merck), 1 mM PMSF 
LB medium 1 % NaCl, 0.5 % yeast extract, 1 % tryptone 
PBS buffer 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM 
KH2PO4  
PEG buffer 100 mM LiOAc, 10 mM TRIS pH 8.0 with HCl, EDTA 
pH 8.0 with NaOH, 40 % PEG3350 
Respiration/ROS assay 
buffer 
225 mM sucrose, 75 mM mannitol, 10 mM TRIS pH 7.4, 
10 mM KH2PO4, 5 mM MgCl2, 10 mM KCl 
SDS running buffer 25 mM TRIS, 191 mM glycine, 0.1 % SDS 
SDS sample buffer (1x) 2 % SDS, 10 % glycerol, 60 mM TRIS pH 6.8 with HCl, 
1 % b-mercaptoethanol, 0.01 % bromphenol blue 
SDS-PAGE resolving gel 
mix 
10-16 % acrylamide/bisacrylamide (30 %, 37.5/1), 380 mM 
TRIS-HCl pH 8.8, 0.1 % SDS, 0-3.5 % Glycerol, 0-100 mM 
sucrose 
SDS-PAGE stacking gel mix 5 % acrylamide/bisacrylamide (37.5/1), 80 mM TRIS-HCl 
pH 6.8, 0.1% SDS 
SEM buffer 250 mM sucrose, 20 mM MOPS pH 7.2 using HCl, 
1 mM EDTA 
SORB buffer 100 mM LiOAc, 10 mM TRIS pH 8.0 with HCl, EDTA 
pH 8.0 with NaOH, 1 M sorbitol, pH 8.0 with HAc 
TAE buffer 40 mM TRIS, 20 mM acetic acid, 1 mM EDTA pH 8.0 
TBS-T 20 mM TRIS pH 7.5 with HCl, 62 mM NaCl, 
0.1 % Tween 20 
Transfer buffer 20 mM TRIS, 150 mM glycine, 0.02 % SDS, 20 % ethanol 
Translation buffer 600 mM sorbitol, 150  mM KCl, 15 mM potassium 
phosphate buffer pH 7.4, 20  mM TRIS pH 7.4 with HCl, 
3  mg/mL BSA, 4  mM ATP, 0.5 mM GTP, 
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6  mM α-ketoglutarate, 8  mM creatine phosphate, 0.1  mM 
methionine-free amino acid mix, 5  µg /mL cycloheximide, 
12,7 mM MgSO4, 256 µg/mL creatine kinase 
Tricine SDS anode buffer 0.2 M TRIS pH 8.9 with HCl 
Tricine SDS cathode buffer 0.1 M Tricine, 0.1 M TRIS, 0.1 % SDS, pH 8.25 with HCl 
Tricine SDS gel buffer (1x) 1 M TRIS, 0.1 % SDS, pH 8.45 
Tricine SDS-PAGE 
resolving gel mix 
10-18 % acrylamide/bisacrylamide (49.5 %/3 %), 1x Tris-
Tricine gel buffer (see above), 0-13 % glycerol 
Tricine SDS-PAGE stacking 
gel mix 
4 % acrylamide/bisacrylamide (49.5 %/3 %), 1x TRIS-
Tricine SDS gel buffer (see below) 
Urea buffer (for protein 
unfolding) 
8 M urea, 30 mM MOPS pH 7.2 with KOH, 50 mM DTT 
Urea SDS running buffer 50 mM Tris, 192 mM glycine and 0.1 % SDS 
Urea SDS-PAGE resolving 
gel mix 
30 % acrylamide/bisacrylamide (60 %/0.8 %), 5.4 M urea, 
680 mM TRIS-HCl pH 8.8, 8 mM NaCl, 0.09 % SDS 
Urea SDS-PAGE stacking 
gel mix 
9 % acrylamide/bisacrylamide (60 %/0.8 %), 3.6 M urea, 
100 mM TRIS-HCl pH 6.8, 0.12 % SDS 
YNB medium, 
SD/SG/SGal 
0.67 % YNB (-aminoacids), 0.07 % CSM (-relevant 
metabolite) with 2 % glucose/3 % glycerol/2 % lactate 
YPD/YPG/YPGal/YPLac 
medium 
1 % yeast extract, 2 % peptone, 2 % glucose/3 % glycerol/ 
2 % galactose/2 % lactate (pH 6.0 with KOH for YPLac) 
Zymolyase buffer 20 mM KPO4 pH 7.4, 1.2 M sorbitol, 0.57 g/l zymolyase 
 
2.2 Methods 
2.2.1 Working with Microorganisms 
2.2.1.1 Growth conditions for E. coli 
Using standard procedures, E. coli XL1 Blue was grown at 37 °C in lysogeny broth (LB) (Green 
et al., 2012). For selection, 0.1 g/l ampicillin was added. Same applied for using plates, 
supplemented with 15 g/l agar. Plasmid carrying E. coli were preserved as cryo stocks at -80 °C 
by adding 800 µl of liquid culture to 200 µl sterile 80 % glycerol. 
2.2.1.2 General handling and growth conditions for yeast 
The standard culturing of all yeast strains was obtained in YP medium (Table 2-9), 
supplemented with glucose (YPD), glycerol (YPG), galactose (YPGal) or lactate (YPLac; 
pH 6.0 with KOH), at a growth temperature of 30 °C and shaking at 160-220 rpm, unless it is 
mentioned otherwise.  
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For selection of antibiotic resistant strains (KANMX4, NATNT2), 200 mg/l G418 sulphate or 
100 mg/l nourseothricin, respectively, were added. Selective minimal media were used for 
selection for auxotrophic marker (HISMX6) or culturing of plasmid-carrying strains (URA), 
containing yeast nitrogen base without aminoacids (YNB), complete supplement 
mixture (CSM) lacking the relevant metabolite and glucose (SD), glycerol (SG), galactose (SGal) 
(Table 2-9). 25 g/l agar was added for casting plates. 
For strain preservation as cryo stocks, 800 µl of a liquid overnight culture in YPD or SD were 
added to 200 µl sterile 80 % glycerol and stored at -80 °C.  
In general, the maintenance of the genome is a high priority and the strains were freshly streaked 
from previously prepared cryo stocks for analysis. The strains were kept on plates for 1-3 weeks 
and restreaked if needed. 
2.2.1.3 Growth test 
For comparing the yeast growth in different media, the corresponding strain’s cells were 
cultured overnight in YPD or the appropriate selective minimal medium SD, diluted to an optic 
density (at 600 nm; OD600) of 0.5 and grown for 2 h. After thorough washing in sterile water, 
the cells were spotted in serial dilution (OD600 1-0.0001) on plates. As a fermentable carbon 
source, glucose and as non-fermentable carbon sources, glycerol or lactate were used. Plates 
were incubated at 30 °C, 25 °C and/or 37 °C for 2-5 days.  
2.2.1.4 Whole cell lysate preparation of yeast 
For analyzing the protein content of whole cells an appropriate amount of cell material was 
harvested either from plate or an equivalent amount from liquid culture (OD600 1.0). Cells were 
resuspended in cold 25 % trichloroacetic acid (TCA) (diluted with phosphate buffered saline, 
PBS) and incubated at -80 °C for 30 min for protein precipitation. After a washing with 80 % 
ice-cold acetone, pellets were dried at room temperature, finally resuspended in 0.1 M NaOH 
and 1 % sodium dodecyl sulfate (SDS) containing solution and incubated at 30 °C for at least 
15 min in a shaking motion. SDS-sample buffer was added and samples were subjected to SDS-
PAGE analysis, as described in section 2.2.3.2. 
2.2.1.5 Isolation of mitochondria 
Essentially, isolation followed previously described procedures (Meisinger, Pfanner and 
Truscott, 2006). Yeast was grown in YPG or SG (YPGal or SGal for respiratory defective 
strains) in at least two separate precultures prior to a 2 l mainculture, raised until an OD600 of 
1.0-4.0. Cells were harvested for 15 min at 4 000 rpm (Sorvall) and washed in water once 
(Beckmann-Coulter). Then, pellets were incubated for 30 min at 30 °C in 2 ml/g cell wet weight 
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(CWW) dithiotreitol (DTT) buffer (Table 2-9) and after a centrifugation of 4 000 rpm, 8 min, 
washed with 1.2 M sorbitol. In order to degrade the cell wall, cells were resuspended in 
7 ml/gCWW zymolyase buffer (Table 2-9) and incubated at 30 °C, 90 rpm for 1-2 h with allowing 
O2 supply. The resulting spheroblasts were spun down at 3 000 rpm for 8 min, washed again in 
100 ml cold zymolyase buffer without enzyme and resuspended in 7 ml/gCWW cold 
homogenization buffer (Table 2-9). Cells were opened with a cell homogenizer (potter) at 
900 rpm for 15 strokes on ice. The homogenate was first centrifuged at 3 000 rpm for 5 min, 
4 °C and the supernatant was subjected to an additional step of 4 000 rpm for 10 min, 4 °C. 
Crude mitochondria fraction was obtained by centrifugation at 12 000 rpm for 15 min, 4 °C and 
washed with SEM buffer (Table 2-9) with 1 mM PMSF. Finally, mitochondria were 
resuspended in SEM buffer, adjusted to a protein concentration 10 mg/ml using Bradford assay 
(see 2.2.3.1), frozen in liquid nitrogen and stored at -80 °C.  
2.2.2 Molecular biology methods 
2.2.2.1 Transformation of E. coli 
Competent E. coli cells (50 µl aliquot) were thawed on ice, mixed with 5 µl of ligation product 
or 100-200 ng plasmid DNA, incubated for 30 min on ice and underwent a heat shock at 42 °C 
for 1.5 min. After chilling down on ice again for 5 min, cells were resuspended in LB, incubated 
at 37 °C, 1 000 rpm for at least 1 h and finally plated on LB plates containing ampicillin (see 
2.2.1.1). Plates were incubated at 37 °C overnight. Single colonies were picked and transferred 
into liquid culture for further processing after section 2.2.2.2. 
2.2.2.2 Plasmid DNA isolation 
For purifying plasmids expressed in E. coli, 2 ml culture (see 2.2.1.1) was harvested and the 
Wizard® Plus SV Minipreps DNA Purification System (Promega) was used, following the 
manufacturer’s protocol. The isolated plasmid DNA was finally eluted with nuclease free water, 
concentration measured with the Nanodrop (Thermo Scientific) and stored at -20°C. 
2.2.2.3 Transformation of yeast 
Yeast transformation followed essentially the procedure after Knop et al. 1999 (Knop et al., 
1999). For preparing competent yeast cells, overnight culture, grown in YPD, was diluted to 
OD600=0.25, incubated again for ~3 h at 30 °C (until OD600=0.5-0.7) and harvested at 
2 000 rpm, 5 min. Pellet was washed with sterile water and SORB buffer (Table 2-9). After 
removing SORB buffer, cells were resuspended in 360 µl SORB buffer per 50 ml culture and 
40 µl herring sperm carrier DNA (previously heated at 95 °C, 10 min, put on ice). Competent 
cells were aliquoted into 50 µl and were either stored at -80 °C, without shock freezing, or 
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subsequently used for transformation. Depending on the desired transformation, 1-5 µl of 
plasmid DNA or 10 µl of PCR product were added to the competent cell mixture followed by 
the 6-fold volume (300 µl) of PEG buffer (Table 2-9), incubated for 30 min at room 
temperature, until DMSO was added to an end concentration of 10 % and heat shock was 
performed at 42 °C, 15 min. After centrifugation (4 000 rpm, 5 min), cells were resuspended in 
fresh YPD and either spread directly on selective plates in case of auxotrophic marker genes, or 
incubated for another 2 h at 30 °C in case of antibiotic resistance genes before spreading. 
Colonies were picked after 3-7 days, and streaked again on selective plates before single colonies 
were tested for expression and used for further experiments. 
2.2.2.4 Yeast genomic DNA isolation 
Yeast genomic DNA is isolated from a 20 ml overnight culture, harvested at 2 000 rpm, 10 min. 
Cells are resuspended in 1 ml DTT buffer (Table 2-9), incubated at 30 °C, 30 min, 750 rpm and 
washed with 1 ml zymolyase buffer (Table 2-9) without enzyme before incubation with 1 ml of 
the same buffer, enzyme added, at 30 °C, 1 h, 750 rpm, allowing O2 supply. The spheroblasts 
are spun down with 4 000 rpm, 10 min and DNA is solubilized with 0.1 M NaOH, subsequently 
diluted to 33 mM NaOH. An incubation at 100 °C for 5-10 min followed and samples were 
chilled down on ice. Precipitates were spun down at 13 000 rpm, 10 min, 4 °C, the supernatant 
was transferred and diluted with water 1|100-1|1000, concentration was measured using the 
Nanodrop (Thermo Scientific), and stored at -20 °C.  
In cases of simple confirmation analysis, small amounts of yeast cell material were scraped from 
plate and microwaved for 1 min before subjected to polymerase chain reaction, as described 
below in 2.2.2.5.  
2.2.2.5 PCR 
Polymerase chain reaction (PCR) was performed for amplifying DNA segments from plasmids, 
genomic DNA or previous PCR products by using KOD polymerase (Novagen) following the 
manufacturer’s protocol. Recommended cycling conditions were adjusted for improving the 
yield. Polymerase activation was achieved by incubation at 95 °C, 5 min and depending on the 
appropriate primer pair (listed in Table 2-4), the first 10 cycles were performed as it follows: 
Denaturation at 95 °C, 20 s, annealing at 52-58 °C, 10 s and extension at 70 °C, 15-25 s/kb 
depending on target size. The following 25 cycles ran with a reduced annealing temperature of 
46-52 °C, 10 s, and extension was completed with 70 °C, 2 min. Analysis and separation of the 
PCR fragments was accomplished, after adding 1x loading dye (Thermo Scientific), by 
horizontal agarose gel electrophoresis (1.5 % agarose, 1x ROTIâGelStain in TAE buffer; 
BioRad chamber) at 120 V for 20-30 min. With the help of GeneRuler DNA ladder mix 
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(Thermo Scientific) as a standard, PCR fragments were visualized on a UV-table and purified 
from gel with Wizard® SV Gel and PCR Clean-Up System (Promega), according to 
manufacturer’s instructions. Concentration was measured with the Nanodrop (Thermo 
Scientific) and PCR samples were stored at -20 °C until further use. 
2.2.2.6 Cloning of plasmids 
Generating plasmids for the purposes of this study (Table 2-5) followed principles of standard 
protocols (Green et al., 2012). Therefore, purified PCR sample (2.2.2.5) and the desired plasmid 
were used for restriction digestion with adequate FastDigest enzymes (Thermo Scientific) 
following the manufacturer’s protocol. The incubation proceeded at 37 °C for 30 min, digested 
PCR product (insert) and plasmid (backbone) were cleaned up, following the same protocol as 
for PCR products (2.2.2.5), and used for ligation with Rapid DNA Ligation Kit (Thermo 
Scientific). Pursuing the manufacturer’s user guide, 10-100 ng of vector and an applicable 
amount of insert were utilized for ligation. Insert concentration was calculated with the 
following formula: massinsert(ng) = 3·massvector(ng)·lengthinsert(bp)/lengthvector(bp) to gain an insert 
to vector molar ratio of 3|1. Ligation product was used for transformation of E. coli as described 
in 2.2.2.1. Plasmid DNA was purified as in section 2.2.2.2 and successful cloning was verified 
by restriction digestion analysis and further by sequencing (Microsynth SEQLAB, Göttingen). 
2.2.2.7 Chromosomal deletions/insertions in yeast 
For deleting genes or integration of tags genomically in yeast, a PCR based strategy was used 
following standard procedures (Longtine et al., 1998; Knop et al., 1999; Janke et al., 2004). In 
case of deletions HIS3MX6, KANMX4 (Longtine et al., 1998) or NATNT2 (Janke et al., 2004) 
cassettes were amplified using primers with homology region sequences up- and downstream 
(~500 bp) of the targeted open reading frame (ORF). For insertion of 3HA-tag, plasmid pYM2 
(Knop et al., 1999) was utilized and primers contained homology region sequences matching the 
3’-end of the ORF excluding the Stop codon and ~250 bp downstream the ORF, respectively 
(listed in Table 2-4). PCR products were used for transformation as indicated in section 2.2.2.3. 
True-positive clones were confirmed with PCR and/or western blotting 
2.2.2.8 In vitro transcription and translation 
For labeling precursor proteins with [35S]-methionine, mMassage mMachine SP6 kit (Invitrogen) 
was first used to produce capped mRNA. PCR products containing SP6 promoter in front of 
the ORF were generated from either plasmid or yeast genomic DNA, additionally considering 
the number of encoded methionine. According to the manufacturer’s protocol, for a 20 µl 
reaction, 1x NTP/CAP, 1x reaction buffer, 1 µg PCR product and 2 µl enzyme mix were mixed 
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and incubated at 37 °C for 90 min. 1 µl Turbo DNase was added to remove DNA template and 
incubation at 37 °C for 15 min followed. RNA was precipitated by adding 30 µl LiCl solution, 
optionally adding 30 µl nuclease-free water and incubating at -20 °C for at least 30 min. RNA 
was pelleted at 14 000 rpm, 15 min, 4 °C, washed with cold 70 % ethanol, dried, resuspended 
in 50 µl nuclease-free water, concentration was measured at the Nanodrop (Thermo 
Scientific)and stored at -80 °C. The translation reaction was then carried out with the FlexiÒ 
Reticulocyte Lysate System (Promega). In order to enhance efficiency, RNA was heated prior 
usage for 3 min at 65 °C and 1 µg RNA was used per 50 µl reaction. For this, 33 µl FlexiÒ 
Reticulocyte Lysate, 1 µl amino acid mix without methionine (1 mM), 70-120 mM KCl, 0-2 mM 
MgAc2, 0-2 mM DTT, depending on the protein synthesized (see Table 2-10) and 30 µCi 
[35S]-Met were mixed and incubated for 90 min at 30 °C. When adequate plasmids were 
available, transcription and translation were carried out in a coupled reaction from plasmid 
DNA, containing SP6-promoter, with using TNTÒ Quick Coupled Transcription Translation 
kit (Promega). Per 50 µl reaction, 40 µl of TNTÒ Quick Master Mix and 20 µCi [35S]-Met were 
added to 1 µg plasmid DNA. Lysates were shock-frozen with liquid nitrogen and stored 
at -80 °C. 
In case of [35S]-labeled Cox12, lysate was precipitated for reducing and unfolding the protein 
prior to import reactions. Thus, prepared [35S]-Cox12 lysate, 20 mM EDTA (pH 8.0 with 
NaOH), sat. (NH4)2SO4 (in total v|v ratio is 2|1, added in two steps) were mixed thoroughly 
before incubating for 30 min on ice and spinning at 14 000 rpm, 15 min, 4 °C. The pellet is 
resuspended in 1/3 of the initial volume with urea buffer incubated at room temperature at 
450 rpm for 15 min, spun down again at 14 000 rpm, 15 min, 4 °C. Supernatant was used as 
lysate. 
 
Table 2-10: Conditions for FlexiÒ Reticulocyte Lysate System. 
Precursor KCl [mM] MgAc2 [mM] 
Cox12 70 0.95 
Cox13 70 0.95 
 
2.2.3 Protein biochemistry methods 
2.2.3.1 Bradford assay – determination of protein concentration 
Protein Concentration was determined by using RotiÒ-Quant (Roth) after Bradford (Bradford, 
1976). For this, a standard curve 0-75 µg/µl of bovine immunoglobuline was detected, and three 
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different dilutions per sample were measured, using RotiÒ-Quant in a 1|10 dilution. 
Measurement was accomplished using the UV-Spectrophotometer (Varian) at 595 nm. 
2.2.3.2 SDS-PAGE 
For separating denatured proteins, SDS polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out based on principles of Laemmli (Laemmli, 1970). Depending on the size range of 
the examined proteins, uniform resolving gels were casted in different polyacrylamide 
concentrations ranging from 16-10 %, using a commercial 30 %/0.8 % acrylamide/bis-
acrylamide solution (Roth) mixed along with 386 mM TRIS pH 8.8 with HCl, 0.1 % SDS. To 
gain a better resolution in some cases, SDS gradient gels from 10-16 % polyacrylamide were 
applied. The same protocol for preparing the acrylamide mixtures was used, except for adding 
100 mM sucrose and 3.5 % glycerol to the heavy gel mix. For casting the gradient, a custom-
made gradient mixer was used. A stacking gel with 5 % polyacrylamide, 80 mM TRIS pH 6.8 
with HCl, 0.1 % SDS was poured over the resolving gel. Ammonium persulfate (APS) and 
tetramethylenediamine (TEMED) were used for polymerization. Electrophoresis was 
performed in a custom-made midi system or the Mini-Protean II (BioRad) with 30 mA/gel with 
SDS running buffer (Table 2-9). 
Urea SDS-PAGE helped to resolve proteins of low molecular weight. For this, the resolving gel 
consisted of 17.5 % acrylamide (60 %/0.8 % acrylamide/bis-acrylamide solution), 683 mM 
TRIS pH 8.8 with HCl, 7.8 mM NaCl, 5.4 M urea and 0.1 % SDS. The stacking gel was casted 
with 5.4 % acrylamide (60 %/0.8 %), 108 mM TRIS pH 6.8 with HCl, 3.3 M urea, 0.12 % SDS. 
APS and TEMED were used for polymerization. Electrophoresis was carried out under same 
conditions as standard SDS-PAGE with urea SDS running buffer (Table 2-9). 
Tricine SDS-PAGE was used in order to aim for the best resolution for radioactively labeled 
translation products, as described in section 2.2.5.2. Similar to Schägger (Schägger, 2006), a 
gradient of 10-18 % polyacrylamide was applied, using a 48 %/1.5 % acrylamide/bis-acrylamide 
solution along with 1 M TRIS pH 8.45 with HCl, 0.1 % SDS and 13 % glycerol in the heavy gel 
mix, in a custom-made gradient mixer, and overlaid with stacking gel (4 % polyacrylamide, 1 M 
TRIS pH 8.45 with HCl, 0.1 % SDS). APS and TEMED were used for polymerization. For 
electrophoresis, a custom-made midi system and 25 mA/gel with Tricine SDS cathode buffer 
and Tricine SDS anode buffer were used (Table 2-9). 
Before loading onto SDS-PAGE, SDS sample buffer (Table 2-9) was added and samples were 
incubated at 95 °C for 5 min or under mild agitation at 37 °C for 20 min. If necessary, samples 
were stored at -20 °C.  
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2.2.3.3 Blue-Native PAGE 
Native separation of protein complexes was accomplished by blue-native PAGE (BN-PAGE), 
following previously standardized principles of Dekker and colleagues (Schägger and von 
Jagow, 1991; Dekker et al., 1996; Wittig, Braun and Schägger, 2006). Separation gels with a 
polyacrylamide gradient of 4-10 %, 4-13 %, 4-16 %, 6-10 % were applied, using a 48 %/1.5 % 
acrylamide/bis-acrylamide solution along with 50 mM BIS-TRIS pH 7.0 with HCl, 
66.67 mM 6-aminocaproic acid and 20 % glycerol for the heavy gel mix. A custom-made 
gradient mixer helped with casting consistent gradient gels. A 4 % polyacrylamide gel with 
50 mM BIS-TRIS pH 7.0 with HCl, 66.67 mM 6-aminocaproic acid served as stacking gel. APS 
and TEMED were used for polymerization. Gels were cast and ran in the SE600 Ruby system 
(Hoefer, GE Healthcare) with BN-cathode buffer (Table 2-9), first containing 
0.02 % Coomassie Brilliant Blue G250, which was replaced with clear cathode buffer after 1/3 
of the run, and BN-anode (Table 2-9) buffer at 15 mA/gel. Running buffers were precooled to 
4 °C, as well as loading samples was completed at 4 °C. 
For sample preparation, mitochondria were solubilized in either 1 % digitonin or 0.6 % DDM 
BN solubilization buffer (Table 2-9) to a concentration of 1 µg/µl for 20 min on ice. Insoluble 
material was spun down (14 000 rpm, 15 min, 4 °C) and BN sample buffer was added prior to 
loading. 
In order to separate complexes in 2nd dimension, whole BN lanes were incubated for 30 min in 
50 mM DTT containing SDS running buffer (Table 2-9) and subsequently cast into a SDS gel 
following the mentioned principles in section 2.2.3.2. 
2.2.3.4 Western blotting and immunodetection 
In order to detect proteins via immunodetection, standard procedures as described by Gallagher 
and colleagues were used (Gallagher et al., 2004). First, the semi-dry blot system of PEQLAB 
was applied to transfer proteins from polyacrylamide gels onto PVDF membranes (Merck 
Millipore). After short activation in methanol, the membrane was assembled together with the 
gel and filter paper (Heinemann Labortechnik), soaked prior in transfer buffer (Table 2-9). 
Protein transfer was completed after 2.5 h with 25 V, 250 mA in case of SDS-PAGE and after 
3 h with 25 V, 400 mA in case of BN-PAGE. To visualize proteins and protein molecular 
weight marker, membranes were stained and destained as described in 2.2.3.5. Then, the 
membrane was cut into stripes, according to the respective proteins to be detected, destained 
and reactivated in methanol. TBS-T (Table 2-9) supplemented with 5 % milk was used for 
unspecific blocking for 1 h at room temperature or overnight at 4 °C under mild agitation. 
Specific home-made polyclonal antibodies, diluted in TBS-T with 5 % milk, or commercial 
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antibodies, diluted in TBS-T, were applied for immunodecoration and incubated for 1 h at room 
temperature or overnight at 4 °C under mild agitation. After three washing steps with TBS-T 
for 10 min, membranes were incubated with adequate secondary antibodies (1|5 000-1|10 000 
dilution) for 1 h at room temperature. The same washing procedure was used, and protein 
signals were visualized using enhanced chemiluminescence (ECL) Pierce® ECL Western 
Blotting Detection Reagent (Thermo Scientific) on either X-ray films (Fujifilm) or the 
AmershamTM ImageQuantTM800 system (GE Healthcare). 
2.2.3.5 Coomassie staining of membranes and gels 
In order to visualize proteins in polyacrylamide gels or on membranes after PAGE and western 
blot, they were stained with Coomassie Brilliant Blue Solution (Table 2-9) and destained with 
10 % HAc, 40 % ethanol solution until bands were apparent. 
2.2.3.6 Autoradiography 
For detecting radioactively labeled proteins, gels underwent either western blotting followed by 
Coomassie staining as described in sections 2.2.3.4 and 2.2.3.5, or gels were directly stained and 
destained as mentioned in 2.2.3.5 and subsequently dried, on top of two filter paper and covered 
by plastic foil, on a geldryer (LTF Labortechnik) at 65 °C for 2-4 h. Protein size standard was 
subsequently marked with radioactive ink, covered with sticking tape and exposed on storage 
phosphor screens (GE Healthcare), both the dried membrane and the dried gel. Signals were 
digitalized using the AmershamTM TyphoonTM Scanner (GE Healthcare) and quantified using 
Fiji/ImageJ (Schindelin et al., 2012). 
2.2.3.7 Steady state analysis of protein levels 
To probe and compare steady state levels of mitochondrial proteins, isolated mitochondria were 
directly employed for SDS-PAGE. Therefore, mitochondria were resuspended in SDS-sample 
buffer as in 2.2.3.2 to 1 µg/µl and incubated at 95 °C for 5 min. 
2.2.3.8 Protease protection assay 
Submitochondrial localization of proteins was obtained by protease treatment as described 
previously (Vukotic et al., 2012). For this, intact mitochondria were incubated with either 
hypotonic EM buffer (Table 2-9) to be converted to mitoplasts or with isotonic SEM buffer 
(Table 2-9) to be preserved as such. As a control, mitochondria were lysed with 1 % Triton 
X-100 or sonicated. All samples were divided and treated with 0-180 µg Proteinase K/µg 
mitochondria. Proteinase K was inactivated with 2 mM PMSF and samples were applied to 
SDS-PAGE as in 2.2.3.2. 
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2.2.4 Purification of protein complexes 
2.2.4.1 Crosslinking of Antibodies to PA-Sepharose beads 
Prior to co-immunoprecipitation, specific antibodies were bound to PA-Sepharose beads via 
crosslinking, following previously used protocols (Bareth et al., 2013). Sera were applied in 1|8 
dilutions in 0.1 M KPO4 buffer (pH 7.4) onto 25 µl PA-Sepharose beads, using mobicol 
columns (mobitec), and incubated for 1 h at room temperature under permanent inversion. 
Then, beads were washed with 0.1 M sodium borate (pH 9.0 with NaOH) and afterwards 
crosslinked with 5 mg/ml dimethyl pimelidate (DMP) in 0.1 M sodium borate (pH 9.0 with 
NaOH) for 30 min at room temperature under permanent inversion. Crosslinking reaction was 
quenched with 1 M TRIS (pH 7.4 with HCl) for 2 h at room temperature or overnight at 4 °C 
under permanent inversion. At the end, beads were washed with TBS or PBS for at least three 
times and stored in TBS or PBS supplemented with 2 mM NaN3 at 4 °C. Before and after usage, 
beads were washed twice with NH4Ac buffer (pH 3.4) followed by two TBS or PBS washes. 
2.2.4.2 Co-immunoprecipitation 
Isolation of protein complexes by co-immunoprecipitation (IP) was essentially performed as 
described before (Bareth et al., 2013). Specific polyclonal antibodies against Rcf1, Rcf2, Rcf3, 
Cox2, Qcr8, Cox12, Cox13 were applied as indicated in each experiment. Mitochondria were 
solubilized in IP solubilization buffer (Table 2-9) containing either 1 % digitonin, 0.6 % DDM 
or 0.5 % Triton X-100 with 0.1 % SDS to 1 µg/µl for 40 min at 4 °C under mild agitation, and 
lysate was cleared at 14 000 rpm, 15 min, 4 °C. A total sample was taken and the supernatant 
was split and applied onto appropriate antibody-coupled columns, incubating for 1 h at 4 °C 
under permanent inversion, commercial control columns (Thermo Scientific) served as a 
control for specific co-IP. After intensive washing with the same buffer as mentioned above 
but without detergent in case of DDM, 0.3 % digitonin or 0.3 % Triton X-100, precipitated 
protein complexes could be eluted with 0.1 M glycine (pH 2.8 with HCl) in a two-step elution. 
To this end, glycine was added, columns were incubated at 16 °C for 4 min, spun (200 x g, 1 min, 
4 °C), repeating it again. Small amounts of 1 M TRIS (pH 11.5) were used for neutralization 
and samples were subjected to SDS-PAGE as described in 2.2.3.2. 
2.2.4.3 FLAG isolation 
For native isolation of protein complexes by FLAG isolation, FLAG 2-M Affinity gel 
(Sigma-Aldrich) with 20 µl beads per 1 mg mitochondria were used. Solubilization conditions 
and handling of columns was following same principles as in section 2.2.4.2. Elution was 
completed natively with 1x FLAG peptide (Sigma-Aldrich) in wash buffer in a two-step 
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application, each time incubating for 5 min at room temperature. Samples were either applied 
for SDS-PAGE or BN-PAGE. 
2.2.4.4 HA isolation 
In order to isolate protein complexes via HA-tag, 20 µl PierceTM Anti-HA Agarose (Thermo 
Scientific) beads per 500 µg mitochondria were applied. HA-isolation followed the exact same 
protocol as described for co-IP in 2.2.4.2. The elution followed also the non-native protocol 
with 0.1 M glycine (pH 2.8 with HCl) mentioned in 2.2.4.2, although native elution with 
HA-peptide (Thermo Fisher) would have been possible.  
2.2.5 Specialized assays 
2.2.5.1 In vitro protein import and assembly 
First, proteins were radioactively labeled as described in section 2.2.2.8. In vitro import and 
assembly of the [35S]-Met labeled proteins into isolated mitochondria was carried out similar to 
Ryan et al. (Ryan, Voos and Pfanner, 2001). For this, mitochondria were resuspended in import 
buffer (Table 2-9) supplemented with 2 mM NADH and 2 mM ATP (pH 7.0 with HCl) and in 
case for assembly reactions additionally with 0.1 mg/ml creatin kinase and 5 mM creatine 
phosphate for ATP regeneration. In case of [35S]-Cox12, import buffer without BSA was used. 
As a negative control, one import reaction was mixed with 8 µM antimycin, 1 µM valinomycin 
and 20 µM oligomycin (AVO) to dissipate membrane potential and samples were pre-incubated 
for 3 min at 450 rpm, 25 °C. Import was started by adding –[35S]-labeled precursor proteins and 
stopped after various time-points by adding AVO-mix. Then, samples were treated either with 
Proteinase K (25 µg/ml), to remove unimported protein, or instantly pelleted (14 000 rpm, 
15 min, 4 °C) and washed with cold SEM buffer. For SDS-analysis of imported protein, samples 
were applied to SDS-PAGE as in section 2.2.3.2. In order to analyze the assembly of 
radioactively labeled protein in protein complexes, samples were solubilized and applied to BN-
PAGE as described in section 2.2.3.3.  
In the end, membranes or gels were handled as described in section 2.2.3.5 and samples were 
analyzed with autoradiography as mentioned in section 2.2.3.6. 
2.2.5.2 In vitro translation assay in isolated mitochondria 
Isolated mitochondria were subjected into translation buffer and mitochondrial translation 
products were radiolabeled for 10 min with 20 µM [35S]methionine at 30 °C, in principle as 
described previously (Westermann, Herrmann and Neupert, 2001). The reaction was stopped 
by adding 40 mM cold methionine. Mitochondria were reisolated and washed in SEM buffer 
(Table 2-9). Samples were either used for further co-immunoprecipitation as in 2.2.4.2 or 
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directly analyzed with Tricine SDS-PAGE according to 2.2.3.2. Proteins were transferred to 
PVDF membranes as described in section 2.2.3.4 and labeling was analyzed via autoradiography 
(2.2.3.6). Afterwards, an additional probing with antibodies (2.2.3.4) completed the analysis. 
2.2.5.3 Crosslinking with chemical crosslinker 
A second crosslinking reagent used in this study was bis(sulfosuccinimidyl)suberate (BS3; 
Thermo Scientific). As a homobifunctional crosslinker it is reacting with primary amino groups 
at pH 7-9. To this end, isolated mitochondria were resuspended in crosslinking buffer Table 
2-9, BS3 was added to an end concentration of 5 mM and incubated at room temperature for 
1 h. Reaction was quenched and mitochondria were lysed in one step by adding SDS in TRIS 
(pH 8.0 with HCl) to an end concentration of 2 % SDS and 50 mM TRIS. Incubation followed 
with 10 min at room temperature. Samples with this treatment were applied directly for 
SDS-PAGE (2.2.3.2). In case of a favored co-IP analysis, quenching and lysing was achieved in 
two steps. For this, crosslinking reaction was quenched by adding TRIS (pH 8.0 with HCl) to 
an end concentration of 50 mM for 10 min at room temperature, mitochondria were reisolated 
(14 000 rpm, 10 min, 4 °C) and subsequently lysed with solubilization buffer as described in 
sections 2.2.4.2 and 2.2.4.4, containing 0.3 % Triton X-100 and 0.1 % SDS to reduce detergent 
related effects on beads.  
2.2.5.4 Determination of oxygen consumption rates 
Oxygen consumption was assessed from isolated mitochondria using high resolution 
respirometry (Oxygraph-2k; Oroboros Instruments, Innsbruck, Austria) in 2 mL of respiration 
buffer (Table 2-9) at 30 °C. Samples and all supplements/drugs were added by using syringes 
(Hamilton) in different sizes (10-50 µl) and the different states were determined only from stable 
signals detected by the oxygen sensor. Wildtype and mutant’s oxygen consumptions were 
measured always in a direct comparison, using both chambers by turns. 50 µg/ml mitochondria 
were used for all assessments, which was tested before by a premeasurement. Pyruvate (5 mM) 
and malate (2 mM) were applied to address non-phosphorylating respiration (LEAK). Adding 
ADP to a saturating concentration (1 mM) (State 3) followed by succinate (10 mM) determined 
the maximal capacity for coupled oxidative phosphorylation (OXPHOS). By adding antimycin 
A (5 µM) electron transfer from complex III to complex IV was inhibited and respiration was 
killed. Ascorbate (2 mM) and TMPD (500 µM) were added to address OXPHOS capacity 
specifically via shuttling electrons to complex IV. To distinguish between respiration and 
auto-oxidation of TMPD/ascorbate, NaN3 (100 mM) was added to block the O2 binding site 
of complex IV for residual oxygen consumption (ROX), and the values were subtracted from 
the values after TMPD/ascorbate addition. 
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2.2.5.5 Determination of H2O2 production rates 
The assay is following essentially the protocol from Krumschnabel et al. 2015 using a 
simultaneous approach for measuring mitochondrial H2O2 production and oxygen 
consumption (Krumschnabel et al., 2015). It was adapted to be solely performed in cuvettes. 
Substrates (5 mM pyruvate, 2 mM malate, 10 mM succinate) were added to ROS assay buffer. 
Horseradish peroxidase (HRP, Sigma) (1 U/ml) was used to catalyze fluorescence reaction with 
10 µM AmplexTM UltraRed (Invitrogen, in DMSO). Addition of 100 µg isolated mitochondria 
started the reaction, recorded with the spectrofluorometer Xenius (SAFAS) (Excitation 555 nm, 




3.1 Characterization of Rcf-proteins 
3.1.1 Rcf-proteins share similar orientation within mitochondria 
Supercomplex or respirasome assembly within the mitochondrial respiratory chain is still elusive 
regarding the factors which are responsible for attaching the multimeric complexes to each 
other. In yeast S. cerevisiae, especially the Rcf-protein family came into our attention as players in 
supercomplex assembly and stabilization while the mechanism remains unclear. Rcf1 was shown 
to be essential for respiration and supercomplex stabilization, however, was also associated with 
cytochrome c oxidase maturation (Strogolova et al., 2012). Rcf2 has been described to overlap 
in functions with Rcf1, as well as with Rcf3, possibly linked closely to the homologous regions 
the proteins harbor (Figure 3-1A) (Strogolova et al., 2012, 2019; Römpler et al., 2016). This study 
aimed for a better understanding of the distinct and overlapping roles of these factors and 
enlighten the mechanism of supercomplex assembly. Thus, it was important to bring all three 
Rcf-proteins in one context and start with a basic characterization of the protein family. 
Before focusing on the localization and functionality of the partly homologous domains of the 
Rcf-proteins, the overall topology was of interest. It was shown before that all three proteins 
are integrated into the inner mitochondrial membrane (Chen et al., 2012; Vukotic et al., 2012; 
Römpler et al., 2016; Strogolova et al., 2019). But partly contradictory data exists about the 
topology of Rcf2 and Rcf1. While Rcf1 was first identified as harboring two transmembrane 
spans (Chen et al., 2012; Vukotic et al., 2012), a NMR (nuclear magnetic response) analysis 
revealed five transmembrane spans when expressed in E. coli and reisolated in detergent 
micelles. The prediction annotates the C-terminus residing in the mitochondrial matrix (Zhou 
et al., 2018b). The same group determined five transmembrane spans, with the C-terminus 
exposed to the mitochondrial matrix, by transferring the setup to Rcf2 (Zhou et al., 2018a; Zhou 
et al., 2020). Yet, in silico analysis identified four transmembrane spans for Rcf2 (Römpler et al., 
2016). Since the protein orientation within the mitochondrial membrane depends on the 
number of transmembrane segments, even or uneven, data respecting the orientation and 
overall topology of the Rcf-proteins was obtained.  
 
To this end, a protease protection assay was performed in wild-type mitochondria, and proteins 
of the outer mitochondrial membrane (OMM), intermembrane space (IMS), inner 
mitochondrial membrane (IMM) and mitochondrial matrix can be distinguished. Always 
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accessible for protease treatment, peripheral OMM proteins, like Tom20, are immediately 
digested and serve as a control for protease treatment. IMS proteins and IMM protein signals 
are decreased only in swollen mitochondria, losing the OMM as a barrier. However, one has to 
take the (predicted) topology into consideration and the detectable part of the protein the 
antibody is binding with. Matrix proteins’ signals remain stable throughout the whole 
experiment, as long as the IMM is intact. Prior solubilization with Triton X-100 provides 
evidence regarding a general protease digestion ability.  
 
Figure 3-1: Rcf-proteins share homologous domains and similar orientation within mitochondria.  
A) Topology model, modified from Römpler et al., 2016. Grey nuances indicate homologous transmembrane spans between 
the three proteins. HIG1 labels the homology region for hypoxia induced genes. B) Wild-type mitochondria remained intact in 
isotonic SEM-buffer, converted to mitoplasts in hypotonic EM-buffer or lysed with 1 % Triton X-100, treated with 
proteinase K (PK; 0-180 µg/ml), applied to 10-16 % SDS-PAGE and western blotting. Tom20, Tim23 and Tim44 served as 
controls for outer membrane, inner membrane and matrix proteins of mitochondria. C) Isolated mitochondria from cox5a∆rcf2∆ 
expressing FLAGRcf2 were subjected to protease protection assay as described in B). 
The amounts of Rcf1, Rcf2 and Rcf3 are decreased as soon as the isolated mitochondria are 
converted into mitoplasts by osmotic swelling. The detected levels remain stable in intact 
mitochondria (Figure 3-1B). Each serum is raised against the C-terminus of the protein, and we 
concluded that the C-termini are residing in the IMS. When repeating the experiment with 
mitochondria from cells expressing FLAGRcf2, it shows an accessible N-terminus, detectable in 
this case with a-FLAG, when the outer mitochondrial membrane is ruptured (Figure 3-1C). 





spans as described before (Römpler et al., 2016) and suggests a Nout-Cout orientation. Moreover, 
the experiment indicates that the predicted confirmation of Rcf1 by Zhou et al. (2018b) does 
not correspond with our in vivo determined situation. 
 
3.1.2 Rcf-proteins and their influence on respiration 
As a next characterization of the Rcf-proteins we investigated their role in mitochondrial 
respiration. A Growth-test on fermentable (YPD - glucose) against non-fermentable (YPG - 
glycerol, YPLac - lactate) media is a helpful tool in this regard. While on fermentable media, 
glycolysis metabolism is able to supply yeast with energy, the oxidative phosphorylation 
machinery (OXPHOS) has to be fully functional when media are non-fermentable.  
 
Figure 3-2: Rcf1 is a vital protein for respiration, Rcf2 and Rcf3 only in combination.  
Cells of wild-type (Wt), rcf1∆, rcf2∆, rcf3∆, rcf2/3∆ were spotted on glucose, glycerol, lactate media plates in serial dilution and 
grown at 37 °C. 
Rcf1∆ shows heavily affected growth ability when strains are tested on non-fermentable media, 
whereas rcf2∆ and rcf3∆ display about wildtype like growth on YPG and YPLac (Figure 3-2). 
Combining both mutations to a double mutant rcf2∆rcf3∆, the cells cannot cope with the 
respiratory malfunction and a similar growth phenotype as in rcf1∆ appears. This corroborates 
precedent data of Chen et al. and Vukotic et al., while discussing the relevance of Rcf1 for 
supercomplex stabilization (Chen et al., 2012; Vukotic et al., 2012). Römpler et al. (2016) showed 
comparable results for rcf2∆rcf3∆, explaining the overlapping role of the two proteins and 
ascribed the phenotype to a drop of complex IV activity (Römpler et al., 2016). 
 
Although the RCF1 mutant shows a drastic growth phenotype, protein levels remain more or 
less stable (Figure 3-3A). Only the complex IV subunits Cox3 and Cox13 show a subtle 
decrease, other probed cytochrome c oxidase constituents (Cox1, Cox2, Cox12, Cox5a, Cox5b) 
were not reduced when isolated mitochondria of the different mutant strains were analyzed on 
SDS-PAGE. Tested complex III proteins (Cor1, Rip1, Qcr8) did not display any difference in 
levels as well as the remaining Rcf-proteins. Despite the rcf1∆ resembling growth phenotype of 
rcf2∆rcf3∆, the other RCF mutants did not result in a protein level change.  
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Rcf1 and Rcf2 harbor the conserved HIG1 (hypoxia induced gene) domain, and Rcf1 was 
demonstrated to elevate oxidative stress in cells (Chen et al., 2012). Thus, we monitored the ratio 
of Cox5a and Cox5b to get a reliable prediction of the sensed oxygen status of the cell. Cox5a 
and Cox5b are opposing isoforms, the first being expressed under normoxia and the latter under 
hypoxia (Hodge et al., 1989). Even though grown under normal growth conditions, the wild-type 
already shows a basal expression of Cox5b. This can be ascribed to a lack of external oxygen 
supply and culturing in shaking flasks. At the same time, Cox5b levels remain the same 
throughout the tested mutants, concluding the Rcf-proteins themselves do not affect the sensed 
oxygen state of the cells.  
 
Figure 3-3: Supercomplex assembly is affected in rcf1∆, not reflected by a major decrease in COX subunits.  
A) Isolated mitochondria of wild-type (Wt), rcf1∆, rcf2∆, rcf3∆, rcf2/3∆ subjected to SDS-PAGE (10-16 %) and urea 
SDS-PAGE (17.5 %) for Cox5a/b separation. Tom70 and Aco1 serve as loading controls. Complex III is analyzed with 
antibodies against Cor1, Rip1, Qcr8 and complex IV via Cox-antibodies. Asterisks mark protein signals caused by a previous 
detection with a different antibody. B) Wt, rcf1∆, rcf2∆, rcf3∆, rcf2/3∆ mitochondria solubilized with 1 % digitonin are applied 
to BN-PAGE (4-10 %). Atp5 serves as a loading control, detecting complex V. Rip1 reveals complex III and Cox1 complex IV. 
Although the protein levels of RCF mutants seem to be ordinary, the formation of 





factors. The first assessment of respiration capacity additionally implies that the complex 
association might be disturbed. By BN-PAGE analysis, using the mild detergent digitonin, the 
structure as respiratory supercomplexes remains intact and the different protein complex 
formations can be obtained (Schägger and Pfeiffer, 2000). In a wild-type situation, there is a 
tendency to form the highest molecular respiratory supercomplex III2IV2, detected in this case 
with complex IV constituent Cox1 and complex III constituent Rip1 (Figure 3-3B). 
Additionally, complex III2IV and small amounts of complex III dimer can be obtained (Figure 
3-3B). The RCF1 mutant shows a clear rearrangement towards III2IV and III2, only minor 
amounts of III2IV2, and in a longer exposure even free complex IV can be determined. This 
effect confirms precedent studies, where rcf1∆ caused a rearrangement of respiratory 
supercomplex (Chen et al., 2012; Vukotic et al., 2012). In parallel, both single and double 
deletions of RCF2 and RCF3 do not lead to a discernible alteration of supercomplex 
arrangement. The respiratory defect, revealed in the growth test, is not represented by an overall 
reorganization of the respiratory chain or major compromised protein levels. This was also 
shown previously by Römpler et al., (2016) arguing Rcf2 and Rcf3 act as more regulatory 
proteins in respect to the respiratory chain (Römpler et al., 2016). 
 
Overall, Rcf1 caused visible phenotypes on protein level and complex association suggesting 
furthermore a structural involvement, while the definition of Rcf2 and Rcf3 function is not as 
obvious. In light of the altered Cox3 and Cox13 levels, we expected that Rcf1 interacts primarily 
at this site. 
 
3.1.3 Rcf-proteins interact with newly synthesized complex IV 
core subunits 
Previous studies showed an interaction of Rcf1 with newly translated Cox3, reporting a role for 
complex IV assembly (Strogolova et al., 2012; Su, McStay and Tzagoloff, 2014; Garlich et al., 
2017). It remained unclear, however, if the other proteins Rcf2 and Rcf3 may have a similar 
capacity and we were wondering if we can obtain this by adapting their protocols.  
To this end, a mitochondrial translation labeling assay was performed. By inhibiting cytosolic 
translation with cycloheximide and supplementing with 35S-Methionine, it is possible to label 
exclusively mitochondrial translation products. The generated radioactive proteins are in turn 
detectable via autoradiogram. In order to conclude specific interactions to Rcf-proteins the 
Rcf-specific complexes were isolated via immunoprecipitation. In this case, the translation assay 
was not performed in vivo with whole cells, but with isolated mitochondria to facilitate the 
CHARACTERIZATION OF RCF-PROTEINS 
 52 
following immunoprecipitation with the Rcf-protein’s antisera. For confirming the specificity 
of an association with Cox3, the PET494 mutant was included in this examination. Pet494 is a 
mRNA activator of COX3 and deleting PET494 abolishes COX3 expression without having to 
mutate the mitochondrial genome itself (Müller et al., 1984; Costanzo and Fox, 1986). To be 
able to ignore a possibly occurring supercomplex assembly, DDM was utilized as a detergent, 
disrupting complex III2IV(1-2) association. 
 
Figure 3-4: Rcf-proteins co-isolate mitochondrial encoded proteins.  
Isolated wild-type (Wt) and pet494∆ mitochondria are subjected to radioactive labeling of mitochondrial encoded proteins with 
35S-methionine for 10 min, followed by solubilization with 0.6 % DDM and co-immunoprecipitation with Rcf1, Rcf2, Rcf3 and 
control beads. Totals (5 %) and glycine elution (100 %) were subjected to Tricine-SDS PAGE (10-18 %), western blotting, 
autoradiogram and subsequently immunodetection. Tim44 serves as a control for specific complex isolation. 
Eliminated COX3 translation does not interfere with translation of the other seven 
mitochondrially encoded proteins, and their radioactive signals remained stable (Figure 3-4). We 
could determine that Rcf1 most dominantly interacts with Cox3 in a wild-type situation, 
compared with the other labeled proteins. This gets in line with previous results from Strogolova 
et al. (2012) and Garlich et al., (2017) showing an interaction in Triton solubilized mitochondria 
of His-tagged Rcf1 with radioactive labeled Cox3 (Strogolova et al., 2012; Garlich et al., 2017). 
The Rcf-protein were demonstrated to interact with each other under digitonin solubilizing 
conditions. DDM solubilization however, previously showed that the Rcf-protein interaction is 
labile and the proteins easily dissociate under these conditions (Römpler et al., 2016). Although 
utilizing DDM for solubilization in our experiment, small amounts of Rcf2 can be co-isolated 
proceeding the isolation from Rcf1 (Figure 3-4). In parallel, this does not apply vice versa for 
immunoprecipitation with Rcf2.  
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Surprisingly, Rcf2 and Rcf3 could co-isolate mitochondrial translation products as well, which 
was not part of previous studies. Along with Rcf2 only minor amounts of newly translated Cox3 
are co-purified, while Rcf3 brings down almost comparable amounts as Rcf1. Overall, Rcf2 
shows the lowest efficiency in immunoprecipitation under these conditions considering bait 
protein levels, whereas Rcf3 co-purifies both Rcf2 and Rcf1. 
Nevertheless, other mitochondrial encoded proteins like Cox2 and Cob, even ATPase 
constituents can be isolated along the three antibodies. Interaction with Cox2, also displayed in 
previous studies (Strogolova et al., 2012; Garlich et al., 2017) argues for already matured 
cytochrome c oxidase in interaction with the Rcf-proteins. Cob isolation speaks for a parallel 
interaction with complex III independent of complex IV under these circumstances. 
 
The association of not only Rcf1 but also Rcf2 and Rcf3 with newly synthesized Cox3 and Cox2 
was indicative for an interaction site of the proteins. Yet, we were aiming for a more detailed 
characterization of interactors since the functional mechanism of Rcf-proteins is still obscure. 
Considering that the Rcf-proteins are suggested as transient interactors of complex IV (Vukotic 
et al., 2012; Römpler et al., 2016; Garlich et al., 2017), we aimed for catching those associations 
by chemical crosslinking. Combined with mass-spectrometric analysis, performed with 
collaborators (Linden et al., 2020), this represents a high-quality screening method. 
 
3.2 Crosslinks reveal Rcf2 and Rcf3 in close interaction with 
COX subunits 
The Rcf-proteins were identified as they are able to interact independently with complex IV and 
complex III (Vukotic et al., 2012; Römpler et al., 2016). In parallel, it is proven that they associate 
with the respiratory supercomplexes and can be isolated along with them (Chen et al., 2012; 
Strogolova et al., 2012; Vukotic et al., 2012; Römpler et al., 2016). In earlier cryo-EM structures 
obtained from yeast respiratory supercomplex III2IV(1-2), none of the three Rcf proteins could 
be resolved (Mileykovskaya et al., 2012; Hartley et al., 2019; Rathore et al., 2019), arguing for a 
substoichiometric interaction. A proposed interacting site at the interface of complex IV  and 
complex III as supercomplex assembly factors (Vukotic et al., 2012) stands in contrast to the 
influences on the assembly of the peripheral proteins Cox13 and Cox12 (Vukotic et al., 2012; 
Strogolova et al., 2019). However, Hartley and colleagues just recently identified Rcf2107-205 as a 
peripheral constituent of supercomplex III2IV in a cryo-EM analysis (Hartley et al., 2020). Here, 
they isolated the complex with the help of 6xHis tagged Cox13 in a cox5a∆ background to 
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enhance homogeneity of the complex (see section 3.2.1). This, on the other hand, suggests a 
stoichiometric interaction of Rcf2 with the supercomplex at least under these conditions and 
questions the idea of Rcf2 as an assembly factor. 
 
Consequently, it was an interesting finding when we identified Rcf2 and Rcf3 together with 
collaborators in mass spectrometry analysis of crosslinked mitochondria (Linden et al., 2020). 
We used the chemical, homobifunctional crosslinker BS3, harboring a linker length of 11.4 Å. 
BS3 links primary amino groups by reacting as a sulfo-NHS ester (N-hydroxysuccinimide), 
consequently, N-termini of polypeptide chains and the sidechains of lysine are targeted. By 
utilizing whole mitochondria, only a fraction of crosslinked proteins originated from the 
respiratory chain. Yet, the advantage was that the data represented in vivo behavior of the 
proteins. 
We could determine the N-terminus of Cox12 crosslinked to the N-terminus of Rcf3, as well 
as the C-terminal region of Rcf2 (Figure 3-5A) (Linden et al., 2020). In parallel, the same amino 
acid of Rcf2 was found to crosslink with a C-terminal region of Cox13 (Figure 3-5A). 
Interestingly, no crosslinks were obtained within the Rcf-family under those conditions, in 
regard of the proteins interacting with each other (Römpler et al., 2016). In parallel, Rcf1 was 
not identified as crosslinked to respiratory chain complexes (Linden et al., 2020), although a 
similar localization was suggested earlier as for Rcf2 (Strogolova et al., 2019; Dawitz et al., 2020).  
 
 
Figure 3-5: Rcf2 and Rcf3 are crosslinked to Cox12 and Cox13. 
A) Model representing the mass spectrometry results of whole mitochondria subjected to crosslinking with BS3 reduced to 
Rcf-protein data, as published in Linden et al. (2020). Numbers mark the crosslinked amino acids connected by lines. Dark grey 
areas display putative transmembrane segments. B) Isolated wild-type mitochondria were crosslinked with 50 µM BS3 for 1 h, 
subsequently quenched and lysed with 2 % SDS in TRIS (pH 8.0), applied to SDS-PAGE (10-16 %) and western blotting. 




In order to confirm this mass spectrometry data, we performed a crosslinking assay, using the 
same protocol as in Linden et al. (2020). Isolated wild-type mitochondria were subjected to 
crosslinking with BS3, quenched with TRIS and lysed with SDS. We first analyzed the general 
crosslink pattern by probing for the different candidates and comparing samples with and 
without crosslinker (Figure 3-5B). Prominent crosslinks for Cox13 could be determined at 
around 30 kDa, 40 kDa and 60 kDa. Cox12 showed specific signals around 18 kDa, 21 kDa, 
30 kDa, and a strong crosslinking blur appeared above 37 kDa. For Rcf3, only low amounts of 
crosslinks at 30 kDa and around 40 kDa could be detected. Whereas for Rcf2, stronger signals 
were detectable at approximately 30 kDa and 40-50 kDa.  
 
3.2.1 Rcf2 crosslinks specifically to Cox12 and Cox13 
To be able to uncover specific crosslinks for the different proteins biochemically, 
co-immunoprecipitation with antisera against Rcf2, Cox13 and Cox12 was carried out. To this 
end, the experiment was executed in the same way as before, except mitochondria were 
solubilized with low concentrated Triton X-100 and SDS. Any native interaction should be 
disrupted under these conditions and only crosslinked protein complexes were co-purified, still 
providing appropriate conditions for efficient antigen-antibody reactions on coated beads. 
 
 
Figure 3-6: Rcf2 specifically crosslinks with Cox12.  
Wild-type mitochondria were subjected to crosslinking with 50 µM BS3 for 1 h, reaction was quenched with TRIS, mitochondria 
were lysed with 0.5 % Triton and 0.1 % SDS, and applied to co-immunoprecipitation with Rcf2, Cox12, control beads. Totals 
and glycine eluates were used for SDS PAGE (10-16 %) and western blotting. Signals were detected with Rcf2 and Cox12 
antibodies, respectively. Control samples without added crosslinker went through the same procedure in parallel. x1, x2 and x3 
mark specific crosslinks between Rcf2 and Cox12. 
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The respective antibody against the opposite, crosslinked protein was used for detection and 
vice versa, in order to identify the definite association. In fact, different crosslinks or 
crosslink-regions could be purified and detected by this approach (Figure 3-6). 
A crosslinking ladder at ~30-40 kDa (x1), another one right beneath at ~21-28 kDa (x2) and one 
specific crosslink at ~16 kDa (x3) were isolated with both, Cox12 and Rcf2 
co-immunoprecipitation, and detected with the particular other antibody. This indicates a 
specific appearance, although full-length Rcf2 (25 kDa) and Cox12 (10 kDa) can only be 
responsible for the crosslinks x1, according to their size. X2 might occur due to a processed 
version of Rcf2, which is detectable in enriched quantity after Rcf2 immunoprecipitation (Figure 
3-6, lane 3).  
An internal processing event of Rcf2 was studied previously by Römpler et al. (2016) resulting 
in a stable Rcf2C fragment (~21 kDa) (Römpler et al., 2016). This corresponds to the fragment 
detected at ~18 kDa in this case. This minor discrepancy can be justified with the usage of 
different gel systems and standard reference markers. It has to be noted, however, that another 
fragment can be enriched as well at ~16 kDa, which is not represented in previous published 
data (Römpler et al., 2016). In contrast to the slightly larger fragment, that fragment is not 
detectable in the total and could be an artefact caused by the procedure itself.  
Upon addition of the molecular weight of Rcf2C and Cox12 to ~28 kDa, it can be conceived 
that those partners generate the isolated crosslink x2. The obtained crosslink x3 however, is only 
~7 kDa larger than Cox12 and the interacting partner remains unknown. 
 
In order to identify the crosslinks of Rcf2 and Cox13, we used the same Rcf2 elution fraction 
for a second SDS-PAGE, loaded next to the Cox13 bound fraction (Figure 3-7). By this, the 
detection can occur from the same gel or membrane and mutual crosslinks can be specified with 
higher certainty. At first sight, the isolation of crosslinks between these two proteins appears to 
be less efficient than before with Cox12. Although general co-immunoprecipitation capacity 
seems to be at a satisfying level (Figure 3-7, lanes 3 and 13), the detection with the respective 
other antibody was weak (Figure 3-7, lanes 6 and 12). Paying attention to longer exposures of 
the corresponding lanes (5, 6, 11 and 12), we could obtain two crosslinks, corresponding the 
two proteins by size. Full-length Rcf2 (25 kDa) and Cox13 (15 kDa) can be added up to 40 kDa, 
which is roughly where x1 is detected. Considering again the Rcf2C fragment at ~18 kDa, the 
other crosslink x2 finds an explanation. However, there is a third crosslink x3 of unknown nature 
isolated, as well ~7 kDa larger than the protein of interest, Cox13. Once more, a smaller 
fragment of Rcf2 could be detected, also present in the Cox13 elution. One has to note, that an 
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obvious amount of unlinked Cox13 can be determined upon Rcf2 co-immunoprecipitation 
(lane 12) but only under crosslinking conditions. Arguing for a tight interaction of the two 
proteins, this should have been detectable in the sample without crosslinker as well. It could 
also indicate a strong association of Cox13 to another Rcf2 crosslinked protein which was not 
identified by mass spectrometry. 
 
 
Figure 3-7: Rcf2 specifically crosslinks with Cox13.  
Wild-type mitochondria were subjected to crosslinking with 50 µM BS3, reaction was quenched with TRIS, mitochondria were 
lysed with 0.5 % Triton and 0.1 % SDS and applied to co-immunoprecipitation with Rcf2, Cox13, control beads. Totals and 
glycine eluates were used for SDS PAGE (10-16 %) and western blotting. Signals were detected with Rcf2 and Cox13 antibodies, 
respectively. Control samples without added crosslinker went through the same procedure in parallel. x1, x2 and x3 mark specific 
crosslinks between Rcf2 and Cox13. 
In the end, those identified crosslinks are consistent with the idea of Rcf2 as interacting with 
the peripheral part of the oxidase. The recently published cryo-structure of complex III2IV 
resolved Rcf2107-205 in association with the respirasome where it sits between Cox13 and Cox3 
clamped right below Cox12 (Figure 3-8A) (Hartley et al., 2020). This structure not only helped 
to confirm the proposed crosslinks by analyzing the distances but also indicates in which state 
the crosslinks occurred. In fact, the distance between Cox12-K41 and Rcf2-K203 measures 
11.6 Å, which corresponds well to the linker length of BS3 of 11.4 Å (Figure 3-8B). This implies 
that the crosslinked Rcf2 is positioned at the supercomplex not only the cytochrome c oxidase 
itself. It is also interesting to note, that exclusively the C-terminus is resolved in this 
cryo-structure and it appears that also the Rcf2C fragment itself can be found crosslinked to 
Cox12. Since processed Rcf2 is not part of a protein database for mass-spectrometry calculation, 
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the only evidence is our biochemical analysis. Yet, it indicates that not only full-length Rcf2 but 
also Rcf2C is still in proximity to Cox12 and Cox13. 
Analyzing the crosslink observed between Rcf2-K203 and Cox13-K85 with the help of the 
available cryo-structure however, resulted in a distance of 60.5 Å (Figure 3-8C). It is known that 
the theoretical crosslink linker length can differ from the actual distance. It was shown that BS3 
crosslinks up to 30 Å distant lysine chains due to dynamic reasons (Merkley et al., 2014), but the 
distance between Rcf2 and Cox13 exceeds this threshold twice as much. This suggests that the 
crosslink between those chains does not take place at the endpoint represented by cryo-EM and 
might rather be a result of a dynamic interaction of Rcf2 with the cytochrome c oxidase.  
 
 
Figure 3-8: Structural analysis reveals crosslink of Rcf2 and Cox12 likely to happen at the supercomplex.  
A) Localization of Rcf2 at cytochrome c oxidase extracted from cryo-EM structure of Hartley et al. (2020) (PDB ID 6T15). 
Dark red: Rcf2, green: Cox13, yellow: Cox12, grey surface: remaining COX subunits B) and C) Crosslink between lysine 
sidechain K203 of Rcf2 (dark red) and lysine sidechain K41 of Cox12 (yellow) or lysine sidechain K85 of Cox13 (green), 
respectively. The dashed line indicates the suggested crosslink. Analysis and editing were performed with Pymol software. 
 
3.2.2 Rcf3 specifically crosslinks to Cox12 
In addition to Rcf2, Rcf3 was also found to crosslink with Cox12. In the interest to confirm 





co-immunoprecipitation. As previously, eluates of the complexes were probed with the 
respective other antibody to verify mutual crosslinks. The only considerable enriched signals 
appeared at ~30 kDa (x1) and ~23 kDa (x2). Both roughly correspond the added size of the 
proteins 14 kDa for Rcf3 and 10 kDa for Cox12. Since x2 is enriched to a greater extent, this 
crosslink was assumed as characteristic for Rcf3 and Cox12. Other signals, detected in higher 
molecular weight regions were identified as unspecific since they were detectable in both 
samples, with or without crosslinker. 
 
 
Figure 3-9: Rcf3 specifically crosslinks with Cox12.  
Wild-type mitochondria were subjected to crosslinking with 50 µM BS3 for 1 h, reaction was quenched with TRIS, mitochondria 
were lysed with 0.5 % Triton and 0.1 % SDS and applied to co-immunoprecipitation with Rcf3, Cox12, control beads. Totals 
and glycine eluates were used for SDS PAGE (10-16 %) and western blotting. Signals were detected with Rcf3 and Cox12 
antibodies, respectively. Control samples without added crosslinker went through the same procedure in parallel. x1 and x2 mark 
specific crosslinks between Rcf3 and Cox12. 
Rcf3 shares homologies with the N-terminus of Rcf2 and was shown to overlap in functions 
(Römpler et al., 2016). Thus, it could be expected that it is located at a similar interaction site as 
Rcf2. Although Rcf3 is not resolved in the cryo-structure (Hartley et al., 2020), we could still 
conclude an appropriate position from our results (Figure 3-8A). Considering the linker length 
of BS3 (11.4 Å), it is likely that the crosslink of Rcf3 and Cox12 occurs next to Rcf2, but there 
is no indication whether the crosslink happens at the level of supercomplexes. Nevertheless, we 
provided the novel evidence for Rcf3 interacting with the peripheral cytochrome c oxidase. 
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3.3 Min8 – a novel complex IV interactor 
In context of the crosslinking analysis, it was intriguing to discover the so far uncharacterized 
protein Min8 (YPR10C-A) crosslinked to Cox12 (Figure 3-10A) and Pet9 (Aac2). The small 
protein of 72 amino acids was part of mitochondrial proteome studies of Morgenstern et al. 
(2017) and identified as a single span IM protein but not included in further investigations. 
Re-evaluation of previous mass-spectrometry results indicate an association of Min8 with the 
respiratory supercomplex, although a relation to complex IV could not be specified (Vukotic et 
al., 2012). 
In order to analyze the association of Min8 at complex IV, the previous biochemical analysis of 
crosslinks (see 3.2.1 and 3.2.2) was transferred to this purpose as well. A HA-tagged version of 
Min8 was utilized to facilitate Min8 detection, but also co-immunoprecipitation. First, an overall 
pattern of the crosslinks of Min8-HA was obtained in direct comparison with the wild-type and 
the respective antibody detection (Figure 3-10B).  
 
Figure 3-10: The uncharacterized protein Min8 (YPR010C-A) is specifically crosslinked to Cox12.  
A) Model representing the mass spectrometry results of whole mitochondria subjected to crosslinking with BS3 reduced to 
Cox12 and Min8, as published in Linden et al. (2020). Numbers mark the crosslinked amino acids connected by lines. Dark grey 
area displays the transmembrane segment. B) Isolated wild-type and Min8-HA mitochondria were treated with 50 µM BS3 for 
1 h, reaction was quenched with TRIS. Control samples without added crosslinker went through the same procedure in parallel. 
Mitochondria were lysed with 2 % SDS, applied to SDS-PAGE (10-16 %) and western blotting. Cox12 and HA antibody were 
used for detection. C) Crosslinking procedure was performed as in B). After quenching reaction, mitochondria were solubilized 
with 0.5 % Triton and 0.1 % SDS and applied to co-immunoprecipitation with Cox12, HA and control beads. Totals and glycine 
eluates were used for SDS-PAGE (10-16 %) and western blotting. Signals were detected with Cox12 and HA antibodies, 
respectively. Wild-type samples served as a control for HA isolation. x1, x2, x3 and x4 mark specific crosslinks between Min8 
and Cox12 
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Examining the two samples, it is striking that a Cox12 crosslink around 18 kDa disappears in 
Min8-HA, compared to the wild-type (Figure 3-10B lanes 2, 4). The same antibody fails to 
detect a crosslink within the Min8-HA strain, shifted by the corresponding size of the 3xHA 
tag (3 kDa). Still, it implies that this is the specific crosslink between the two proteins.  
 
As performing isolation via Cox12 and the HA-tag in a Min8-HA strain however, a crosslink at 
~22 kDa (x4) could be enriched specifically (Figure 3-10C). Adding up the molecular mass of 
Cox12 (10 kDa) and Min8-HA (8+3 kDa for 3xHA), this prominent crosslink was conceived 
as the specific crosslink between Min8-HA and Cox12. Additionally, other crosslinks at 
~28 kDa (x3), ~36 kDa (x2) and ~50 kDa (x1) could be obtained by this approach. The mass 
spectrometry analysis revealed two amino acids of Cox12 to be crosslinked with Min8. 
Additionally to aa2 which was crosslinked with other proteins, also aa41 (Figure 3-10A) (Linden 
et al., 2020). This leads to the assessment that both isolations could purify Cox12-Min8 in parallel 
to crosslinks of Cox12 with other candidates. Considering the mass estimation from the western 
blot, there are shifts of +6 kDa, (x3) +14 kDa (x2) and + 28 kDa (x1) additionally to the putative 
Cox12-Min8-HA (x4) crosslink. These correspond roughly the identified crosslinked proteins 
of Cox12; Cox9 (7 kDa), Rcf3 (14 kDa) and Rcf2 (25 kDa). Thus, it allows the assumption that 
all these proteins are isolated together in the same experiment. This idea could also fit to the 
unidentified crosslinks detected in the experiments before with Rcf2 (x3 in Figure 3-6, section 
3.2) and Rcf3 (x1 in Figure 3-9, section 3.2).  
 
In the end, Min8 can be positioned in proximity to Rcf2 but also Rcf1, considering a reported 
interaction of Rcf1 with Aac2 and Cox3 (Strogolova et al., 2019). It is likely that the Min8-Cox12 
interaction is happening on a respiratory supercomplex basis, given the evidence from previous 
mass-spectrometry analyses (Vukotic et al., 2012). Acknowledging the mutual interacting 
partners, it was tempting to conceive Min8 as a novel respiratory supercomplex factor. In order 
to gather more information about this proposition, Min8 was examined in regard of its 
involvement in supercomplex formation and respiration. 
 
3.3.1 Influence of Min8 in respiration 
To investigate the role of Min8 in respect of a potential connection to the Rcf-proteins, a double 
deletion strain was created in addition to min8∆: min8∆rcf2∆. Both proteins were found to 
localize adjacent to each other and the idea was that a specific phenotype could arise from a 
double knockout.  
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In a steady state analysis of the respective strains’ mitochondria, no discernible difference could 
be detected, comparing especially complex IV (Cox1, Cox12, Cox13, Cox5a/b) and complex III 
(Cor1, Rip1) subunits (Figure 3-11A). Also, Rcf-protein levels did not differ between wild-type, 
min8∆, rcf2∆ and min8∆rcf2∆. Similarly, the oxygen sensed state of the cell, determined by the 
ratio of the normoxic/hypoxic isoforms Cox5a and Cox5b, remained stable (Figure 3-11B). As 
a following characterization, the cellular respiration capacity was evaluated by performing a 
growth drop-test on non-fermentable media. Neither min8∆ nor min8∆rcf2∆ did develop a 
growth defect on non-fermentable carbon sources (Figure 3-11C). The double mutant rather 
displayed an enhanced growth ability but on both, glucose and glycerol media. Consequently, 
Min8 is not considered vital for respiration, neither in combination with Rcf2. 
 
 
Figure 3-11: Min8 is not essential for respiration.  
A) Isolated mitochondria of wild-type (Wt), min8∆, rcf2∆, min8∆rcf2∆ were lysed in Laemmli-buffer and subjected to 
SDS-PAGE (10-16 %) and western blotting. Tom70 and Aco1 served as loading controls. Cor1 and Rip1 represent complex III, 
Cox1, Cox12 and Cox13 complex IV. The asterisk marks unspecific cross-reactions of the Cor1 antibody. B) As in A) but 
mitochondria are applied to urea SDS-PAGE (17.5 %) and western blotting. C) Wild-type, min8∆, rcf2∆, min8∆rcf2∆ cells are 
spotted on plates in a serial dilution, containing glucose or glycerol media, and grown at 30 °C and 37 °C.  
For specifying the role of Min8 and its position at the cytochrome c oxidase, different BN 
analyses were carried out. To ensure that no complex IV constituent was missed in the prior 
steady state experiment, the first assessment was performed with DDM solubilized 





dimer and the overall amount of complexes can be estimated. While complex IV can be detected 
as two distinct forms, IV* and IV, Cox13 is only part of the slower migrating complex IV* 
(Figure 3-12A). This occurrence was discovered in previous studies and suggested complex IV* 
additionally containing Cox13, Rcf1 and Rcf2 (Vukotic et al., 2012). In both complex IV 
detections, the level of complex IV forms did not change significantly. Similar results were 
obtained when the respective mitochondria were analyzed after digitonin solubilization (Figure 
3-12B). Although a slight tendency of III2IV2-reduction was detected in the particular min8∆ 
strains (Figure 3-12B, lanes 2, 4, 6, 8, 10 and 12), it could not be proven as significant.  
 
 
Figure 3-12: MIN8 deletion does not affect respiration capacity.  
A) Isolated wild-type, min8∆, rcf2∆, min8∆rcf2∆ mitochondria are solubilized with 0.6 % DDM buffer and used for Blue-
Native (BN)-PAGE (6-10 %). Complex IV is detected via Cox1 and Cox13, and complex III via Cyt1. B) As in A) but 
mitochondria were solubilized with 1 % digitonin buffer and subjected to BN-PAGE (4-10 %). Cox4 and Cox1 represent 
complex IV and Atp5 complex V. C) Oxygen consumption measurement of isolated wild-type and min8∆ mitochondria with 
the Oxygraph-2k (n=3). LEAK: non-phosphorylating state; State 3: upon addition of saturating ADP; OXPHOS: maximum 
respiration under coupled conditions; OXPHOS via CIV: complex IV activity in parallel to complex III inhibition. Error bars 
indicate mean ± SEM. 
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Expecting a more sensitive outcome in a respirometry approach, min8∆ mitochondria were 
subjected to the oxygen consumption measurements with the Oxygraph-2k, in comparison to 
wild-type mitochondria. The oxygen consumption was determined in the different states 
LEAK, state 3, OXPHOS and OXPHOS via complex IV (Figure 3-12C). The terminology is 
guided by the Oxygraph-2k manufacturer’s specification (Gnaiger 2020).  
First, mitochondria are applied to the oxygen chamber containing the respiration medium with 
appropriate conditions to maintain the mitochondria intact. Mutant and wild-type mitochondria 
are always measured next to each other to keep the conditions stable for comparison. Pyruvate 
and Malate are added to allow LEAK respiration – oxygen consumption without added 
phosphorylating substrates. By this, high proton leakage would be visible since protons cannot 
escape into the mitochondrial matrix along the membrane potential via complex V. State 3 
allows ATPase performance and is triggered by adding ADP to saturating conditions. OXPHOS 
represents the maximum state of respiration under coupled conditions. For this, succinate is 
supplemented. Complex IV activity, essentially OXPHOS via complex IV, can be measured in 
the end by inhibiting complex III with antimycin A and shuttling electrons specifically to 
complex IV with TMPD and ascorbate. Ascorbate regenerates TMPD, but both undergo 
autoxidation which is appreciated by sodium azide addition and the residual oxygen 
consumption is subtracted in the end. All four measured states did not display any difference 
between min8∆ and wild-type mitochondria.  
 
In the end, these basic characterizing experiments could not assign a specific role for Min8 as 
complex IV interactor: it is not essential for respiration, nor does it influence the arrangement 
or the capacity of the respiratory chain. However, the significant interaction with Cox12 
detected by chemical crosslinking indicated a close interaction at the periphery of complex IV. 
Consequently, we were wondering if Min8 even plays a role in its biogenesis.  
 
3.3.2 Min8 affects Cox12 assembly into cytochrome c oxidase 
Investigating the import of radioactively labeled Cox12 and Cox13 into energized mitochondria, 
we were aiming for evaluating the influence of Min8 on late-stage complex IV assembly in 
general. By choosing appropriate timepoints and BN analysis, the assembled protein is 
detectable in the ultimate complex and/or maturating stages of the complex. Mitochondria with 
disrupted membrane potential (-∆y) represent the negative control for Cox13 import. Cox13 is 
a TIM23 substrate and its import is membrane potential dependent, while Cox12 is an IMS 
protein and a MIA substrate (see section 1.3.2). Thus, Cox12 import is not membrane potential 
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dependent but relies on cysteine-cysteine interactions. These can be disrupted with the cysteine 
alkylating reagent iodoacetamide (IAA) and serves as a negative control. Import is stopped after 
defined time points by disrupting the proton motive force and with a mixture of antimycin A, 
valinomycin, oligomycin (AVO) and the redox-activity of Mia40 with IAA, respectively. 
We compared wild-type and min8∆ mitochondria to each other after import of Cox13 and 
Cox12 and solubilization with 0.6 % DDM (Figure 3-13A). As before, cytochrome c oxidase is 
detectable as a monomer which serves quantification purposes. Additionally, cox4∆ 
mitochondria were used to show significance for complex IV assembly, since it lacks mature 
cytochrome c oxidase.  
 
 
Figure 3-13: Min8 influences late stage assembly of cytochrome c oxidase.  
A) 35S-labeled Cox13 and Cox12 were imported into energized wild-type (Wt), min8∆, cox4∆ mitochondria. Negative controls 
were treated before with an antimycin A, valinomycin, oligomycin (AVO) mix, to disrupt membrane potential (-∆y), and IAA 
to inhibit cysteine-cysteine interactions in case of Cox12. Imports were stopped with AVO and IAA, respectively, after indicated 
timepoints. Mitochondria were solubilized with 0.6 % DDM buffer and subjected to BN-PAGE (6-10 %). Gels were dried, 
exposed to phosphoscreen and analyzed via autoradiogram. B) Quantification of 45 min timepoint of n=3 experiments from 
A) in ImageJ with background subtraction (Schindelin et al., 2012). Normalization was performed to wild-type signals, error 
bars indicate means ± SEM. Statistical significance was determined with a two-tailed unpaired t-test (*p<0.05, **p<0.005). 
Surprisingly, we could not detect Cox12 assembling into mature complex IV but in a slightly 
faster migrating complex which was not seen before. Additionally, Cox12 assembly into this 
complex seems to occur independent of mature complex IV. The cox4∆ mutant displays an 
accumulated complex with even higher intensity than the other two strains after 45 min (Figure 
3-13A, lane 19). Comparing min8∆ against wild-type, Cox13 assembly appears to be specifically 
more efficient in the mutant, while Cox12 assembly is hindered (Figure 3-13B).  
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Although Min8 as a putative novel complex IV subunit did not significantly alter the considered 
protein environment of the respiratory supercomplexes under tested conditions, we could 
assign a role for late-stage complex IV assembly – by facilitating Cox12 assembly into a 
presumed complex IV intermediate on the one side and regulating Cox13 assembly on the other. 
 
3.4 Functionality assessment of the Rcf-domains 
Since we could now identify specific interaction sites of Rcf2 and Rcf3 at complex IV and even 
broaden the spectrum of complex IV associated proteins, an analysis of the respective 
transmembrane domains of Rcf-proteins was the next step. By this we were aiming for valuable 
information to define the so far indistinct functions of the Rcf-proteins. Evaluating the 
transmembrane features of Rcf-proteins, it was remarkable that the Rcf2 sequence comprises 
homologies to both, Rcf3 and Rcf1 (section 3.1.1, Figure 3-1A) (Römpler et al., 2016). In 
addition, an internal processing event of Rcf2 with unknown purpose was described previously. 
The C-terminus of Rcf2 harbors a conserved HIG1 domain, homologous to Rcf1, while the 
N-terminus shares a homologous sequence with Rcf3 (Römpler et al., 2016). Following this, we 
were wondering if the respective domains would complement one another or if they display 
distinct functions and we could identify a purpose for Rcf2 processing. 
Conclusively, we constructed fusion proteins of Rcf3 and Rcf1 and swap proteins with Rcf2. 
To this end, respective domains of Rcf2 were exchanged with the corresponding homologous 
protein partner. This resulted in the artificial constructs Rcf3-Rcf1, Rcf2N-Rcf1 and Rcf3-Rcf2C. 
 
3.4.1 Mimicking Rcf2 with fusion proteins 
For transforming the fusion proteins into the cells, the particular coding sequences for the 
protein regions were fused and cloned into a single copy plasmid for yeast expression. The 
proteins were expressed under the respective endogenous promotor of the N-terminal protein, 
while being aware that this ignores possible differences in protein levels. Regarding the 
conserved HIG1 domain (aa89-180) and keeping it intact, we decided the Rcf2 sections to be 
Rcf2N (aa1-83) and Rcf2C (aa84-224) (Figure 3-14A).  
The first assessment showed that all three artificial proteins are expressed in yeast cells and 
successfully imported into mitochondria. The proteins can be detected with the respective 
antibodies, yet the signals indicate that their expression level differs (Figure 3-14B). Comparing 
the signals to the respective endogenous protein, the difference is not as pronounced, except 
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for Rcf3-Rcf2C. The protein is detected with the antibody against Rcf3 and binding might be 
disturbed due to the additional C-terminus containing Rcf2. Detection of this protein with the 
Rcf2 antibody is possible in general, but the signals overlap in the chosen gel system. 
Nonetheless, we proceeded with those constructs, but it was important to consider this possible 
difference for interpretation. When the constructs were first expressed in wild-type cells, steady 
state analysis did not show significant differences in the tested proteins related to respiration. 
Furthermore, expressing additional parts of the proteins does not interfere with the endogenous 
protein expression and the Rcf-protein levels remain stable. 
 
 
Figure 3-14: Expressing fusion proteins in yeast.  
A) Model representing the constructed fusion proteins Rcf3-Rcf1, Rcf2N-Rcf1, Rcf3-Rcf2C. Light grey boxes indicate putative 
transmembrane spans representing/homologous to the N-terminus of Rcf2, dark grey boxes indicate transmembrane spans 
representing/homologous to the C-terminus of Rcf2. B) Isolated mitochondria of wild-type (Wt) cells expressing Rcf3-Rcf1, 
Rcf2N-Rcf1 or Rcf3-Rcf2C, where indicated, were lysed in Laemmli-buffer, subjected to SDS-PAGE (10-16 %) and western 
blotting. Fusion proteins were detected via mixture of Rcf1 and Rcf3 antibodies. 
 
3.4.2 Rcf3-Rcf1, Rcf2N-Rcf1 and Rcf3-Rcf2C are functional 
mitochondrial proteins 
In order to examine the functionality, we introduced the different fusion proteins into the 
mutants rcf1∆ and rcf2∆rcf3∆ and evaluated the respective protein complementation in a growth 
drop test. The mutants alone are not able to respire on non-fermentable media and display a 
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heavy growth phenotype (section 3.1.2). Functional proteins would overcome the respiration 
disability and the corresponding strain regains growth on non-fermentable media. 
The experiment showed that Rcf3-Rcf1, Rcf2N-Rcf1 and Rcf3-Rcf2C were able to compensate 
the rcf2∆rcf3∆ growth phenotype (Figure 3-15). Cells expressing the artificial proteins recover 
almost wild-type like growth. This was surprising; especially that both proteins containing parts 
of Rcf2 could either function as Rcf2 or Rcf3. However, if Rcf3-Rcf2C is behaving like Rcf2 or 
Rcf3 cannot be distinguished in this experimental setup. It seemed intuitive, that rcf1∆ cells 
expressing Rcf2N-Rcf1 or Rcf3-Rcf1 could overcome the mutant’s growth phenotype as well. 




Figure 3-15: Fusion proteins can substitute for Rcf-proteins.  
Cells of the indicated strains were spotted on glucose and glycerol plates in a serial dilution and grown for several days at 30 °C. 
As controls, wild-type cells and at least one mutant (rcf1∆, rcf2∆rcf3∆) expressing the empty plasmid were spotted next to the 
investigated strains. 
At the same time, Rcf3-Rcf2C could not restore respiration in rcf1∆. This was partly expected, 
since Rcf2 itself cannot substitute for Rcf1 function, as apparent in rcf1∆. For that reason, the 
rcf1∆ strain expressing Rcf3-Rcf2C was not taken along for the following experiments. 
In order to examine if the proteins can influence protein levels in the mutants, a rough steady 
state analysis was carried out with the respective isolated mitochondria. Considering the low 
impact of RCF deletions in terms of protein levels, only the core complex IV subunits (Cox1, 
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Cox2, Cox3) plus Qcr8 as a complex III constituent were probed additionally to the 
Rcf-proteins (Figure 3-16). When expressed in rcf1∆, both Rcf2N-Rcf1 and Rcf3-Rcf1 were able 
to restore the subtle Cox3 decrease (Figure 3-16A), which was determined before in section 
3.1.2 (Figure 3-3A). Again, the expression of the different fusion proteins did not alter 
Rcf-protein expression (compare section 3.4.1). 
 
 
Figure 3-16: Fusion proteins do not influence protein levels.  
A) Isolated mitochondria of rcf1∆ cells expressing Rcf3-Rcf1 or Rcf2N-Rcf1, where indicated, were lysed in Laemmli-buffer, 
subjected to SDS-PAGE (10-16 %) and western blotting. Fusion proteins were detected via mixture of Rcf1 and Rcf3 
antibodies. B) As in A) with isolated mitochondria of rcf2∆rcf3∆ cells expressing Rcf3-Rcf1, Rcf2N-Rcf1 or Rcf3-Rcf2C, where 
indicated. 
After assessing general functionality, we were further interested if the fusion constructs would 
behave Rcf-protein like or even Rcf2 like in regard of supercomplex association. This was 
determined via degenerating 2nd dimension SDS analysis after BN-PAGE of isolated 
mitochondria from wild-type cells expressing the respective fusion protein (Figure 3-17). By 
this, the distinct complexes are first resolved in their native conformation and subsequently the 
participating proteins are separated upon SDS lysis. 
The complex III subunit Qcr8 served as a control for respiratory supercomplexes. While Rcf1 
and Rcf2 clearly co-migrate with the III2IV(1-2) complexes Rcf3 displays only weak association 
with the supercomplexes (Figure 3-17). The majority of Rcf-proteins however, migrates within 
smaller molecular weight complexes. All three fusion proteins in turn, could be determined as 
colocalizing at the complexes III2IV(1-2), although to a different extent. While Rcf3-Rcf1 and 
Rcf3-Rcf2C could be detected in amounts comparable as Rcf2 and Rcf1 at III2IV(1-2), Rcf2N-Rcf1 
harboring complexes seem to be smaller and faster migrating.  
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In conclusion, all constructs Rcf3-Rcf1, Rcf2N-Rcf1 and Rcf3-Rcf2C were conceived as 
functional mitochondrial proteins. Although expressed under different promotors, they could 
successfully restore the detected growth phenotypes for rcf1∆ and rcf2∆rcf3∆ and did not alter 
any protein levels in a harmful way. Additionally, it was shown that they function Rcf-protein 




Figure 3-17: Fusion proteins colocalize at 
respiratory supercomplexes.  
A) Digitonin solubilized mitochondria from wild-type 
(Wt) cells expressing Rcf3-Rcf1 were subjected to BN-
PAGE (4-13 %) and the lane was used for 2nd 
dimension SDS-PAGE (16 %) and western blotting. 
The complex III subunit Qcr8 represents respiratory 
chain supercomplexes. B) and C) As in A) with 
mitochondria from Wt cells expressing Rcf2N-Rcf1 
and Rcf3-Rcf2C, respectively.  
 
3.4.3 Rcf2N-Rcf1 and Rcf3-Rcf1 facilitate supercomplex 
assembly 
Besides the systemic phenotype of rcf1∆ represented in failing respiration, the RCF1 deletion 
furthermore causes a rearrangement of the respiratory chain, described above (section 3.1.2). In 
order to determine if the fusion proteins with Rcf1 can rescue this phenotype and function as 
such, we conducted BN analysis with digitonin solubilized mitochondria.  
In fact, Rcf3-Rcf1 and Rcf2N-Rcf1 were both able to restore the respirasome assembly (Figure 
3-18). Complex III was detected with Rip1 and complex IV with Cox4 antibody. Both obtained 
native complex formation demonstrate the clear phenotype of rcf1∆ ((Figure 3-18A+B, lanes 9 
and 15) and an almost wild-type like organization when Rcf3-Rcf1 or Rcf2N-Rcf1 (Figure 3-18, 






Figure 3-18: Expression of Rcf3-Rcf1 and Rcf2N-Rcf1 rescues rcf1∆ phenotype in supercomplex arrangement.  
A) and B) Digitonin solubilized mitochondria from wild-type (Wt), rcf1∆ and rcf2∆rcf3∆ cells expressing Rcf3-Rcf1 and 
Rcf2N-Rcf1, where indicated, were applied to BN-PAGE (4-10 %) and western blotting. Atp5 as complex V subunit serves as 
a loading control, complex III is detected via Rip1 and complex IV via Cox4. 
Rcf2N-Rcf1, however, could not overcome the disbalanced arrangement completely, in contrast 
to Rcf3-Rcf1. This indicates that both proteins can fulfill a role as Rcf1, but with the Rcf2N 
fragment attached, the capacity is less pronounced. Wild-type and rcf2∆rcf3∆ do not show any 
significant alteration in supercomplexes when the artificial proteins are present. 
 
3.4.4 Rcf3-Rcf1 and Rcf2N-Rcf1 support Cox13 assembly 
Additionally to the reported support of Rcf1 during supercomplex assembly, it was previously 
shown that Rcf1 is playing a role in Cox13 assembly (Vukotic et al., 2012). Another interesting 
finding in that study is that distinct subsets of cytochrome c oxidase exist – with and without 
Cox13. These can easily be detected by DDM solubilization and thereby disruption of the 
respiratory supercomplexes on BN-PAGE. To further review the effects of the fusion proteins, 
DDM solubilized mitochondria from the different wild-type and mutant cells expressing the 
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constructs were used for BN-PAGE analysis. Especially in regard to the observed phenotype 
of rcf1∆, we were questioning if Cox13 assembly can be modulated. 
As expected, almost no complex IV* is detectable in rcf1∆ and Cox13 assembly is heavily 
impaired (Figure 3-19, lanes 5 and 16). At the same time, we could demonstrate that Rcf3-Rcf1 
can restore Cox13 assembly to almost wild-type levels. Rcf2N-Rcf1was able to rescue the 
phenotype to some extent, however, Cox13 incorporating complex IV* appeared still at a 
decreased level. Interestingly, we could observe a slight decrease in complex IV* level in the 
wild-type with Rcf2N-Rcf1 being present, as well. The double mutant, expressing either of the 
fusion proteins, did not show any difference in complex CIV* levels. 
 
Figure 3-19: Rcf3-Rcf1 and Rcf2N-Rcf1 compensate Cox13 assembly phenotype in rcf1∆.  
DDM (0.6 %) solubilized mitochondria from wild-type (Wt), rcf1∆ and rcf2∆rcf3∆ cells expressing Rcf3-Rcf1, Rcf2N-Rcf1 and 
Rcf3-Rcf2C, where indicated, were applied to BN-PAGE (6-10 %) and western blotting. 
Consequently, the fusion proteins containing Rcf1 can support Cox13 assembly in a RCF1 
deletion situation. At the same time, the N-terminal transmembrane spans of Rcf2 fused to Rcf1 
seem to interfere with the function of Rcf1 in regard to Cox13 assembly.  
 
3.4.5 Fusion proteins act flexible upon respiration 
The expression of the fusion proteins Rcf3-Rcf1 and Rcf2N-Rcf1 could compensate not only 
the phenotypes on the protein level but also within the in vivo growth test on non-fermentable 
media (section 3.4.2). With the experiments of the isolated mitochondria in mind, we were 
questioning how the fusion constructs manage the situation with none of the Rcf-proteins being 
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present. Thus, the test was repeated with rcf1∆rcf2∆rcf3∆ cells expressing the fusion proteins 
(Figure 3-20). The construct Rcf3-Rcf2C was left out in this case, since it did not improve 
respiration on glycerol in rcf1∆, initially.  
To provide evidence for specificity, Rcf3 and Rcf1 were expressed in the triple RCF mutant to 
exclude that already one of the proteins has an impact on respiratory function. Interestingly, 
both proteins Rcf3-Rcf1 and Rcf2N-Rcf1 were able to rescue the heavily affected rcf1∆rcf2∆rcf3∆ 
in terms of growth on glycerol. Meanwhile, Rcf3 or Rcf1 alone failed to enhance respiration 
ability, when expressed in the triple mutant. This was expected, since rcf2∆rcf3∆ and rcf1∆rcf2∆ 
do show a similar disrupted function. The combined deletion of RCF1 and RCF2 corresponds 
to published results of Strogolova et al. (2012) and Dawitz et al. (2020). Both studies indicate 
that this impaired respiration ability is even more distinct than of rcf1∆ (Strogolova et al., 2012; 
Dawitz et al., 2020).  
 
It could not be determined in this setup if the domains are able to operate within the same 
protein or from different proteins. However, the proteins could accomplish a function as Rcf2 
or Rcf3 and Rcf1 at the same time. Conclusively, the proteins are capable of using the 
appropriate domains flexibly and adapt to the particular demands. 
 
 
Figure 3-20: Rcf3-Rcf1 and Rcf2N-Rcf1 
rescue rcf1∆ and rcf2∆rcf3∆ respiration 
phenotype simultaneously. 
Cells of the indicated strains were spotted 
on glucose and glycerol plates in a serial 
dilution and grown for several days at 
30 and 20 °C. 
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3.4.6 Rcf2 fragments Rcf2N and Rcf2C alone are not functional 
As described before in section 3.4.2, the fusion constructs harboring parts of Rcf2 were able to 
compensate the respiration phenotype detected in rcf2∆rcf3∆. Since this was entirely unexpected, 
it was important for us to study the effects of Rcf2 fragments alone. We were questioning if 
both parts of Rcf2 alone would have the same ability. Thus, plasmids encoding for 
Rcf2N (aa1-83) and Rcf2C (aa84-224) were transformed into rcf2∆rcf3∆ and into wild-type cells.  
 
Figure 3-21: Rcf2N and Rcf2C 
fragments alone are not functional. 
Cells of the indicated strains were 
spotted on glucose and glycerol plates 
in a serial dilution and grown for 
several days at 30 and 20 °C.  
 
We subsequently performed a growth drop-test with the respective strains and the result proved 
that the rescue of respiration phenotype of rcf2∆rcf3∆ was specific to the Rcf2N-Rcf1 construct 
(Figure 3-21). Both fragments of Rcf2 failed to enhance respiration significantly and are not 
functional as such. This is counterintuitive, yet not completely surprising. Römpler et al., (2016) 
made a similar discovery when they tested the functionality of Rcf2 fragments, after they 
imported them successfully into mitochondria. Even though the C-terminal fragment of 
Rcf263-224 could assemble into respiratory supercomplexes, it could not function as full-length 
Rcf2 and rescue the growth phenotype of the RCF2 RCF3 double mutant. And neither could 
the corresponding fragment Rcf21-62 accomplish that (Römpler et al., 2016). 
In the end, it was an important observation, that the functionality of the fusion proteins did not 
rely exclusively on the Rcf2 fragments and was specific. Especially with these results in mind, it 
was intriguing that Rcf2N-Rcf1 possesses enough functionality to rescue the respiration 




3.4.7 Oxygen consumption and ROS measurements reveal 
dynamic functions of fusion proteins 
Given the effect on respiration of the particular fusion proteins, we expected to obtain a detailed 
understanding of the mechanistic influence regarding the protein domains by measuring the 
respiration rate and ROS production. The RCF mutants displayed respirational phenotypes in 
terms of oxygen consumption on the one hand, and undesired release of reactive oxygen 
species (ROS) on the other hand (Vukotic et al., 2012; Römpler et al., 2016). Loss of Rcf1 causes 
a higher ROS production with concurrent oxygen consumption impairment and drop of 
complex IV activity (Vukotic et al., 2012). Rcf2 and Rcf3 revealed their overlapping regulatory 
role of complex IV while rcf2∆ results in enhanced ROS production as well (Römpler et al., 
2016).  
Both assays are performed with isolated mitochondria in the same respiration medium which 
allows comparability. ROS production is detected, in this case, with AmplexUltra Red which 
reacts with H2O2 to fluorescent resorufin. H2O2 only represents a subset of ROS, yet H2O2 is 
formed when superoxide anions react with superoxide dismutase (SOD). Consequently, it is a 
sufficient indicator of ROS production in mitochondria. H2O2 concentration was measured with 
saturated amounts of non-phosphorylating supplements. Thus, measuring conditions are in 
principle similar to those during LEAK respiration. The different oxygen consumption states 
and their conditions were mentioned more in detail above in section 3.3.1. 
As in the other analyses, isolated mitochondria from wild-type cells were applied for a first 
assessment. While mitochondria of wild-type cells expressing Rcf3-Rcf1 display a similar ROS 
level like wild-type mitochondria itself, overexpressing parts of Rcf2 lead to a significantly higher 
ROS production (Figure 3-22A). At the same time, oxygen consumption remains stable in the 
Rcf2N-Rcf1 containing strain, compared to wild-type (Figure 3-22B). Apparently, higher ROS 
production is not necessarily caused by higher respiration activity. Overexpression of Rcf3 due 
to the fusion proteins attenuates respiration capacity, especially together with Rcf2C 
overexpression. Surprisingly, their effect is not bound to complex IV activity, although this 
seem to be their major interacting complex. The effect of Rcf3 overexpression implies to be 
more systemic in regard to the whole respirasome.  
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Figure 3-22: Overexpressing parts of Rcf2 results in higher 
ROS production.  
A) Isolated mitochondria from wild-type (Wt) cells expressing 
different fusion proteins were applied for H2O2 concentration 
measurements with fluorescent dye AmplexUltra Red (n=3). 
Emission (Exc: 555 ± 10 nm, Em: 581 ± 5 nm) was measured 
after adding HRP as catalysator. Normalization: 
100 % = Wt(900s) B) Oxygen consumption measurement of 
same mitochondria as in A) with the Oxygraph-2k (n=3). LEAK: 
non-phosphorylating state; State3: upon addition of saturating 
ADP; OXPHOS: maximum respiration under coupled conditions; 
OXPHOS via CIV: complex IV activity in parallel to complex III 
inhibition. Normalization: 100 % = Wt(OXPHOS). Error bars 
indicate mean ± SEM 
 
Overall, overexpressing the Rcf-proteins as part of the fusion constructs appears to interfere 
with proper endogenous Rcf-protein function. The fact that Rcf3-Rcf1 and Rcf3-Rcf2C are 
behaving differently indicates that the domains still display a distinct functionality although 
fused to others. 
 
Next, we were focusing on the effects of the fusion proteins within the mutants. With regard to 
comparability of results and dimension of the different measurements, they were normalized to 
the wild-type measurements. As it was also determined in a previous study, the RCF1 deletion 
mutant shows a significantly higher ROS production than the wild-type and a heavily impaired 
respiration (Vukotic et al., 2012). Rcf2N-Rcf1 appeared to be promising by modulating 
OXPHOS capacity as well as complex IV activity back to wild-type level in rcf1∆ (Figure 3-23C). 
The high ROS production of rcf1∆ is also decreased, however, it cannot rescue the phenotype 
completely (Figure 3-23A). Rcf3-Rcf1 shows the opposite behavior – although undesired ROS 
production can be prevented and is comparable to wild-type level (Figure 3-23B), the OXPHOS 
capacity is only moderately enhanced (Figure 3-23D). Complex IV activity can be restored and 







Figure 3-23 Fusion proteins modulate oxygen consumption and H2O2 production in a flexible way.  
A) and B) Isolated mitochondria from rcf1∆ or rcf2∆rcf3∆ cells expressing different fusion proteins were applied for H2O2 
concentration measurements with fluorescent dye AmplexUltra Red (n=3). Emission (Exc: 555 ± 10 nm, Em: 581 ± 5 nm) 
was measured after adding HRP as catalysator. Normalization: 100 % = Wt(900s). C) and D) Oxygen consumption 
measurement of same mitochondria as in A) and B) with the Oxygraph-2k (n=3). LEAK: non-phosphorylating state; State3: 
upon addition of saturating ADP; OXPHOS: maximum respiration under coupled conditions; OXPHOS via CIV: complex IV 
activity in parallel to complex III inhibition. Normalization: 100 % = Wt(OXPHOS). Wt control is identical through all 
experiments. Error bars indicate mean ± SEM. 
The double mutant did not show a drastic difference in respiration in general, yet complex IV 
activity is even more affected than in rcf1∆. When Römpler and colleagues (2016) compared 
rcf2∆rcf3∆ respiration to the wild-type, respiration via complex IV was similarly affected but also 
respiration principally (Römpler et al., 2016). Our results, however, indicate that measured 
OXPHOS capacity and complex IV activity do not necessarily promote each other.  
 
When we investigated the ROS level of rcf2∆rcf3∆ mitochondria, it was significantly higher than 
of wild-type mitochondria, yet not as high as of rcf1∆ ((Figure 3-23A+C). Together with the 
observation that in contrast to rcf1∆, the respiratory supercomplex arrangement is not altered, 
the results confirm the different nature of both mutants. Nevertheless, the endpoints as 
complex IV activity, ROS production and growth on non-fermentable media appear similar. 
Neither of the fusion proteins were able to lower the ROS production in the double mutant 
(Figure 3-23B). Rcf2N-Rcf1 even enhanced the ROS level significantly. At the same time, this 
protein version displayed the highest OXPHOS capacity of all measured mitochondria, which 
was paradoxically not mediated through a significantly increased complex IV activity compared 
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to wild-type (Figure 3-23D). In parallel, the LEAK respiration was enhanced, indicating a 
proton leakage through the inner mitochondrial membrane, which might be even more 
pronounced upon addition of supplements addressing the OXPHOS state. 
The fusion proteins comprising Rcf3 show in general a downregulation of oxygen consumption, 
which means that the domains fused to each other cannot fulfill the functions of endogenous 
Rcf2 or Rcf3. They rather interfere with their intrinsic determination. 
 
In the end our results demonstrated that the artificial fusion constructs can act very flexibly 
depending on the requirements when one or several Rcf-proteins are not present. However, it 
revealed also, that the constructs are not acting as the respective full-length endogenous proteins 
and still harbor distinct functionalities. After this general assessment of mitochondrial function, 
it was important to furthermore examine the influence on specific interaction sites. All 
endogenous Rcf-proteins were found to bind to newly synthesized complex IV subunits 
(section 3.1.3), while Rcf1 was reported as potential player in cytochrome c oxidase maturation 
(Strogolova et al., 2012; Garlich et al., 2017). Consequently, we were wondering, whether the 
fusion constructs can influence this function in a similar flexible manner.  
 
3.4.8 Fusion proteins influence Rcf1 association with newly 
translated Cox3 
To characterize the role of transmembrane domains with respect on the involvement of Rcf1 
during complex IV maturation, another labeling approach with isolated mitochondria was 
conducted. Upon radioactive labeling of mitochondrial translated proteins with 35S-Metionine, 
the co-immunoprecipitation followed with Rcf1 specific antiserum to isolate Rcf1 specific 
complexes. First, mitochondria from wild-type cells expressing the different artificial proteins 
were investigated. The assay was performed as before in section 3.1.3. with a 35S-Met pulse 






Figure 3-24: Rcf3-Rcf1 and Rcf2N-Rcf1 support post-translational interaction with Cox3. 
A) Isolated mitochondria from wild-type (Wt) cells expressing the indicated fusion proteins are subjected to radioactive labeling 
of mitochondrial encoded proteins with 35S-methionine for 10 min, followed by solubilization with 0.6 % DDM and 
co-immunoprecipitation with Rcf1 and control beads. Totals and glycine elution were subjected to Tricine-SDS 
PAGE (10-18 %), western blotting and autoradiogram. B) Immunodetection of A). Tom70 and Aco1 serve as control proteins 
for specific isolation. C) Quantification of isolated Cox3 and Cox2 from A) with n=3. Results are normalized to the respective 
total signals and were quantified using ImageJ software with background subtraction (Schindelin et al., 2012). Error bars indicate 
mean ± SEM. 
It seemed to be intuitive that proteins harboring extra Rcf1, co-purify more labeled Cox3 (Figure 
3-24A+C). Furthermore, Cox2 was also co-isolated specifically as mentioned before (section 
3.1.3), but apparently in a different ratio in the Rcf3-Rcf2C strain compared to the other strains. 
This implies that there is a ratio shift of Rcf1 interacting exclusively with the COX3 module, 
but not with mature complex IV. This could also be determined via immunodetection (Figure 
3-24B), where Cox1 is specifically co-isolated with Rcf1 when Rcf3-Rcf1 and Rcf2N-Rcf1 are 
present. In parallel, other interactors of Rcf1 are eluted in a decreased concentration as it is the 
case for Cox3, Rcf2, and Rcf3, while purification efficiency of Rcf1 remained stable. It indicates 
that Rcf3-Rcf2C rather interferes while Rcf3-Rcf1 and Rcf2N-Rcf1 support endogenous Rcf1 
function in terms of post-translational Cox3 binding and its modular assembly. But it could also 
be a result of the different expression levels, as mentioned before (section 3.4.1). 
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Figure 3-25: Post-translational interaction of Rcf1 with Cox3 is impaired in rcf2∆rcf3∆.  
A) and B) Isolated mitochondria from rcf1∆ or rcf2∆rcf3∆ cells expressing the indicated fusion proteins are subjected to 
radioactive labeling of mitochondrial encoded proteins with 35S-methionine for 10 min, followed by solubilization with 0.6 % 
DDM and co-immunoprecipitation with Rcf1 and control beads. Totals and glycine elution were subjected to Tricine-SDS 
PAGE (10-18 %), western blotting and autoradiogram. C) and D) Quantification of isolated Cox3 and Cox2 from A) with 
n=3. Results are normalized to the respective total signals and were quantified using ImageJ software with background 
subtraction (Schindelin et al., 2012). Error bars indicate mean ± SEM. E) and F) Immunodetection of A). Tom70 and Aco1 
serve as control proteins for specific isolation.  
Next, we wanted to study those effects of the respective plasmids encoding for the fusion 
proteins when transformed into the mutants rcf1∆ and rcf2∆rcf3∆. The fusion proteins 






(Figure 3-25B+D), but not as effective as from rcf1∆ (Figure 3-25A+C) or before from wild-type 
mitochondria (Figure 3-24A+C). Already the situation of the double mutant itself distinguishes 
from the wild-type situation. Apparently, deletion of RCF2 and RCF3 affects the 
post-translational interaction of Rcf1 with Cox3. The immunodetection of Cox3 displays an 
affected interaction with Rcf1 as well, including the overall accessible Cox3 from complex IV. 
This might stand in relation to the proposed mutual role of Rcf1 and Rcf2 in Cox3 assembly 
and/or folding (Strogolova et al., 2019). 
 
Still, the effect of the fusion proteins in the rcf2∆rcf3∆ background is not as different, considering 
the initial level of interaction. The existence of Rcf2 fragments or Rcf3, yet seem to interfere 
with Rcf1 function when endogenous Rcf2 and Rcf3 are not present. The interaction of solely 
Rcf3-Rcf1 and Rcf2N-Rcf1 with newly synthesized Cox3 in the rcf1∆ mutant is comparable to 
the wild-type situation, overexpressing at least parts of the Rcf-proteins. This means that the 
overexpression itself does not have an effect in this regard but the domains fused to each other. 
Those assays confirmed again the dynamic and flexible role the fusion proteins can occupy.  
Given that the Rcf-protein family obviously interacts with already maturing cytochrome c 
oxidase, we were moreover aiming to enrich the proposed state of interaction at the site of Cox3 
and Cox2. For this, the deletion of Cox5a seemed to be a useful tool. Cox5a represents an early 
assembling protein of the COX1 module (section 1.4.3) (Fontanesi et al., 2006; Mick et al., 2007). 
A deletion consequently results in disrupted COX1 modular assembly and the other modules, 
more relevant in regard to Rcf-proteins, can be studied more independently. On the other hand, 
Hartley et al. (2020) could resolve a Rcf2 association with complex III2IV in a cox5a∆ condition 
via cryo-EM. Thus, we were curious about a possible influence on Rcf-protein association at 
complex IV when Cox5a is absent. 
 
3.5 Interaction of Rcf2 with complex III 
3.5.1 Cox5a∆ reveals specific interaction of Rcf2 with 
complex III2 
Working with cox5a∆ or cox5b∆ yields the advantage that there is no mixed population of 
hypoxic and normoxic supercomplexes as the proteins represent oxygen dependent 
isoforms (see also section 1.4.4). This is usually ignored under wild-type conditions, where also 
small amounts of the hypoxic isoform are expressed (Figure 3-26A). A steady state analysis of 
cox5a∆ and cox5b∆ mitochondria showed, that the cox5b∆ does not display a significant change 
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of either complex IV or complex III subunits on a protein level, compared to wild-type (Figure 
3-26A). Since Cox5b is expressed only in minor amounts in a wild-type situation, it is expected 
that its deletion does not have a strong impact. Cox5a∆ mitochondria, in contrast, display a 
heavy decrease in complex IV subunits. The reason is probably the expression level of Cox5b. 
In a cox5a∆ situation the level of the hypoxic isoform is only slightly increased and cannot 
compensate for loss of Cox5a. Complex III subunits like Rip1 and Qcr8 as well as the 
Rcf-proteins are not significantly affected (Figure 3-26A). 
 
 
Figure 3-26: Hypoxic isoform Cox5b cannot compensate for loss of Cox5a. 
A) Isolated wild-type (Wt), cox5a∆ and cox5b∆ mitochondria were lysed in Laemmli buffer and applied to SDS-PAGE (10-16 %) 
and Urea SDS PAGE (17.5 %) for resolving Cox5a and Cox5b. Rip1 and Qcr8 represent complex III subunits, Cox-antibodies 
complex IV. B) Digitonin solubilized mitochondria from Wt, cox5a∆ and cox5b∆ cells were subjected to BN-PAGE (4-10 %). 
Complex IV is detected via Cox1, Cox2 and Cox3, complex III via Cyt1 and Atp5 serves as loading control detecting complex 
V.  
This result is also reflected by BN analysis. Since only minor amounts of Cox5b are present, 
supercomplex assembly is almost completely abolished (Figure 3-26B). Small amounts of 





is found as dimeric III2. At the same time, cox5b∆ shows almost wild-type like supercomplex 
formation. 
To further investigate the association of Rcf-proteins in the cox5a∆ situation, a 2nd dimension 
analysis after BN-PAGE was conducted in comparison to wild-type mitochondria (Figure 3-27).  
It confirmed the first assessments of the 1st dimension, with the majority of complex III being 
present as a dimer, but small amounts of supercomplex III2IV being built in cox5a∆. In the 
wild-type analysis (Figure 3-27A), previous observations could be confirmed with all three 
Rcf-proteins residing at complex III2IV(1-2) (Vukotic et al., 2012; Römpler et al., 2016). Yet, the 
majority of Rcf1, Rcf2 and Rcf3 co-migrates in smaller complexes.  
 
 
Figure 3-27: Rcf2 associates with complex III2 in cox5a∆ while supercomplex assembly is impaired.  
A) and B) Digitonin solubilized mitochondria from wild-type (Wt) or cox5a∆ cells, respectively, were subjected to 
BN-PAGE (4-16 %) and the lane was used for 2nd dimension SDS-PAGE (16 %) and western blotting. Complex IV is 
represented by Cox1, Cox2, Cox3 and Cox13 detection, complex III by Rip1, Cor1 and Qcr8. 
Remarkably, Rcf2 could be detected as residing at the supercomplex and complex III2 in cox5a∆ 
as well (Figure 3-27B). Although the ability of Rcf2 to bind with complex III was shown 
previously (Römpler et al., 2016), a significant detection at complex III2 has not been 
experienced yet. Rcf1 and Rcf3 are barely detectable at higher molecular weight complexes in 
the cox5a∆ situation. While the majority of Rcf3 is migrating at around 66 kDa, Rcf1 is resolved 
similarly to Cox3. The migration of the smaller Rcf-complexes, however, does not change 
significantly when Cox5a is missing. 
It seems a bit contradictory, on the one hand having Rcf2 resolved in complex III2IV at the 
periphery of complex IV and on the other being able to detect it at complex III2, both in cox5a∆, 
an alleged hypoxic state. Only the C-terminus of Rcf2 was resolved within the cryo-EM 
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structure (Hartley et al., 2020), therefore we were questioning a specific involvement of the 
distinct Rcf2 domains. On the one side half of Rcf2 could be responsible for complex III2 
association, while the C-terminus of Rcf2 is crucial for III2IV interaction under these conditions. 
Consequently, we utilized once more the verified tool of Rcf fusion proteins with the intention 
to study the relevance of the different transmembrane domains for the interaction. 
 
3.5.2 Behavior of fusion proteins in cox5a∆ 
Upon expression of Rcf3-Rcf1, Rcf2N-Rcf1 and Rcf3-Rcf2C in cox5a∆ cells, we addressed if the 
localization of the constructs changed from a wild-type situation (section 3.4.2) and conducted 
2nd dimension analysis after BN-PAGE. Complex III2IV is represented by complex IV subunits 
Cox1, Cox2 and Cox13 and complex III subunits Rip1 and Qcr8 (Figure 3-28).  
Although only small quantities of complex III2IV are built, the constructs can be determined at 
the supercomplexes, except for Rcf2N-Rcf1 (Figure 3-28B). However, the protein amounts 
detectable in this case are low, and apparently, neither of the proteins behave like endogenous 
Rcf2 and reside at complex III2. Like before, the majority of Rcf1 and Rcf3 migrate at lower 
molecular weight complexes in this background. Nevertheless, the fusion construct of Rcf3 and 
Rcf1 is detectable at III2IV (Figure 3-28A), leading to the assumption that the topology itself 
plays an important role in the complex association. 
In addition, we were paying attention to the processed versions of Rcf2, since these represent 
the single transmembrane regions descending from endogenous Rcf2. Thus, investigating the 
Rcf2 fragments might reveal a specific interaction site for the transmembrane regions which we 
could not detect with the fusion proteins. Exclusively the endogenous C-terminal of Rcf2 is 
recognized by the antibody. Interestingly, we could determine that it co-localizes like full-length 
Rcf2 at both complex III2IV and III2 (Figure 3-28). This raised the question, how the internal 
processing event could be related to this unexpected behavior. By tracing the processed versions 
of Rcf2 we were aiming not only for understanding the association of Rcf2 but also for 







Figure 3-28: The minority of fusion proteins resides 
at III2IV and Rcf2C co-migrates with III2. 
A) Digitonin solubilized mitochondria from cox5a∆ cells 
expressing Rcf3-Rcf1 were subjected to BN-PAGE (4-
16 %) and the lane was used for 2nd dimension SDS-
PAGE (16 %) and western blotting. Complex IV is 
represented by Cox1, Cox2 and Cox13 detection, 
complex III by Rip1 and Qcr8. B) and C) as in A) with 
mitochondria from cox5a∆ cells expressing Rcf2N-Rcf1 
and Rcf3-Rcf2C, respectively. 
 
3.5.3 Tracing processed Rcf2 in the cox5a∆ background 
The fact that Rcf2C can be observed to associate with complex III2 in a cox5a∆ situation, raised 
the question, what the role of the more labile Rcf2N could be. We were furthermore wondering 
if the co-localization differs from full-length Rcf2 or Rcf2C. When Römpler et al. (2016) first 
studied the processed versions of Rcf2 under wild-type conditions, they found Rcf2C still 
associated to the supercomplexes, while Rcf2N could not be detected to interact with them. For 
studying the N-terminal fragment they introduced a FLAG-tagged version of Rcf2 (FLAGRcf2). 
By this, Rcf2N detection was possible via FLAG antibody (Römpler et al., 2016). We adopted 
this approach and FLAGRcf2 was expressed from a centromeric plasmid and transformed into 
the cox5a∆rcf2∆ and cox5a∆ background. First, we determined, if both fragments, Rcf2C and 
Rcf2N can be isolated together with Qcr8 in cox5a∆. To exclude that the expression of FLAGRcf2 
has an effect on the interaction, cox5a∆ with endogenous expression of Rcf2 served as a control. 
It appeared that expression of FLAGRcf2 is increased, compared to wild-type Rcf2. The 
FLAG-tagged version also seems to promote processing of Rcf2, which can be detected via 
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Rcf2 antibody (Figure 3-29A). Both versions are purifiable via Qcr8 co-immunoprecipitation, 
considering that the majority of Qcr8 is present in complex III2. In addition, the remaining 
FLAGRcf2N fragment is associated with Qcr8. When isolating from the FLAG tag, FLAGRcf2 can 
be enriched together with small amounts of FLAGRcf2N and sufficient amounts of Qcr8 (Figure 
3-29B). The immunoprecipitations from both sides – Rcf2 and complex III, confirm the 
previous proposition with a specific Rcf2 interaction with complex III. However, the evidence 
was still circumstantial that this happens at complex III2 because 2nd dimension analysis 
demonstrates a co-migration and not necessarily a complex association. While isolating from 
Qcr8 and FLAGRcf2, we cannot distinguish between III2IV and III2 complexes.  
 
 
Figure 3-29: Processed versions of Rcf2 associate with complex III2IV and III2.  
A) Digitonin (1 %) solubilized mitochondria from cox5a∆ and cox5a∆rcf2∆ cells expressing FLAGRcf2, as indicated, where 
applied to Qcr8 co-immunoprecipitation. Totals and glycine eluates were analyzed via SDS-PAGE (10-16 %) and western 
blotting. Tom70 decoration and control columns prove specific interaction. B) Same mitochondria as in A) were solubilized 
with 1 % Digitonin and used for FLAG-immunoprecipitation. Native elution was conducted with FLAG-peptide. Totals and 
eluates were analyzed via SDS-PAGE (10 16 %) and western blotting. Cox5a∆ mitochondria and Tom70 decoration serve as 
negative controls for specific isolation via FLAG-tag. C) As in B) with digitonin (1 %) solubilized mitochondria from 
cox5a∆rcf2∆ cells expressing FLAGRcf2. Sample was subjected to BN-PAGE (4-16 %) and the lane was used for 2nd dimension 
SDS-PAGE (16 %) and western blotting. Complex IV is detected via Cox2 and complex III via Qcr8. FLAGRcf2 and FLAGRcf2N 





Consequently, we were further examining the hypothesis that the isolated complexes are in fact 
complex III2 by deploying the 2nd dimension analysis in combination with native FLAG 
isolation. To this end, we could obtain the FLAG eluate enriches complex III2IV artificially, 
where the greater proportion of the Rcf2 versions is localized (Figure 3-29C). Interestingly, we 
could prove both fragments and full-length Rcf2 reside at complex III2IV and complex III2. 
Even the ratio of localization appears to be similar with the majority being present at III2IV.  
Thus, the fragments did not show a different accumulation in this analysis and we cannot 
conclude a specific interaction via one part of Rcf2 or the other. Yet, the interaction appears to 
descend from the initial interaction of full-length Rcf2. The sequence of that particular 
association remains unclear. Two scenarios are possible: the association with complex III2 
happens due to degradation of the supercomplex III2IV or it occurs during an upstream process 
towards supercomplex assembly. Additionally, it is elusive if this finding stands in direct relation 
to cox5a∆ and the alleged hypoxic state or whether the accumulation is caused by disabled 
supercomplex assembly.  
Overall, it was a remarkable and surprising result to find Rcf2 and its fragments additionally at 
complex III2 considering its preferred association with complex IV (Vukotic et al., 2012; 






A vast effort has been made over the past century to shed more light into the dynamics of the 
mitochondrial respiratory chain. The view on the multimeric complexes made progress from 
the “solid-state” model towards a “plasticity” model. By now, it is a well-accepted theory that 
the respiratory chain is dynamically organized in so-called supercomplexes. Over the recent 
years, more and more valuable data has been gathered about the structure of the respiratory 
supercomplexes and helped to identify unknown interactors and subunits of the cytochrome c 
oxidase and cytochrome bc1 complex. 
Novel cryo-EM structures of yeast respiratory supercomplexes revealed a close interaction 
between complex IV and complex III forming a connecting bridge via Cox5a/b and Cor1 
(Hartley et al., 2019, 2020; Rathore et al., 2019). However, the mechanism and regulation of 
supercomplex assembly remains elusive. At this point, the Rcf-proteins came into attention as 
potential players in yeast supercomplex assembly. Rcf1 was found to be essential for efficient 
respirasome assembly (Chen et al., 2012; Vukotic et al., 2012). In parallel, there is evidence that 
the crucial interaction already takes place at the level of complex IV modular assembly. Rcf2 
and Rcf3 were assigned to be involved in more regulatory pathways of complex IV and the 
supercomplex (Strogolova et al., 2012, 2019; Römpler et al., 2016; Garlich et al., 2017; Dawitz et 
al., 2020). However, the key interactors and localization were still ambiguous at the starting 
point of this study. In the end, our investigations aimed towards a better understanding of the 
role of the Rcf-proteins with respect to supercomplex assembly and their functional 
environment. 
 
4.1 Topology and orientation of the Rcf-proteins 
One of the first and basic observations we made was the relative orientation of the Rcf-proteins 
within the inner mitochondrial membrane. Previous studies claimed a Nout-Cout orientation for 
Rcf1 and Rcf2. On the one hand with different detection methods targeting the different termini 
of the proteins (Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 2012) and on the other 
with in silico analysis (Römpler et al., 2016). The cryo-structure of Hartley et al. (2020) resolves 
the C-terminus of Rcf2 as facing towards the IMS and represents strong evidence for this model 
as well. Our proteinase accessibility analysis (section 3.1.1) confirms the C-termini of the three 
proteins protruding into the IMS. By including the analysis of the N-terminal FLAG-tagged 
version of Rcf2 we could find – once more – evidence for the N-terminus of Rcf2 being 
accessible from the IMS and at the same time verify the idea of an even number of 
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transmembrane segments. Additionally, the crosslinking data acquired in collaboration with 
Linden et al. (2020), and our biochemical experiments displayed the C-terminus of Rcf2 
crosslinked to Cox12 (IMS protein) and to a C-terminal domain of Cox13 (K85) (section 3.2.1). 
Due to the crosslinking data, we could also conclude valuable findings about the topology of 
Rcf3. We were able to verify a crosslink between Rcf3 and Cox13, and according to the mass 
spectrometry results, it is developed by the N-terminus of Rcf3 and the same C-terminal amino 
acid of Cox13 (K85) as with Rcf2 (section 3.2.2). Together with the previously mentioned 
proteinase accessibility assay, this suggests a Nout-Cout for Rcf3, as well. 
 
Nevertheless, Zhou et al., (2018a; 2018b; 2020) analyzed Rcf1 and Rcf2 within NMR studies 
and suggested five transmembrane segments for both proteins. This topology is supported by 
the assumption that the C-termini are exposed to the mitochondrial matrix. The analyses had 
been performed in a membrane free environment using detergent micelles and the results are 
clearly contradictory to all mentioned findings. Thus, we conclude that this is not consistent 
with the in vivo behavior of Rcf2 and Rcf1. It rather displays a flexible and in fact interesting 
characteristic of both proteins. They found hydrophilic residues shield their polarity from the 
lipophilic surface and form so-called “charged zipper” interactions within the lipid layer. By this, 
they found the proteins homo-dimerize with a second molecule Rcf1/Rcf2 (Zhou et al., 2018b; 
Zhou et al., 2020). We could not confirm the observation of Rcf1 or Rcf2 dimers with any of 
our experiments, however, this could be a possibility to interact with other proteins and pictures 
a responsive nature of Rcf1 and Rcf2. 
 
In the end, our data yielded valuable information about the arrangement of the Rcf-proteins 
and their residues with favoring the respective termini to stretch into the IMS. 
 
4.2 Localization of Rcf-proteins 
4.2.1 Rcf-proteins as substoichiometric interactors of COX 
Different cryo-EM structures did not resolve the Rcf proteins as part of the respiratory 
supercomplexes (Mileykovskaya et al., 2012; Hartley et al., 2019; Rathore et al., 2019). Rcf1 and 
Rcf2 were found, however, as part of the corresponding mass spectrometry data (Hartley et al., 
2019, 2020). Garlich et al. (2017) characterized Rcf1 as it transiently associates to complex IV 
and does not remain at the complex. In addition, different populations of complex IV can be 
detected (Vukotic et al., 2012; Garlich et al., 2017). A considerable amount of Rcf-proteins does 
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not reside at the supercomplexes or mature complex IV (Römpler et al., 2016; Dawitz et al., 
2020). Co-immunoprecipitation experiments indicate that the Rcf-proteins interact among each 
other as well (Römpler et al., 2016). Consequently, they were classified as substoichiometric 
interactors of complex IV and within the supercomplexes III2IV(2).  
 
A recently published cryo-EM structure of the yeast respiratory supercomplex, remarkably 
resolved Rcf2107-205 as a structural subunit of the hypoxic complex III2IV (Hartley et al., 2020). 
In a previous approach of the same group, a similar density could be identified within the same 
pocket, formed by Cox3, Cox12 and Cox13 in complex III2IV2, but not assigned with certainty 
(Hartley et al., 2019). They argue that isolated from Cox13 as a late-stage assembled protein, 
completely matured supercomplexes can be isolated efficiently. Additionally, different 
experiences proved that the association of Rcf-proteins as peripheral interactors is sensitive to 
detergent treatment (Vukotic et al., 2012; Römpler et al., 2016). This might be a reason why the 
proteins were missed in previous structures. Our analyses rather corroborate previous data with 
the Rcf-proteins, including Rcf2, as substoichiometric interactors of the supercomplex. The 
endogenous proteins were detected in a wild-type situation to localize at the supercomplexes, 
yet, the majority of the proteins migrate in smaller complexes (section 3.5.1). These findings 
deliver circumstantial evidence for a population of supercomplexes being present without 
Rcf-proteins.  
In order to address this question, one could ideally isolate from proteins assembling at a 
different stage or even the Rcf-proteins themselves and subject the sample to BN-PAGE. The 
proteins would have to be tagged that native application is possible and isolation efficiency 
remains comparable. When working on this approach we repeatedly faced the problem that the 
proteins were not fully functional and caused problems in vivo in biogenesis of the respiratory 
chain. Consequently, some adjustments would be necessary and functionality can be controlled 
with the respective RCF mutants as they display impaired growth on non-fermentable media 
(section 3.1.2). 
 
4.2.2 The interaction network of Rcf2 and Rcf3 
Chemical crosslinking with subsequent mass-spectrometry analysis revealed Rcf2, Rcf3 and a 
so far uncharacterized protein Min8 (to be discussed in section 4.1) crosslinked to the 
cytochrome c oxidase (Linden et al., 2020). We could prove these crosslinks to be specific in our 
biochemical analyses (section 3.2.1 and 3.2.2). It places all three proteins at the periphery of 
complex IV in contact with Cox12 and, in the case of Rcf2, with Cox13 as well. When evaluating 
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our biochemical analysis of Rcf2 crosslinks we could also detect the C-terminal fragment of 
Rcf2. Our data indicate that the fragment remains at the same localization as full-length Rcf2 as 
similar specific crosslinks occurred but shifted by the size of cleaved Rcf2N (section 3.2.1). This 
finding furthermore matches the resolved C-terminus of Rcf2 in the cryo-structure of Hartley 
et al. (2020). The reason that the N-terminus is not resolved could be indicative for partial 
processing of Rcf2 leading to a heterogeneity in supercomplex populations. In contrast to Rcf2 
and Rcf3, crosslinks with Rcf1 could not be detected in the approach we used with crosslinking 
whole mitochondria (Linden et al., 2020). Due to the high amounts of mitochondrial protein 
crosslinks, low abundant proteins with transient interactions are hard to detect. Additionally, 
the topology and transmembrane spans are playing a role since the residues embedded into the 
membrane are barely accessible for the crosslinker (Linden et al., 2020). An adaption of the 
analysis as described below could still resolve the interaction with Rcf1 and complex IV by a 
crosslinking-mass spectrometry approach. 
 
The crosslinking results themselves cannot conclude any timeframe the interaction takes place, 
being obtained from whole mitochondria. However, it is likely that the crosslink occurs at the 
supercomplex level, since Rcf2, Rcf3 and Min8 were found in previous mass-spectrometry data 
collected from supercomplex isolation via Cor1TAP (Vukotic et al., 2012). Rcf1 and Rcf2 were 
also found in mass-spectrometry data of supercomplex isolation via Cox13His. Therefore, it 
would be interesting if Rcf3 and Min8 were present as well (Hartley et al., 2019, 2020). 
Unfortunately, the data was only partly published in this case.  
In order to get a better understanding of the involvement of the Rcf-proteins and Min8 it could 
also be a feasible approach to use the Cor1TAP isolated supercomplex for a more structural 
analysis. Since the proteins can be co-isolated, a subsequent crosslinking and mass-spectrometry 
analysis could identify the interaction on the level of the supercomplex. It could also give more 
information about the stoichiometry of the proteins. By this, however, one would have to rely 
on a stable interaction for the isolation beforehand. The advantage of our approach (Linden et 
al. 2020) is that the crosslinking procedure with whole mitochondria is performed without the 
effects of detergents. Subsequently, harsher detergents like SDS can be used for solubilization 
without disrupting the chemical connection the proteins established via the crosslinker. Thus, 
one could use this idea the other way around: First, whole mitochondria are subjected to 
chemical crosslinking and afterwards isolated via Cor1TAP to run the mass-spectrometry analysis. 
Even transient interactions with the supercomplexes would be enriched and a close to in vivo 
situation could be evaluated. 
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4.1 Min8 – a novel oxidase associated protein 
4.1.1 Interaction with COX – a new complex IV subunit? 
Chemical crosslinking together with mass spectrometric analysis revealed Min8 as a so far 
uncharacterized interactor of cytochrome c oxidase (Linden et al., 2020). Vukotic et al. (2012) 
could identify the small single-pass membrane protein in mass spectrometry data when isolating 
supercomplexes. Yet, the assignment to complex IV was not addressed. The identified 
interaction with Cox12 indicates that Min8 is assembled at a late stage of complex IV or 
supercomplex maturation at the periphery of the complex. The proposed localization of Min8 
(Linden et al., 2020) furthermore corresponds with the structure of supercomplex resolved by 
cryo-EM with Rcf2 being present (Figure 4-1A and B) (Hartley et al., 2020). 
We first considered a similarity to the Rcf-protein family but our experiments implied that this 
is not the case (section 3.3.1). We could prove that Min8 is not essential for respiration and 
complex IV activity. Our radioactive import experiments however, showed that Cox13 and 
Cox12 assembly was specifically influenced by MIN8 deletion (section 3.3.2). While Cox13 
assembly was more efficient, Cox12 assembly appeared to be compromised. This suggests a 
specific, although non-essential, role for Min8 in complex IV biogenesis. Interestingly, we found 
that the topology of Min8 (Linden et al., 2020) resembles the recently identified single spanning 
IMM protein Cox26. While proven as a structural subunit of complex IV (Hartley et al., 2019), 
its absence only mildly affects respiration or catalytic function of cytochrome c oxidase. At the 
same time, biogenesis of complex IV is compromised but supercomplex assembly is not 
disrupted (Levchenko et al., 2016; Strecker et al., 2016). Consequently, Min8 might represent a 
structural subunit of complex IV supporting complex stability, similar to Cox26. 
Investigations of the human complex IV associated protein NDUFA4/COXFA4 furthermore 
revealed a partial homology between the transmembrane span of Min8 and NDUFA4 (Balsa et 
al., 2012). Even more intriguing in this context is the discovery of NDUFA4 within the cryo-EM 
structure of complex IV, identifying the protein as a structural subunit of cytochrome c oxidase 
(Zong et al., 2018). Moreover, the interacting site of NDUFA4, resolved in this structure, 
resembles notably the suggested association of Min8 with yeast cytochrome c oxidase (Figure 
4-1B and C) (Zong et al., 2018; Linden et al., 2020). In light of these findings, we propose Min8 
as a structural subunit of cytochrome c oxidase. To evaluate this hypothesis, future biochemical 
experiments are necessary. 
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Figure 4-1: Comparing resolved and modeled structures of yeast Rcf2, Min8 and human NDUFA4.  
A) Resolved structure of yeast cytochrome c oxidase with Rcf2 (red) extracted from PDB file 6T15 (Hartley et al., 2020). 
B) Resolved structure of yeast cytochrome c oxidase extracted from PDB file 6HU9 (Hartley et al., 2019) with modeled structure 
of Min8 (dark blue) from Linden et al. (2020). C) Resolved structure of human cytochrome c oxidase with NDUFA4 (cyan), 
(PDB file 5Z62; Zong et al., 2018). Editing was performed with the Pymol Software. 
 
4.1.2 Role in Cox12 assembly 
Given the background of the influence of Min8 on cytochrome c oxidase biogenesis, we 
discovered a puzzling Cox12 assembly stage, resolved under DDM conditions (3.3.2). It is 
migrating faster than mature cytochrome c oxidase and still detectable in cox4∆ mitochondria. 
Cox4 represents a structural subunit of complex IV and its deletion causes the absence of 
mature cytochrome c oxidase (Mick et al., 2007; Vukotic et al., 2012; Su et al. 2014).  
Considering Cox12 as a late-stage assembling protein (Mick, Fox and Rehling, 2011), it was 
surprising that a Cox12 containing complex is still detectable even when Cox4 is absent (section 
3.3.2). It appears that Cox12 assembles first into an intermediate complex, which occurs earlier 
than Cox4 assembly. However, it is completely unexpected that Cox12 is not detectable in 
mature complex IV, in wild-type and min8∆ mitochondria. This indicates that Cox12 as an IMS 
protein dissociates easily from the complex and cannot be observed at mature cytochrome c 
oxidase under DDM solubilizing conditions. A sensitivity towards DDM had been determined 
in investigations of the mammalian homologue COX6B as well (Weishaupt and Kadenbach, 
A B C 
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1992; Lazarou et al., 2009). Lazarou et al. (2009) even conducted similar import studies but with 
mitochondria from human fibroblasts. They obtained a clearly weaker radioactive signal in 
DDM compared to digitonin solubilized mitochondria after import. Despite this correlation, 
they found Cox12 also assembled at mature complex IV and an intermediate state was not 
detected (Lazarou et al., 2009).  
 
Still, the question remained: which proteins are comprised in this newly observed intermediate 
state? One could imagine that this complex represents an intermediate import state of Cox12. 
Cox12 as an IMS protein harbors a specific cysteine motif and is imported via Mia40 (Chacinska 
et al., 2004; Vögtle et al., 2012). Comparing with studies of the MIA pathway with import of 
other Mia40 substrates (Chacinska et al., 2004), the observed MIA complex resembles 
remarkably our detected complex. Moreover, Cox12 is assumed to play a role in copper transfer 
to Cox2. Although this is not completely resolved, it is suggested that Cox12 acts together with 
the copper chaperones Coa6 and Sco1 on CuA integration into Cox2 (Ghosh et al., 2016). 
Furthermore, it is proposed that the COX2 module can assemble independently from COX3 
and COX1 modules (Franco et al., 2018). Thus, the complex we detect could be a COX2 module 
maturating state. And the accumulation of radiolabeled Cox12 complex in cox4∆ could be 
justified in this model. Both discussed scenarios involve the cysteine motif which leads to a 
more stable interaction of Cox12 than in assembled cytochrome c oxidase. This in turn could 
explain the nature of our detection and that Cox12 cannot be displayed at mature complex IV.  
 
In the end, Min8 shows a specific influence in Cox12 assembly, independent of the composition 
of the obtained complex. Yet, it would be interesting which proteins are part of this complex. 
This could be addressed by an adjustment of Cox12 import studies: an antibody shift assay after 
radiolabeled import could give information about an involvement of Mia40, the copper 
chaperones and Cox2 for example. To this end, the import sample would be incubated with 
specific sera against the proposed interacting proteins. When the addressed protein is present 
in this association, the detected complex would be shifted considerably. In our attempts, 
however, this displayed a special challenge because the radioactive signal is weak and hard to 
detect against the background (data not shown). Thus, different optimization steps would be 
required to improve import efficiency. Additionally, COA6 mutant mitochondria could be 
utilized for testing the copper chaperone theory – whereas an import intermediate with Mia40 
would remain unaffected.  
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Nevertheless, this sort of search for potential Cox12 interactors in this complex is biased and 
only suspected proteins would be part of it. It would be advantageous to work with a screening 
approach with mass spectrometry analysis. The challenge in this case, would be the enrichment 
of that specific complex. This could be accomplished by tagging Cox12 and native 
co-immunoprecipitation followed by BN-analysis and complexome investigations. However, 
special mindfulness is required in regard of in vivo behavior of a tagged Cox12 version. This can 
be examined by phenotype rescue studies, since cox12∆ is characterized by impaired growth on 
non-fermentable media (LaMarche et al., 1992). 
 
4.2 Fusion proteins as a tool to study Rcf-functions 
The Rcf protein family is interconnected through their homologous domains and their 
interaction network regarding the respiratory supercomplexes. A reported processing event 
splits Rcf2 and results in two fragments resembling even more Rcf1 and Rcf3 (Römpler et al., 
2016). Consequently, we were curious if we could mimic functions by fusing and swapping the 
respective domains. By this, we intended to get insight into the distinct functional domains. 
Surprisingly, all three constructs Rcf3-Rcf1, Rcf2N-Rcf1 and Rcf3-Rcf2C appeared to be 
functional. This was assessed by different growth drop tests, since rcf1∆ and rcf2∆rcf3∆ display 
a severe phenotype regarding proper respiration on non-fermentable media (sections 3.1.2, 
3.4.2). Thus, these strains represent a useful tool as a transformation background for such 
functionality tests. It was even more surprising considering that other approaches of tagging the 
proteins often interfered with proper protein functioning (data not shown). Even the impaired 
supercomplex formation and Cox13 assembly in rcf1∆ mitochondria could be complemented 
by expression of the Rcf1 containing constructs (sections 3.4.4, 3.4.5). In the case for 
Rcf3-Rcf2C it is difficult to ascribe the functionality to either one of the parts or the overall 
protein. On the one side, Rcf2C alone is not functional (section 3.4.6) and the fusion construct 
is co-localizing specifically at supercomplexes (section 3.4.2). This differs from endogenous 
Rcf3. On the other side, we cannot distinguish if the protein forms two sub-populations. One, 
acting as Rcf3 and the other acting as Rcf2. In the end, this sets the limit to our investigations: 
The fusion proteins could act as one single protein or as two proteins at different subsets of 
complexes which we cannot resolve by this approach. 
Overall, it was intriguing that the fusion proteins were all functional regarding the respiration. 
Although we could not directly conclude a specificity for the particular domains we could prove 




4.3 Rcf-proteins – genuine respiratory supercomplex factors? 
The Rcf-proteins were first characterized as supercomplex assembly factors – all three proteins 
are able to interact with complex III and complex IV independently. This unique feature placed 
them intuitively at the interface of both complexes. Recent findings and our results from this 
study provide another understanding. Rcf3 and Rcf2 can be placed more peripherally at the 
cytochrome c oxidase (section 4.2.2 and Linden et al., 2020) and Rcf1 seems to be involved in 
earlier steps of cytochrome c oxidase assembly (sections 3.1.3, 3.4.8 and Strogolova et al., 2012, 
2019; Garlich et al., 2017; Dawitz et al., 2020).  
 
4.3.1 Rcf1 – Dual role in supercomplex assembly 
Rcf1 was shown to interact post-translationally with Cox3 as it could be co-purified 
subsequently to translation assays performed in isolated mitochondria (Strogolova et al., 2012; 
Su et al., 2014; Garlich et al., 2017). Consequently, the rearrangement of the respiratory chain 
supercomplexes was ascribed to rather be a cytochrome c oxidase assembly defect than a 
supercomplex assembly defect itself. Supercomplex assembly is not completely abolished when 
Rcf1 is absent, however, the presence of the protein facilitates the maturation significantly 
(section 3.1.2, and Chen et al., 2012; Vukotic et al., 2012; Su et al., 2014; Dawitz et al., 2020).  
The early model of the yeast supercomplex envisioned, similarly to mammalian respirasome 
(Althoff et al., 2011; Dudkina et al., 2011), complex IV interacting with complex III via its convex 
side, represented by Cox13 (Heinemeyer et al., 2007). The observed association of Rcf1 with 
Cox13 (Vukotic et al., 2012) furthermore indicated that Rcf1 could act as a proteinaceous link 
between the complexes. It was shown that Rcf1 plays a role in Cox13 assembly and facilitating 
Rcf2 assembly (Vukotic et al., 2012). These steps take place in late stage of 
complex IV/supercomplex assembly. In parallel, Rcf1 still resides at the supercomplexes 
(Vukotic et al., 2012), which we could also confirm in this work (3.4.2, 3.5.1). 
The later obtained cryo-structure of yeast supercomplex of Mileykovskaya et al. (2012) however, 
provided strong evidence that complex IV orientation differs from mammalian complex IV in 
the respirasome and complex IV interacts with the opposite side via Cox5a/b with complex III. 
Consequently, the first anticipated interaction at the interface was discarded. Nevertheless, 
several studies pointed towards an influence of Rcf1 on catalytic activity of the cytochrome c 
oxidase by mediating effective cytochrome c binding and slowing down oxygen reduction when 
deleted (Rydström Lundin et al., 2016; Rydström Lundin and Brzezinski, 2017; Schäfer et al., 
2018). This implied an interaction near the cytochrome c binding center (Cox2), again allowing 
to consider Rcf1 localizing at the now proven interface of complex IV and complex III.  
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Due to the evidence for Cox3 and Cox13 interaction, recent publications pictured Rcf1 possibly 
interacting (similarly to Rcf2, see section 4.2.2) at the periphery of complex IV, opposing the 
associating side towards complex III (Strogolova et al., 2019; Dawitz et al., 2020). The interaction 
of Rcf1 with Cox3 is suggested as promoting complex IV integrity by supporting phospholipid 
integration into Cox3 (Garlich et al., 2017; Hoang et al., 2019; Strogolova et al., 2019). 
Consequently, the above-mentioned influence on the active site of Cox1 could be mediated 
indirectly through a different phospholipid environment of Cox3. It was reported that mutating 
the lipid binding sites of Cox3 in Rhodobacter sphaeroides has a similar effect as if Cox3 was 
completely absent. The integrated phospholipids influence the stable interaction with Cox1 and 
protect its active site (Svensson-Ek et al., 2002; Varanasi et al., 2006). 
 
This study’s analysis of the fusion proteins shows a specific association of Rcf1 with newly 
synthesized Cox3 but also Cox2 (section 3.4.8). This speaks not only for an involvement in 
COX3 modular assembly but also in COX maturation. And by this, arguing for the mentioned 
indirect influence on complex IV activity. Rcf2N-Rcf1 and Rcf3-Rcf1 promoted that interaction 
and simultaneously facilitated supercomplex and Cox13 assembly, yet to a different extent. 
Rcf2N-Rcf1 enhanced the interaction of Rcf1 with Cox3 the most (section 3.4.8), but 
supercomplex- and Cox13 co-localization was less pronounced than with the other fusion 
proteins (sections 3.4.3 and 3.4.4). This allows the assumption that a tight interaction of Rcf1 
with Cox3 does not necessarily generate a favorable basis for supercomplex or Cox13 assembly. 
This could indicate an involvement of Rcf1 on two different stages with a tight regulation of its 
presence, first COX assembly and second, supercomplex assembly (Figure 4-2). Similar results 
are shown in recent studies about the human homolog HIGD2A. There, it was reported that 
HIGD2A plays first a role in early Cox3 biogenesis, integration of COX3 module in cytochrome 
c oxidase and assembly of complex IV into the supercomplex (Hock et al., 2020; Timón-Gómez, 
Garlich, et al., 2020b).  
Interestingly, the small protein Coi1 was identified similarly being involved in two so far distinct 
stages: supercomplex assembly but also Cox1 biogenesis (Singhal et al., 2017). Although a drop 
of supercomplex assembly in the COI1 deletion mutant could be ascribed to the altered heme 
integration within Cox1, the study provided strong evidence that Coi1 is additionally involved 
at the level of supercomplexes (Singhal et al., 2017). They found not only complex III 
components as part of the Coi1-complex isolation but also the Rcf-proteins, indicating that the 
proteins act on the same stage (Singhal et al., 2017). 
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These observed interactions of Rcf1 but also Coi1 on two stages could be accomplished in a 
model where complex IV assembly occurs simultaneously to supercomplex assembly (Figure 
4-2). This is supported by different experienced and published observations: When radiolabeled 
Cox13 is imported into energized mitochondria, it appears to almost directly assemble into the 
respiratory supercomplexes (Brandner et al., 2005; Mick et al., 2007; Vukotic et al., 2012). And in 
fact, recent investigations promote a cooperative complex IV maturation at the site of 
complex III. Protasoni et al. (2020) revealed an essential role of complex III2 as a structural unit 
for complex IV maturation in the mammalian system.  
 
The different modules COX1, COX2 and COX3 were found to assemble partly separate from 
each other, but also in interaction (for a more detailed description see section 1.4.3.). In the 
imagined model, the COX1 module would represent the initiator of complex IV but also 
supercomplex assembly, being the first module to interact with complex III2. It was suggested 
that Cox1 is undergoing less frequent turnover since fewer amounts of newly synthesized Cox1 
was found to be present within mature complex IV, compared to Cox2 and Cox3 (McStay, Su 
and Tzagoloff, 2013). This could be reasoned on the one hand that Cox1 maturation takes 
additional intermediate states for heme and copper integration and consequently a longer period 
of time. Or it means Cox1 survives complex IV degradation and waits for newly synthesized 
Cox2 and Cox3 and structural subunits to be assembled again (McStay, Su and Tzagoloff, 2013). 
Our labeling experiments in isolated mitochondria with subsequent isolation of Rcf1-complexes 
displayed exactly this behavior. Although labeled Cox2 and Cox3 could be co-purified together 
with Rcf1, labeled Cox1 was barely detectable in the bound fraction. Yet, western blot analysis 
determined that Cox1 was present, speaking for maturated complex IV but with exclusively 
Cox2 and Cox3 being newly translated (section 3.4.8).  
Our model envisions furthermore that COX2 module could either directly interact with COX1 
or with COX3 already assembled with COX1. Patient fibroblasts with Cox3 deficiency displayed 
an association of COX2 and COX1 (Tiranti et al., 2000) while yeast cox2 mutants showed 
another intermediate: COX3 associating with COX1 in a COX2 independent manner (Horan 
et al., 2005). This is the probable first association of Rcf1 according to our above-mentioned 
findings (Figure 4-2, path a). The stabilization of associated COX1 at complex III2 occurs 
through interacting Rcf1 at COX3 by adequate lipid integration. Therefore, we postulate Rcf1 
still as a supercomplex assembly factor.  
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Figure 4-2: Model of Rcf-protein involvement with complex IV and supercomplex assembly.  
COX1 module with Cox5a/b, Cox6, Cox8 and probably Cox4 are interacting directly with complex III2. COX2 either directly 
interacts with COX1, or enters the assembly pathway after COX3 with Rcf1 as an assembly factor (a). COX3 incorporates 
Cox7 and in some cases also Cox4. Rcf1 remains at maturating complex IV or dissociates. As facilitating Cox13 and Cox12 
assembly, Rcf1 is recruited again (b) for late stage assembly of complex IV. It is not resolved at which stage Cox26 and Cox9 
enter complex IV biogenesis. Rcf1 dissociates from fully assembled complex III2IV2 but can be recruited under certain 
conditions, i.e. complex IV activity modulation. Rcf2 is recruited to the supercomplex after Rcf1, Cox13 and supposedly Cox12 
assembly (c). Rcf2 and/or Rcf3 alternate with Rcf1 for complex IV regulation. Rcf2 interacts with complex III2 under certain 
conditions (d), possibly facilitating complex IV assembly and dissociates during further complex IV/supercomplex assembly. 
The other scenario is, that Rcf2 associates with complex III2 upon disassembly of the supercomplex (e) and demonstrates sort 
of a recycling mechanism for re-assembly of complex III2 with complex IV. The sequence of events is not resolved and the 
model does not claim completeness. 
Upon finalized supercomplex assembly, it seems that Rcf1 is not present in all supercomplex 
populations and interacts with the complex depending on its needs such as complex IV activity 
upregulation. Certainly, Rcf1 is again present at the site of assembled complex IV for efficient 
Cox13 assembly (Figure 4-2, path b). In the end, the stages where Rcf1 is active are not explicit 
and rather indistinct, supporting the high dynamics of the respiratory complexes.  
To deliver more evidence for this model, however, additional analyses are required. One could 
be the already mentioned approach with isolating from different stages of assembled 
supercomplex/cytochrome c oxidase (see section 4.2.1). In addition, import experiments with 
radioactively labeled Rcf1 combined with different chase timepoints could give more 
information about the fate and intermediate states of the protein during complex IV and 
supercomplex biogenesis.  
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4.3.2 Rcf2 – regulation and assembly factor 
Together with previous studies our investigations localize Rcf2 specifically at the periphery of 
complex IV (see also section 4.2.2). Rcf1 facilitates Cox13 assembly and Rcf2 assembly. Cox13 
in turn, influences Rcf2 assembly (Vukotic et al., 2012). Consequently, the sequence of assembly 
is imagined as Rcf1, Cox13 and then Rcf2 (Figure 4-2, path c).  
Our translation assay with following Rcf2 co-immunoprecipitation displayed an interaction with 
de novo translated Cox3 and Cox2 (section 3.1.3) indicating an earlier timepoint in cytochrome c 
oxidase association than anticipated. Again, this could support the theory of concurrent 
complex IV and supercomplex assembly, as mentioned above (4.3.1).  
 
Precedent investigations displayed Rcf2 as a regulatory factor for complex IV activity. When 
Rcf2 is not present, complex IV activity and respiration are upregulated, while double mutation 
with Rcf3 lead to a specific drop of complex IV activity (Römpler et al., 2016). And by this, 
representing a counterpart to Rcf1. Since both proteins are supposed to interact at the same site 
at Cox3, one could imagine that the proteins’ association alternates depending on the required 
conditions (Figure 4-2). In addition, a recent study of Hoang and colleagues (2019) indicated a 
role for Rcf2 to prevent a proton back leak through complex IV. This is accompanied with a 
decreased membrane potential when RCF2 is deleted (Hoang et al., 2019; Strogolova et al., 2019). 
On the contrary, other studies did not experience a drastic change in membrane potential: 
Import studies of Cox13 – which is strictly membrane potential dependent – by Vukotic et al. 
(2012) did not represent a decrease in membrane potential, as well. However, these data rather 
supported the idea of Rcf2 as a regulatory factor of complex IV and the respiratory 
supercomplex. 
 
Remarkably, we could identify Rcf2 specifically interacting with complex III2 in a cox5a∆ 
situation (section 3.5.1). In light of the introduced model in section 4.3.1, this might indicate a 
specific role of Rcf2 in assembly of cytochrome c oxidase adjoined to complex III2. Deleting 
COX5A creates a special environment: on the one side disturbing COX1 modular assembly by 
deleting or decreasing an early associated protein. And on the other side generating 
cytochrome c oxidase exclusively with the other, hypoxic isoform – Cox5b which is expressed 
in a lesser extent under normoxic conditions (section 3.5.1). Supercomplex assembly is 
compromised due to the low amounts of cytochrome c oxidase, however, complex III2IV is 
built by incorporating Cox5b. This supercomplex basically represents the hypoxic arrangement, 
although the culture is grown under normal oxygen supply. Consequently, association of Rcf2 
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at III2 additionally to III2IV can be caused by three different reasons: One, the protein is 
recruited to the complex specifically under hypoxic conditions (see also section 4.4.2). Two, the 
situation we detect is visible because of an arrest of complex IV maturation due to delayed 
assembly (Figure 4-2, path d). And three, our results represent a degradation process with Rcf2 
still present or recruited to the dimer after complex IV dissociates from the supercomplex 
(Figure 4-2 path e). This could represent a sort of a recycling mechanism and reassembly of the 
supercomplex. Although Rcf2 is proven to not being essential for supercomplex assembly 
(Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 2012), this observation represents an 
exclusive and unique feature, in either of the pictured scenarios.  
 
However, it is hard to imagine that Rcf2 is acting on complex III and complex IV on opposing 
sites at the same time. It rather speaks for different detected endpoints, the flexible nature of 
Rcf2 and the dynamics of supercomplex assembly. Since it is prone to interact with complex IV 
(Vukotic et al., 2012; Römpler et al., 2016), our data indicate that Rcf2 is involved in complex IV 
assembly at the site of complex III.  
 
4.3.2.1 Role of transmembrane spans 
It was intriguing that the N-terminal part of Rcf2 (aa1-83) fused to Rcf1 possesses enough 
function to rescue the double mutant’s phenotype (3.4.2). The HIG1 domain stretches from 
aa89 to 180 and, in the case of Rcf2N-Rcf1, is only present in Rcf1. At the same time, the 
fragment itself is not capable of functioning (section 3.4.6) and it appears that the overall Rcf2-
like topology supports proper assignment. It could also indicate that the HIG1 domain or the 
rather polar residues (described in section 4.1) are crucial for guiding the protein to the required 
localization and the protein fulfills the function through its topological characteristics. Still, this 
might not be at the level of supercomplexes since we could not detect Rcf2N-Rcf1 as strongly 
associated there (sections 3.4.2, 3.5.2.). Another reason for functionality of Rcf2N-Rcf1 or 
Rcf3-Rcf2C in contrast to the single Rcf2 fragments could be that the dedicated import pathway 
might be impaired and the fragments are not folded properly into the IMM. Rcf-proteins do 
not harbor a presequence and it is not completely resolved, which import route the Rcf-proteins 
take. Rcf2 was found to be depleted upon OXA1 COX18 double deletion (Stiller et al., 2016). 
This argues for Rcf2 undergoing the conservative sorting pathway comprising concerted action 
of TIM23 and Oxa1 (see also section 1.3.2) (Römpler, 2016; dissertation). Oxa1 dependent 
export might rely on the presence of specific transmembrane spans which would be disrupted 




Although we could determine the functionality of Rcf2N-Rcf1 as Rcf2-like in terms of 
respiration capacity, we found the strains expressing Rcf2N-Rcf1 experienced elevated ROS 
levels (section 3.4.7). This points towards enhanced stressing conditions, yet with unclear 
reason. When the internal processing event fulfills the function of regulating the presence of 
Rcf2N, it might be disturbed when Rcf1 is fused to the fragment and leads to interference with 
endogenous Rcf2 action. Since Rcf2N stretches until aa83 in our construct, the processing site 
is likely to be still present; it was proposed to occur at ~aa63 (Römpler et al., 2016). In fact, 
different experiments also led to the detection of processed versions of the fusion protein, still 
detectable with the antibody against Rcf1 (data not shown). Although it would be interesting to 
follow the idea of affected processing, it is difficult to directly compare endogenous Rcf2 
processing with Rcf2N-Rcf1 since both products would be detected with different antibodies. 
Assuming that Rcf2N-Rcf1 is processed at least partially at the endogenous Rcf2 processing site, 
this could indicate the importance of overall similar topology for proper processing of Rcf2N. 
This would not be ensured when the C-terminus is lacking, representing another explanation 
for the different capability of the fragment alone (section 3.4.6). 
 
Overall, our results of analyzing Rcf2N-Rcf1 speak for a distinct function of Rcf2N in addition 
to Rcf2C. It was reported previously that assembly of Rcf2 is directed via the C-terminus. A 
truncated N-terminus even facilitated assembly into respiratory supercomplexes, leading to the 
assumption that Rcf2N is rather negligible (Römpler et al., 2016). Our understanding of Rcf2N in 
light of the fusion proteins however, disproves this hypothesis.  
We were furthermore eager whether the fusion constructs expressed in the COX5A mutant 
could resolve if certain domains favor the complex III2 association. But none of the constructs 
showed a co-migration with complex III2 in our 2nd dimension analysis (section 3.5.2). Although 
this does not allow an attribution to any of the Rcf2 halves, it speaks for a unique role of Rcf2 
in this context which was not represented by just fusing its transmembrane spans to Rcf1 or 
Rcf3. 
 
4.3.2.2 Role of internal processing event 
The idea that specific transmembrane spans are responsible for the interaction of Rcf2 with 
complex III2 in cox5a∆, implied at the same time that the processing event itself might be 
essential. We investigated both fragments by adding a FLAG tag N-terminally to Rcf2 as 
introduced before by Römpler et al. (2016). It could be exposed that Rcf2C and FLAGRcf2N, also 
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reside at complex III2IV and III2 (section 3.5.3). That both fragments are present at the same 
complexes indicates that they descend from prior bound full-length Rcf2 upon processing. 
When investigated under wild-type conditions, FLAGRcf2N could not be detected at the 
supercomplexes (Römpler et al., 2016), indicating a labile nature of the fragment and a tight 
regulation. This seem to be a different situation in our experiments in the cox5a∆ background 
and places again special emphasis on the internal processing event of Rcf2.  
 
Interestingly, both fragments co-migrate in a similar ratio at III2IV and III2 as full-length Rcf2 
(section 3.5.3). Unfortunately, this does not provide evidence for a sequence of events. One 
scenario is that processing occurs during or pre supercomplex assembly and facilitates complex 
IV assembly in an upstream motion (Figure 4-3A). However, only a fraction of Rcf2 is 
processed. It is likely that Rcf2 dissociates from the complex upon supercomplex assembly and 
is recruited when required, as described above (section 4.3.2). The second scenario would be 
that the detected co-migration represents degrading steps and Rcf2 is processed at the 
supercomplex (Figure 4-3B). The majority of full-length Rcf2 and both fragments is detectable 
at complex III2IV proposing the processing occurs at this stage. In parallel, it remains 
inconclusive why both fragments and full-length Rcf2 still co-localize at complex III2.  
 
To resolve the sequence of events, one approach could be, observing the interaction of Rcf2 
when complex IV maturation is abolished additionally. This could be accomplished by deleting 
the structural unit Cox4 which assembles later than Cox5a/Cox5b (Mick et al., 2007). Thus, 
Cox5b assembly still occurs but a possible downstream pathway from complex III2IV could be 
excluded. However, it would be essential to increase Cox5b expression similarly to Cox5a under 
normoxic conditions as described in section 4.4.2, otherwise the cell growth is likely to be 




Figure 4-3: Rcf2 processing – model of possible scenarios.  
A) Rcf2 processing occurs during or pre- supercomplex assembly at complex III2. Two populations of Rcf2 exist due to partial 
processing. The dashed lines indicate a fast degradation and lability of Rcf2N. After complete supercomplex assembly, Rcf2 is 
recruited under certain conditions i.e. complex IV activity modulation B) Rcf2 is processed at the supercomplex during a 
degradation mechanism of the supercomplex. The dashed lines indicate a fast degradation and instability of Rcf2N. Rcf2 is still 
found to interact with complex III2. The model only represents complex III2IV for convenience, the processing is envisioned 
to occur the same with a second complex IV monomer. 
Overall, the purpose and triggering conditions of Rcf2 processing are elusive. Especially, since 
the majority of Rcf2 remains intact. In addition, the interaction site of Rcf2 at complex III2 
needs further investigation. To address this question, the biggest challenge would be to dissect 
complex III2 from III2IV but under in vivo conditions. DDM as a detergent is a feasible choice 
to dissociate complex III2 from complex IV. However, it often failed to solubilize the complexes 
together with transient interactors such as the Rcf-proteins (Vukotic et al., 2012; Römpler et al., 
2016). Consequently, other detergent conditions should be tested in this regard. 
 
In the end, it was not the aim of this study to define the processing site, but it appears as a 
crucial point in investigating the role of Rcf2 in the future. The fusion construct could be a 
useful tool in this regard. With different truncations of Rcf2N from both sites – still fused to 
Rcf1, it would be interesting to test if a lack of functionality comes together with truncating the 
putative processing site. 
A 
B 
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4.3.3 Rcf3 – regulation of supercomplex capacity 
Rcf3 as the smallest protein is also the least characterized of the Rcf-protein family. Römpler et 
al. (2016) identified it as a regulatory factor of complex IV. However, only the double deletion 
together with RCF2 demonstrates the substantial relevance for respiration. Complex IV activity 
is then strongly affected and lead to the inability of proper OXPHOS function without causing 
an obvious rearrangement of the respiratory chain (section 3.1.2 and Römpler et al., 2016). Our 
investigations of Rcf3 within the fusion proteins support this understanding but fine-tune it at 
the same time (section 3.4.7). The fusion proteins harboring Rcf3 were able to overcome the 
crucial respiratory defect of rcf2∆rcf3∆ (section 3.4.2). In parallel, they hampered the respiration 
capacity significantly, independent from the presence of endogenous Rcf3 (section 3.4.7). Yet, 
this effect is not measurable via isolated complex IV activity. The constructs appeared to rather 
influence respiration on level of the supercomplexes together with electron transfer via 
complex III, addressed by the other states: LEAK, state 3 and OXPHOS. However, 
endogenous Rcf3 functions seem to be disturbed considering the detected effect regarding 
oxygen consumption of Rcf3-Rcf1 and Rcf3-Rcf2C in rcf2∆rcf3∆ mitochondria. Since the 
expression of fusion proteins is not accompanied by rearrangement of the respiratory chain 
complexes (sections 3.4.2, 3.4.3), the effect does not speak for a substantial structural function 
of Rcf3. It suggests a regulatory role especially pronounced when Rcf3 is associated with the 
respiratory supercomplexes. Our results also indicate that presence of Rcf3 at the site of 
III2IV(1-2) is strongly regulated. The fusion to the transmembrane domains of Rcf2C or Rcf1 
appear to interfere with this process and Rcf3 remains tethered to the complexes. 2nd dimension 
analysis of mitochondria from wild-type cells expressing the fusion proteins confirms this 
impression (section 3.4.2). The constructs harboring Rcf3 show an increased localization to the 
supercomplexes compared to endogenous Rcf3.  
 
We propose that Rcf3 is recruited directly to the supercomplex as a modulating factor for 
respiration and dissociates upon strict regulation with a so far unknown mechanism (Figure 4-2, 
section 4.3.1). At the same time, it appears that Rcf3 already interacts with newly translated 
Cox3 and Cox2 (section 3.1.3). This fact repeatedly supports a model in which supercomplex 
assembly and cytochrome c oxidase maturation are adaptable mechanisms occurring in parallel 
rather than separately. 
DISCUSSION 
 107 
4.4 Role of Rcf-proteins under stressing conditions 
4.4.1 Involvement in oxidative stress 
Several studies connected a putative Rcf-protein function to oxidative stress by protecting from 
ROS production (Chen et al., 2012; Vukotic et al., 2012; Römpler et al., 2016). Rcf1 and Rcf2 
were first characterized to influence ROS production specifically. Vukotic et al. (2012) argued, 
that complex IV*, which harbors Cox13 and likely Rcf1 and Rcf2, prevents from mitochondrial 
ROS production while the respective mutants rcf1∆, rcf2∆, cox13∆ display high ROS levels. Rcf1∆ 
showed the most pronounced phenotype in this regard. This suggested a specific role for Rcf1 
in contrast to Rcf2 or Cox13, and could be explained as a result of the rearrangement of 
respiratory supercomplexes (Vukotic et al., 2012). In recent investigations of supercomplexes 
and their function, however, they found that ROS production was not significantly higher when 
supercomplex assembly itself is disturbed (Berndtsson et al., 2020), arguing even more for a 
specific function of Rcf1. Additionally, cells lacking Rcf1 developed an increased sensibility 
against H2O2 supporting the idea of an essential protein during oxidative stress (Chen et al., 
2012). Since Rcf2 and Rcf3 were assigned to cover overlapping functions (Römpler et al., 2016), 
Rcf3 should be included in this consideration.  
 
Our measurements of mitochondrial ROS production not only confirmed previous findings of 
the RCF1 mutant but also provided new results regarding the RCF2RCF3 double mutant. 
Isolated mitochondria from rcf2∆rcf3∆ cells displayed elevated ROS levels, although not as high 
as from rcf1∆ (3.4.7). We did not determine the ROS level of rcf2∆ in these experiments, thus 
we cannot conclude an effect of additional deletion of RCF3. However, our results in 
section 3.4.7 imply that the increased ROS production is a secondary effect caused by the 
respective deletions. Although the fusion constructs fail to lower the ROS level of rcf2∆rcf3∆ 
and Rcf2N-Rcf1 induces it even more, the characteristic growth-phenotype of the double mutant 
is complemented. Thus, the growth-phenotype is presumably not caused by a sensitivity towards 
the high ROS level. Another phenotype, which is displayed by rcf2∆rcf3∆ is the decreased 
complex IV activity (section 3.4.7 and Römpler et al., 2016). The fusion constructs were all able 
to rescue the lowered complex IV activity. Consequently, the growth-phenotype can be ascribed 
to the effect on complex IV activity.  
Interestingly, the fusion protein Rcf2N-Rcf1 expressed in rcf2∆rcf3∆ results in an OXPHOS 
capacity which exceeds the wild-type capacity over 50 %. As mentioned, this strain caused one 
of the highest ROS levels measured in our studies of the fusion constructs (section 3.4.7). It 
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appears intuitive that high respiration might lead to higher ROS levels, yet rcf1∆ causes both: 
low respiration and high ROS levels (Chen et al., 2012; Vukotic et al., 2012).  
 
In the end, our results indicate a unique involvement of the Rcf-protein family not only by 
preventing from uncontrolled ROS production but also protecting from high ROS levels. Thus, 
the Rcf-proteins appear to play an important role in oxidative stress mediated by the respiratory 
chain. 
4.4.2 Influence in adaptation to hypoxia 
Rcf1 and Rcf2 comprise a conserved HIG1 domain. First, they were identified among genes, 
expressed under hypoxia, which was extended to proteins with the significant motif 
(Q/I)X3(R/H)XRX3Q (or QRRQ). The HIG1 domain, in general, can be clustered into two 
subgroups: HIG1 type 1 and HIG1 type 2 isoforms. While HIG1 type 1 isoforms are only 
present in higher eukaryotes, HIG1 type 2 isoforms are established in all eukaryotes and 
a-prokaryotes. The latter subgroup includes yeast Rcf1, Rcf2 and mammalian HIGD2A, 
whereas HIGD1A is classed amongst HIG1 type 2 isoforms (Bedo et al., 2004; Wang et al., 2006; 
Garlich et al., 2017). Rcf1 and Rcf2 are constitutively expressed, as demonstrated by all our 
experiments. While it was shown that Rcf1 and Rcf2 are even more required under low oxygen 
concentrations, a specific upregulation of Rcf1 and Rcf2, mediated by hypoxia, was not reported 
(Vukotic et al., 2012; Garlich et al., 2017; Strogolova et al., 2019).  
Of the two mammalian homologs, HIGD2A is considered to be a true homolog of Rcf1. In 
complementation assays, HIGD2A was able to rescue Rcf1 mediated yeast phenotype, whereas 
HIGD1A was not (Vukotic et al., 2012). Studies of HIGD1A and HIGD2A showed that they 
display a basal expression under normoxia which is significantly induced during early states of 
hypoxia (Timón-Gómez, Garlich, et al., 2020b). However, another recent study found only 
HIGD1A expression adapted to hypoxia while HIGD2A remains stably expressed (Hock et al., 
2020). In rat cardiomyocytes, Higd1a was reported as an important modulator of complex IV 
activity, by inducing structural changes in the heme a active center of cytochrome c oxidase. At 
the same time, Higd1a prevented hypoxic mediated cell death by advancing ATP production 
(Hayashi et al., 2015). 
Given these presented functions of the mammalian homologues, we can also imagine a similar 
role for yeast Rcf-proteins during adaptation to hypoxia. Rcf proteins can modulate complex IV 
and supercomplex assembly and capacity, not only in a structural way (see sections above). 





It is still obscure, how the respiratory chain copes with the switch between the isoforms 
represented either under normoxia or hypoxia. Especially relevant for the respiratory chain are 
the isoforms Cyc1/Cyc7 and Cox5a/Cox5b in this context (Hodge et al., 1989; Zitomer, Carrico 
and Deckert, 1997; Dodia et al., 2014). While both cytochrome c isoforms (Cyc1/Cyc7) are 
soluble in the IMS and associate with complex III and complex IV for electron transfer, 
Cox5a/Cox5b are integral membrane proteins associated at the interface of complex III and 
complex IV. The interaction of Cox5a/Cox5b with Cor1 links the two complexes and proposed 
as the structural basis for supercomplex formation (Hartley et al., 2019, 2020; Rathore et al., 
2019). Consequently, it is likely that the supercomplex dissociates for an exchange. Either the 
subunit itself is exchanged or mature hypoxic complex IV is incorporated into supercomplexes. 
Our data from evaluating the cox5a∆ situation, together with the cryo-EM structure resolving 
Rcf2 at hypoxic supercomplexes (Hartley et al., 2020), indicate a specific role for Rcf2 during 
hypoxia. We propose a model, where Rcf2 is either recruited to complex III2 or remains 
associated at complex III2 after degradation processes in order to facilitate and stabilize hypoxic 
supercomplex assembly (see also 4.3.2.2).  
 
For further analyses of an involvement of Rcf2 in the hypoxic/normoxic switch of isoforms, it 
would be essential to upregulate the Cox5b level, comparable to the Cox5a level in wild-type. 
This can be either accomplished by working under real hypoxic conditions or by using the 
approach from Hartley et al. (2020). They expressed COX5B under the promotor of COX5A 
in the background of cox5a∆. By this, a hypoxic form of supercomplexes would be generated 
but a putative state of assembly arrest would be omitted.  
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5 Summary and Conclusion 
Oxidative Phosphorylation as the most prominent mitochondrial function, underlies the 
mechanism of efficient electron transport to reduce oxygen to water and the coupled proton 
translocation across the mitochondrial membrane. This is suggested to be one major function 
of the arrangement of stable respiratory supercomplexes. However, the mechanism by which 
the single complexes are organized into this higher order structures is still unclear.  
This study aimed for a better understanding of supercomplex assembly, its stabilization and the 
involvement of the Rcf-proteins. During investigating the interactome of the respiratory chain 
together with Linden et al. (2020), a novel putative subunit of complex IV came into our 
attention: Min8. Basic characterizations revealed that it is not essential for respiration or 
supercomplex formation, however, we obtained an involvement in late-stage complex IV 
assembly. Surprising in this regard was the observation of a supposed complex IV intermediate 
state of Cox12 containing complex which was not experienced before and appears to be 
independent from subsequent complex IV maturation. 
Within the same collaboration (Linden et al. 2020) we could specifically assign interaction sites 
of Rcf2 and Rcf3 with Cox12 and Cox13 and validate the method of chemical crosslinking of 
whole mitochondria together with mass-spectrometry analysis. Cox12 and Cox13 are late-stage 
assembly proteins of complex IV, possibly recruited directly to the supercomplex. This goes in 
line with our observation that the interaction platform of the Rcf-proteins with complex IV are 
predominantly the supercomplexes III2IV(1-2). However, it appeared that the encounter with 
complex IV subunits starts early considering the association with the de novo mitochondrially 
translated subunits Cox3 and Cox2. In light of the “plasticity” model, where it is suggested that 
mature holo-complexes and supercomplexes are undergoing constant dynamic dis-/association, 
our data indicates that this might be taken even a step further. Complex IV maturation could 
not exclusively happen sequestered from supercomplex assembly but in parallel, and we 
envision that Rcf1 plays an important role in the assembly and stabilization of both complex IV 
and the supercomplexes.  
Moreover, our data supports the model of the Rcf-proteins being substoichiometric and 
transient interactors of the supercomplexes and their presence is strictly regulated. Considering 
the shared homologous sequences, artificial fusion proteins with swapped transmembrane 
domains were constructed and their impact on Rcf-function was analyzed in detail. We could 
obtain a very dynamic nature of Rcf-functions and the fusion proteins were able to complement 
the different phenotypes in a highly flexible manner. However, the tight regulation of 
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Rcf-proteins was apparently disturbed and the respective functional domains seemed to be 
tethered to a certain stage, displayed especially by the construct Rcf2N-Rcf1. Although the 
protein was able to restore Rcf2 function, it caused high levels of reactive oxygen species, while 
being retained at complex IV. This speaks not only for distinct roles of Rcf2N and Rcf2C but 
also for a physiological role of Rcf2 processing being compromised under these conditions. 
Rcf3 was proven once more to be a regulator of complex IV, yet, according to our data especially 
on supercomplex level with complex III and complex IV working in tight cooperation. 
Moreover, we could ascertain a specific interaction of Rcf2 with hypoxic supercomplexes by 
utilizing the COX5A deletion strain, whereas Rcf1 and Rcf3, normally present as well, seem to 
dissociate. Rcf2 was determined to interact at complex III2 under the same conditions, which 
we envision as a transition state descending from, or assembling into hypoxic supercomplexes. 
It is tempting to imagine Rcf2 as a player within supercomplex reorganization for the subunit 
exchange due to altering oxygen levels, while intrinsic processing might play a role.  
 
Overall, this work has provided a detailed analysis of Rcf-protein function and put 
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